chemokin
receptor
constitut
express
central
nervou
system
well
character
homeostat
prosurviv
effect
develop
well
human
tcell
lymphotrop
viru
type
htlvi
first
retroviru
associ
human
malign
adult
cell
leukemia
chronic
progress
neurodegen
diseas
htlviassoci
myelopathytrop
spastic
paraperesi
hamtsp
serolog
screen
antibodi
htlviii
implement
blood
bank
reduc
risk
htlvi
transmiss
via
exposur
infect
blood
product
donat
blood
unit
state
screen
enzym
immunoassay
eia
repeatedli
reactiv
specimen
confirm
western
blot
wb
howev
subset
sampl
show
wb
reactiv
without
fulfil
serolog
profil
htlvi
infect
consid
htlviii
seroindetermin
ind
clinic
signific
ind
reactiv
unclear
although
ind
reactiv
wide
report
mani
blood
bank
screen
subset
patient
neurolog
diseas
report
novel
highthroughput
highli
sensit
specif
luciferas
immunoprecipit
system
lip
assay
independ
test
htlvi
specif
antibodi
respons
studi
examin
antibodi
respons
three
htlvi
immunodomin
protein
gag
env
tax
serumplasma
sampl
subject
jamaica
htlviseroneg
donor
ind
lip
assay
abl
detect
antigag
antienv
antitax
antibodi
respons
ind
sampl
also
found
immunoreact
htlvi
gag
lip
correl
reactiv
htlv
wb
addit
show
case
studi
persist
indetermin
htlv
serolog
individu
clear
famili
histori
exposur
htlvi
result
support
hypothesi
htlviii
indetermin
serolog
may
reflect
prior
exposur
htlvi
suggest
viru
may
widespread
previous
thought
inhibit
neuroprotect
matur
neuron
recent
studi
identifi
morphin
neg
regul
neuron
function
effect
reli
increas
level
heavi
chain
subunit
ferritin
fhc
although
fhc
best
known
role
ironsequest
function
ferritin
protein
complex
form
partner
subunit
ferritin
light
chain
flc
fhc
shown
interact
specif
chemokin
receptor
includ
inhibit
endogen
signal
inhibit
alter
neuroprotect
function
axi
like
contribut
neuropatholog
drug
abus
includ
hiv
opiat
user
order
better
character
mechan
involv
fhc
regul
opiat
investig
relationship
ironbind
function
fhc
demonstr
morphineinduc
increas
fhc
flc
vitro
vivo
although
effect
flc
modest
compar
fhc
also
show
increas
neuron
iron
accumul
morphinetr
anim
associ
disrupt
cellular
oxid
balanc
may
promot
neurotox
investig
role
fhc
ironbind
activ
signal
use
fhc
mutant
demonstr
abil
ferroxidasedefici
mutant
wildtyp
fhc
inhibit
signal
specif
physiolog
consequ
alter
fhc
level
suggest
data
show
activ
lead
increas
dendrit
spine
densiti
therefor
futur
ongo
experi
aim
analyz
effect
fhc
dendrit
spine
densiti
togeth
data
suggest
neuropatholog
outcom
increas
fhc
may
disrupt
multipl
cellular
process
may
mediat
neuron
dysfunct
consequ
opiat
abus
involv
antioxid
defens
mainten
metabol
homeostasi
hypothes
express
alter
brain
subject
diagnos
human
immunodefici
viru
hiv
associ
neurocognit
disord
hand
due
neuron
oxid
stress
studi
immunoreact
isocortex
section
subject
compar
agematch
nonhiv
healthi
control
advanc
alzheim
diseas
ad
case
hiv
infect
immunoreact
pattern
shift
neuropil
predomin
n
neuropil
neuronalsoma
codomin
ns
neuronalsoma
predomin
p
chisquar
test
linear
trend
among
hiv
case
show
ns
pattern
hand
case
preferenti
associ
pattern
compar
cognit
intact
case
fisher
exact
test
ad
brain
immunoreact
mostli
intens
neuropil
coloc
phosphotau
immunoreact
subset
neurofibrillari
lesion
phosphotauimmunoreact
neurofibrillari
lesion
rare
hiv
case
occurr
associ
hand
level
isocort
marker
nucleic
acid
oxid
immunoreact
significantli
alter
hand
case
compar
neurocognit
intact
hiv
case
conclus
immunoreact
redistribut
neuron
soma
hand
suggest
uniqu
involv
pathophysiolog
hand
differ
role
ad
pathogenesi
altern
differ
immunoreact
distribut
hand
ad
may
relat
differ
degre
sever
stage
oxid
stress
support
nih
grant
ig
vs
cla
bs
bg
djm
st
hvv
raltegravir
ral
human
monocytederiv
macrophag
mdm
product
immunemedi
expos
hiv
compar
ral
effect
antiretrovir
arv
compound
like
efavirenz
efv
combin
therapi
includ
tenofovir
tdf
emtricitabin
ftc
proinflammatori
cytokin
measur
simultan
tissu
cultur
supernat
primari
mdm
test
ral
alon
combin
tdf
ftc
compar
efv
alon
combin
tdf
ftc
found
ral
treatment
result
lowest
level
five
day
exposur
hiv
compar
arv
formul
also
earlier
time
point
day
lower
formul
includ
ral
although
arv
decreas
product
day
mdm
expos
hiv
compar
nonarv
treat
control
arv
combin
led
increas
day
ral
alon
lowest
indic
possibl
efv
tdfftc
caus
increas
signific
effect
ral
combin
alon
mdm
produt
sinc
function
potent
chemoattract
may
relev
reduc
overal
inflamm
may
impact
bloodbrainbarri
permeabl
explor
effect
ral
proinflammatori
molecul
product
brain
macrophag
may
also
contribut
design
arv
neuroprotect
strategi
chronic
hiv
infect
work
support
nih
grant
ca
bs
et
merck
iisp
grant
ca
increas
cerebr
beta
amyloid
deposit
hiv
posit
subject
neurocognit
impair
cristian
achim
matthew
cronin
mont
buchsbaum
alex
decastro
christin
fennemanotestein
sarah
archibald
thoma
marcott
donald
franklin
benchawanna
soontornniyomkij
virawudh
soontornniyomkij
anya
umlauf
ronald
elli
robert
heaton
igor
grant
email
cachim
ucsdedu
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
ucsd
unit
state
previou
autopsi
studi
show
increas
brain
amyloid
deposit
hiv
subject
perform
control
vivo
pilot
studi
male
hiv
subject
four
hand
without
pet
scan
acquir
use
compound
b
ligand
structur
mri
data
obtain
unpair
onetail
ttest
perform
two
group
determin
statist
signific
differ
bind
present
correl
analysi
perform
region
increas
neurocognit
data
similar
correl
calcul
region
increas
csf
betaamyloid
bind
significantli
greater
p
impair
group
predominantli
within
low
midconvex
frontal
lobe
orbitofront
cortex
later
medial
anterior
tempor
lobe
cerebellum
signific
posit
correl
r
found
global
deficit
score
gd
region
increas
bind
impair
group
addit
remark
correl
found
bind
alon
signific
neg
correl
r
present
ratio
none
subject
studi
carri
apo
allel
preliminari
studi
suggest
deposit
greater
brain
hivindividu
neurocognit
impair
signific
neg
correl
found
bind
csf
suggest
marker
may
use
adjunct
identif
individu
hand
work
support
hnrc
development
grant
mvc
rkh
cla
ig
cfn
sa
tdm
msb
sa
background
previou
work
demonstr
relationship
peripher
activ
monocyt
hiv
dna
individu
neurocognit
statu
current
studi
focus
identifi
cell
cerebrospin
fluid
csf
determin
relationship
occur
materi
method
six
hivinfect
individu
enrol
hawaii
age
hiv
cohort
studi
three
diagnos
normal
cognit
nc
three
hivassoci
dementia
csf
cell
separ
three
cellular
subset
activ
monocyt
nonactiv
monocyt
nonmonocyt
dna
extract
sort
cell
hiv
dna
copi
number
determin
use
quantit
realtim
pcr
total
burden
hiv
dna
copi
number
csf
compar
peripher
hiv
dna
copi
number
result
neg
correl
peripher
hiv
dna
copi
number
total
burden
hiv
dna
csf
cell
seen
addit
median
total
burden
hiv
dna
csf
cellular
subset
higher
patient
nc
conclus
invers
relationship
hiv
dna
copi
number
peripher
cell
total
hiv
dna
burden
csf
patient
consist
compartment
peripheri
csf
data
support
hypothesi
peripher
cell
traffic
hiv
cn
cell
releas
csf
harbor
less
hiv
dna
csf
might
repres
independ
hiv
reservoir
long
termin
repeat
ltr
regul
gene
express
interact
multipl
host
viral
factor
crosssect
studi
prehaart
era
demonstr
singl
nucleotid
polymorph
snp
peripher
bloodderiv
ltr
ctot
chang
posit
cebp
site
andor
posit
sp
site
iii
identifi
snp
often
encount
togeth
ltr
core
enhanc
region
integr
proviru
late
stage
hiv
diseas
addit
variant
correl
dementia
ltr
sequenc
deriv
longitudin
sampl
peripher
blood
singl
patient
drexelm
hivaid
genet
analysi
cohort
result
detect
coselect
snp
onset
neurolog
impair
suggest
snp
may
use
predict
hivassoci
neurolog
complic
rel
fit
ltr
contain
andor
coselect
snp
evolv
nativ
patientderiv
ltr
backbon
structur
demonstr
spectrum
basal
activ
tatmedi
transcript
activ
silico
predict
util
colinear
envelop
sequenc
suggest
patient
peripher
blood
viru
evolv
swarm
prior
develop
neurolog
complic
advanc
hiv
diseas
result
suggest
viral
swarm
evolv
cours
diseas
respons
select
pressur
lead
chang
preval
specif
polymorph
ltr
andor
envelop
gene
could
predict
onset
neurolog
diseas
result
alter
viral
function
cn
infect
hiv
lead
neurolog
dysfunct
character
compendium
motor
cognit
disord
known
hivassoci
dementia
wherea
incid
declin
due
treatment
antiretrovir
preval
rise
establish
model
hiv
latenc
microgli
cell
hiv
major
reservoir
hiv
brain
cell
hiv
induc
hdac
inhibitor
suggest
latenc
associ
chromatinmedi
silenc
similar
latenc
tcell
howev
tcell
hiv
silenc
mediat
primarili
chromatinremodel
enzym
polycomb
repress
wherea
microgli
cell
silenc
involv
distinct
set
enzym
exampl
hiv
latent
infect
tcell
jurkathiv
induc
dznep
inhibitor
compon
chaetocin
inhibitor
hkmt
contrast
microgli
cell
hiv
partial
reactiv
chaetocin
dznep
surprisingli
found
lpsmediat
hiv
reactiv
sever
impair
even
though
lp
activ
system
hypothes
transrepress
pathway
limit
overactiv
proinflammatori
gene
may
play
role
limit
hiv
overreactiv
infect
microgli
cell
support
hypothesi
found
phenelzin
inhibitor
corest
repress
complex
enzym
reactiv
hiv
cell
sensit
lpsmediat
reactiv
hiv
final
shrnamedi
knockdown
corest
partial
induc
provir
reactiv
cell
result
indic
transrepress
pathway
play
role
mainten
hiv
latenc
microgli
cell
cell
work
limit
hiv
overexpress
inflammationmedi
activ
infect
microgli
cell
brain
exploit
pathway
may
lead
uniqu
inductionerad
strategi
elimin
hiv
reservoir
brain
human
retroviru
associ
adult
tcell
leukemia
lymphoma
well
sever
inflammatori
disord
includ
syndrom
neuroinflammatori
disord
associ
myelopathi
tropic
spastic
paraparesi
hamtsp
primarili
infect
primarili
cell
lead
prolifer
activ
subset
cell
regulatori
typic
treg
shown
decreas
function
capac
reg
hamtsp
patient
compar
normal
donor
nd
also
shown
hamtsp
patient
decreas
protein
express
fac
mrna
subset
howev
due
inflammatori
compon
hamtsp
marker
normal
use
character
reg
gitr
limit
identifi
regulatori
cell
inde
thought
reg
lineag
marker
master
regul
treg
function
also
regul
activ
cell
precis
character
treg
cell
use
novel
method
analyz
methyl
statu
specif
cpg
locu
cell
stabli
express
treg
stabli
express
associ
complet
demethyl
locu
cell
enrich
like
subset
contain
cell
dna
cell
analyz
qpcr
primer
direct
treg
cell
specif
demethyl
region
tsdr
show
decreas
demethyl
popul
hamtsp
patient
compar
nd
despit
increas
size
hamtsp
show
correl
overal
expand
popul
cell
chang
group
nd
ham
tsp
patient
postul
imbal
like
contribut
decreas
reg
function
seen
patient
play
crucial
role
pathogenesi
human
lymphotrop
viru
associ
myelopathytrop
spastic
paraparesi
hamtsp
result
level
csf
hamtsp
patient
significantli
elev
p
p
p
respect
importantli
level
significantli
higher
csf
serum
p
demonstr
antibodi
significantli
inhibit
cellular
migrat
hamtsp
pbmc
antibodi
furthermor
absolut
proviru
load
migrat
cell
lower
antibodi
use
compar
control
antibodi
notabl
express
demonstr
csf
cell
hamtsp
patient
conclus
demonstr
interact
play
crucial
role
pathogenesi
hamtsp
antibodi
might
candid
molecul
target
therapi
hamtsp
patient
interact
amyloid
beta
peptid
bloodbrain
barrier
level
ibolya
e
andra
michal
toborek
email
mtoborek
medmiamiedu
univers
miami
school
medicin
unit
state
univers
miami
school
medicin
unit
state
increas
older
popul
infect
emerg
develop
epidemiolog
age
connect
increas
deposit
amyloid
beta
peptid
amyloid
beta
brain
current
studi
propos
amyloid
beta
potenti
toxic
effect
bloodbrain
barrier
bbb
level
address
notion
employ
vitro
model
human
brain
microvascular
endotheli
cell
hbmec
directli
expos
cocultur
infect
human
monocyt
exposur
hbmec
amyloid
beta
presenc
result
markedli
increas
amyloid
beta
bindingentri
hbmec
hypothes
may
either
increas
bindingentri
extern
ad
amyloid
beta
elev
amount
endogen
produc
amyloid
beta
receptor
advanc
glycat
end
product
rage
known
involv
transport
amyloid
beta
across
bbb
brain
rage
immunoreact
stronger
rage
protein
level
elev
hbmec
expos
compar
control
contrast
exposur
decreas
express
lipoprotein
receptor
relat
main
receptor
transport
amyloid
beta
brain
blood
result
indic
decreas
abil
bbb
transport
amyloid
beta
brain
thu
predispos
brain
increas
amyloid
beta
accumul
support
use
cannabi
report
high
among
adolesc
major
psychoact
constitu
cannabi
thc
mediat
antiinflammatori
effect
interact
cannabinoid
receptor
immun
cell
studi
thc
immun
conduct
rodent
role
thc
modul
human
immun
immun
pathogenesi
remain
unclear
impact
cannabi
use
immun
activ
investig
studi
combin
vivo
ex
vivo
approach
express
global
effect
thc
human
monocyt
macrophag
activ
evalu
ex
vivo
total
rna
protein
isol
human
monocyt
monocyt
deriv
macrophag
undifferenti
pma
differenti
monocyt
cell
line
nest
revers
transcriptas
pcr
sequenc
identifi
mrna
cell
type
howev
protein
detect
western
blot
undifferenti
monocyt
cell
line
primari
monocyt
next
impact
thc
inflamm
evalu
thc
pretreat
reduc
tnfinduc
protein
express
undifferenti
cell
monocyt
level
also
significantli
reduc
thc
agonist
lpsactiv
peripher
blood
mononuclear
cell
monocyt
cultur
panel
biomark
immun
activ
associ
neurocognit
impair
overal
morbiditymort
measur
plasma
sampl
cohort
uninfect
subject
group
test
posit
cannabinoid
compar
control
group
vast
major
biomark
cannabi
use
fail
correl
immun
activ
either
group
significantli
decreas
level
observ
cannabinoidposit
subject
compar
cannabinoidneg
subject
control
group
thc
reduc
inflammatori
outcom
monocyt
ex
vivo
lymphocyt
vivo
absenc
hivinfect
fund
nih
gabriel
arendt
philip
albrecht
email
gabrielearendt
uniduesseldorfd
dept
neurolog
univers
duesseldorf
medic
faculti
germani
dept
neurolog
univers
duesseldorf
medic
faculti
germani
dept
neurolog
univers
duesseldorf
medic
faculti
germani
introduct
intern
cohort
studi
reveal
neurocognit
deficit
rise
preval
incid
among
hiv
patient
despit
combin
antiretrovir
therapi
cart
fulli
suppress
viral
load
differ
bodi
compart
due
viral
well
immunolog
factor
far
marker
chronic
inflamm
central
nervou
system
except
thu
addit
biolog
diseas
marker
warrant
free
caspas
activ
measur
cerebrospin
fluid
csf
elev
neurodegen
diseas
like
creutzfeld
jakob
diseas
may
also
serv
surrog
paramet
neuron
degener
hiv
method
hivposit
patient
pair
plasma
csf
sampl
drawn
approv
local
ethic
author
patient
subdivid
group
earli
without
cart
aidsdefin
without
cart
analys
age
durat
count
viral
load
vl
plasma
csf
neurocognit
paramet
psychomotor
speed
trailmakingtest
groov
pegboardtest
compar
free
activ
csf
measur
luminometr
assay
result
caspas
activ
highest
late
stage
patient
independ
cart
medic
significantli
lower
earli
stage
p
independ
cart
patient
without
medic
caspas
activ
correl
csf
plasmavl
late
stage
patient
neuropsycholog
perform
wors
patient
high
caspas
activ
independ
cart
conclus
free
caspas
activ
csf
hivpati
surrog
paramet
neuron
degener
uninfluenc
cart
correl
csfvl
neuropsycholog
deficit
especi
late
diseas
stage
thu
point
hiv
neuropathogenesi
opiat
probdnf
hiv
alessia
bachi
valeriya
avdoshina
italo
mocchetti
email
bachisa
georgetownedu
georgetown
univers
unit
state
georgetown
univers
unit
state
georgetown
univers
unit
state
estim
third
human
immunodefici
viru
type
hiv
infect
individu
usa
intraven
opioid
drug
abus
opiat
render
individu
risk
develop
hivassoci
dementia
neurolog
diseas
character
synapt
simplif
neuron
apoptosi
current
believ
opiat
may
intrins
alter
progress
pathogenesi
better
understand
mechan
mediat
neurotox
presenc
opiat
crucial
develop
effect
therapi
work
explor
novel
hypothesi
opiat
hiv
synerg
alter
trophic
environ
neuron
glia
cell
reli
surviv
use
rat
primari
neuron
observ
hiv
protein
reduc
length
neuron
process
similarli
proneurotrophin
pro
brainderiv
neurotroph
factor
probdnf
intriguingli
effect
probdnf
block
inhibitor
neurotrophin
receptor
suggest
probdnf
share
similar
mechan
neurotox
fact
observ
promot
timedepend
intracellular
extracellular
accumul
probdnf
concomitantli
decreas
matur
bdnf
effect
due
abil
alter
probdnf
process
similar
imbal
ratio
probdnfmatur
bdnf
confirm
postmortem
brain
hiv
posit
subject
cognit
motor
impair
histori
drug
abus
interestingli
cocain
human
brain
affect
level
bdnf
opiat
seem
increas
bdnf
cortex
howev
number
probdnf
posit
neuron
also
increas
brain
subject
histori
opiat
abus
suggest
although
opiat
increas
synthesi
bdnf
brain
alter
controversi
deposit
acceler
brain
hivinfect
individu
human
brain
tissu
found
evid
accumul
rate
acceler
year
hivinfect
subject
compar
agematch
seroneg
control
use
vitro
vivo
approach
studi
potenti
mechan
alter
amyloid
precursor
protein
app
process
set
hivinfect
cell
cultur
experi
determin
combin
dual
tat
heat
inactiv
supernat
hivinfect
macrophag
md
increas
amount
amyloid
precursor
protein
app
express
posttranscript
stabil
involv
heterogen
nuclear
ribonucleoprotein
c
amount
express
also
increas
enhanc
transcript
activ
protein
increas
size
stabil
structur
lipid
raft
increas
coloc
app
bace
lipid
raft
bace
activ
enhanc
result
increas
format
howev
littl
export
cell
accumul
intraneuron
compart
accumul
lysosom
appear
remain
stabl
compart
prolong
period
time
creat
tripl
transgen
model
express
knockin
mutat
human
app
mice
increas
number
size
plaqu
compar
mice
moreov
strike
accumul
intraneuron
mice
began
earli
within
month
worsen
age
level
lipid
raft
associ
ceramid
increas
mice
mice
suggest
express
drive
biochem
effect
thu
set
hivinfect
defect
protein
traffick
may
perturb
neuron
function
trap
intraneuron
compart
hivinfect
subject
abus
alcohol
exhibit
greater
declin
cognit
task
assess
frontal
lobe
function
compar
hivinfect
subject
abus
alcohol
provid
evid
alcohol
impair
traffic
calcium
permeabl
ampa
receptor
acut
ethanol
administr
perturb
structur
plasma
membran
result
collaps
gagliosid
focal
microdomain
ethanol
select
increas
surfac
express
calcium
permeabl
ampa
receptor
cluster
membran
microdomain
although
surfac
express
increas
activ
calcium
permeabl
ampa
receptor
blunt
presenc
alcohol
immedi
follow
alcohol
withdraw
ampa
receptor
activ
enhanc
consist
increas
surfac
express
enhanc
surfac
express
ampa
receptor
follow
ethanol
involv
increas
phosphoryl
serin
serin
pkc
pka
respect
revers
addit
solubl
cholesterol
back
membran
investig
effect
ethanol
ampa
receptor
traffick
hiv
set
develop
bingedrink
model
hiv
tat
transgen
mice
induc
express
tat
ethanol
selfadministr
increas
total
amount
phosphoryl
ethanol
withdraw
tat
mice
phosphoryl
remain
high
although
total
level
return
level
differ
control
mice
data
suggest
alcohol
increas
surfac
express
calcium
permeabl
ampa
receptor
increas
phosphoryl
ctermin
serin
activ
receptor
activ
block
ethanol
becom
activ
ethanol
withdraw
moreov
hiv
tat
may
prolong
phosphoryl
henc
surfac
local
calcium
permeabl
ampa
receptor
ethanol
withdraw
tat
protein
activ
proapoptot
pathway
neuron
asen
bagashev
ruma
mukerje
bassel
e
sawaya
email
templeedu
templ
univers
unit
state
templ
univers
unit
state
templ
univers
unit
state
involv
tat
protein
neuron
deregul
develop
associ
neurocognit
disord
shown
sever
group
includ
howev
mechan
use
tat
caus
deregul
fulli
understood
previous
demonstr
tat
function
pathway
implic
protein
show
tat
deregul
level
lead
phosphoryl
cabl
well
accumul
accumul
result
seri
posttransl
modif
activ
rel
silenc
promot
found
tattreat
neuron
cabl
phosphoryl
tyrosin
residu
tat
lost
abil
promot
accumul
phosphoryl
presenc
mimic
result
led
conclus
tat
protein
induc
neuron
deregul
wellestablish
proapoptot
pathway
regul
addit
studi
need
understand
degre
involv
mechan
overal
pictur
hand
lead
develop
therapeut
improv
qualiti
life
individu
disord
astrogli
glutam
transport
essenti
clear
critic
neurotransmitt
glutam
central
nervou
system
protect
excitotox
transcript
factor
nfkappab
posit
regul
microrna
neg
regul
express
glutam
known
induc
transcript
factor
nfkappab
present
studi
investig
effect
glutamateinduc
activ
nfkappab
glial
cell
cn
includ
primari
astrocyt
regul
promot
regul
studi
demonstr
glutam
mediat
nfkappab
activ
induc
promot
affect
promot
contrast
hiv
induc
proinflammatori
cytokin
induc
nfkappab
activ
activ
promot
inhibit
promot
activ
also
demonstr
glutam
induc
dissoci
absenc
ikappabalpha
phosphoryl
degrad
furthermor
glutam
induc
rapid
phosphoryl
contrast
proinflammatori
cytokin
induc
rapid
phosphoryl
ikappabalpha
phosphoryl
degrad
result
provid
insight
glutamateinduc
regulatori
pathway
distinct
describ
cytokineinduc
nfkappab
activ
regul
astrocyt
silac
proteom
analysi
neuron
expos
cell
free
carlo
barrero
langford
diann
ahmet
ozdemir
jane
kovalevich
inna
rom
salim
merali
email
cbarrero
templeedu
templ
univers
unit
state
templ
univers
unit
state
templ
univers
unit
state
templ
univers
unit
state
templ
univers
unit
state
templ
univers
unit
state
human
immunodefici
viru
neurocognit
disord
hand
remain
common
cn
diseas
link
advanc
viral
infect
viral
host
cell
product
releas
hivinfect
cell
implic
induc
neurolog
diseas
chronic
secret
neurotox
factor
sinc
infect
neuron
direct
effect
hiv
neuron
dysfunct
remain
uncertain
better
understand
global
molecular
mechan
identifi
pathway
involv
hivassoci
neuron
cell
damag
expos
shsi
neuron
cell
cell
free
hiv
use
state
art
proteom
technolog
stabl
isotop
label
amino
acid
cultur
silac
assess
chang
neuron
protein
use
approach
identifi
differenti
express
protein
upregul
downregul
least
ingenu
pathway
analysi
differenti
express
protein
identifi
mass
spectroscopi
highlight
signal
cluster
center
node
retino
acid
akt
pathway
differenti
express
protein
downstream
protein
relat
signal
pathway
valid
western
blot
analysi
network
analysi
differenti
express
protein
indic
associ
three
major
network
cellular
function
mainten
lipid
metabol
molecular
transport
conclus
data
indic
exposur
cell
free
hiv
induc
biolog
relev
chang
neuron
signal
protein
pathway
protein
function
studi
better
understand
pathogenesi
associ
hand
may
repres
novel
target
intervent
aim
improv
neuron
function
hiv
patient
silacbas
quantit
proteom
approach
identifi
vpr
mediat
chang
macrophag
metabol
pathway
carlo
barrero
prasun
datta
kamel
khalili
satish
deshman
satarupa
sen
salim
merali
email
cbarrero
templeedu
biochemistri
templ
univers
unit
state
neurosci
templ
univers
unit
state
neurosci
templ
univers
unit
state
neurosci
templ
univers
unit
state
neurosci
templ
univers
unit
state
biochemistri
templ
univers
unit
state
macrophag
major
viral
reservoir
infect
viral
protein
r
vpr
mediat
mani
process
promot
infect
evas
immun
system
persist
host
although
vpr
mediat
pathogenesi
macrophag
extens
investig
global
molecular
mechan
associ
metabol
pathway
investig
use
stabl
isotop
label
amino
acid
cultur
silac
base
proteom
technolog
determin
differenti
express
protein
deriv
macrophag
transduc
adenovir
vpr
construct
use
approach
identifi
differenti
express
protein
regul
downregul
least
ingenu
pathway
analysi
differenti
express
protein
identifi
mass
spectroscopi
highlight
metabol
pathway
includ
pyruv
metabol
pentos
phosphat
pathway
citrat
cycl
differenti
express
protein
downstream
protein
relat
signal
pathway
valid
western
blot
analysi
network
analysi
differenti
express
protein
indic
signal
cluster
nfkb
complex
center
node
associ
three
major
function
nucleic
acid
metabol
small
molecul
biochemistri
celltocel
signal
interact
conclus
data
indic
vpr
induc
biolog
relev
chang
protein
level
sever
metabol
consequ
macrophag
infect
studi
metabol
pathway
offer
better
understand
mechan
respons
viral
reservoir
persist
macrophag
use
novel
target
drug
discoveri
reduc
viral
load
jame
becker
pablo
cuesta
melissa
fabrizio
gustavo
sudr
emanuel
n
vergi
antoin
douaihi
ricardo
bajo
alli
schubert
oscar
l
lopez
lauri
parkkonen
fernando
maestu
anto
bagic
email
beckerjt
upmcedu
univers
pittsburgh
unit
state
imag
brain
data
compar
individu
hiv
infect
control
baselin
six
month
treatment
result
six
month
haart
pg
show
viral
suppress
improv
cell
count
cognit
function
improv
except
memori
learn
mri
whole
brain
volum
measur
siena
show
increas
interv
function
connect
meg
data
quantifi
use
mean
mutual
inform
mi
critic
sensor
pair
studi
entri
pg
mi
score
mean
hivinfect
subject
treatment
mi
score
improv
level
uninfect
control
conclus
still
one
present
syndrom
hiv
diseas
aggress
treatment
control
peripher
viral
replic
result
immun
reconstitut
also
appear
induc
partial
restor
brain
volum
lead
signific
improv
brain
function
connect
data
also
suggest
meg
measur
function
connect
may
serv
use
biomark
hivassoci
neurocognit
disord
track
respons
pharmacotherapi
rearrang
polyomaviru
jc
noncod
control
region
sequenc
possibl
marker
virul
within
cohort
pediatr
crohn
diseas
patient
treat
infliximab
develop
seriou
complic
progress
multifoc
leukoencephalopathi
pml
caus
jc
polyomaviru
jcv
reactiv
high
incid
hivposit
subject
therefor
aim
studi
investig
possibl
jcv
reactiv
pediatr
cd
patient
treat
infliximab
perform
quantit
pcr
urin
plasma
intestin
biopsi
time
recruit
everi
month
year
followup
analysi
jcv
noncod
control
region
nccr
sequenc
detect
cellular
transcript
factor
bind
site
mutat
result
obtain
show
urin
ileal
specimen
jcv
load
significantli
increas
infliximab
treat
patient
year
treatment
viremia
significantli
higher
jcv
nccr
sequenc
analysi
show
structur
similar
nonpathogen
variant
cy
archetyp
analyz
sequenc
remain
obtain
exclus
plasma
biopsi
evidenc
cy
nccr
organ
two
recurr
nucleotid
chang
g
transvers
boxa
spib
bind
site
transit
boxf
boxd
delet
rearrang
alway
found
within
seven
infliximabtr
cd
patient
present
sever
diseas
month
treatment
observ
colon
biopsi
patient
particular
nccr
sequenc
structur
organ
resembl
pathogen
variant
conclud
rearrang
nccr
sequenc
could
consid
marker
jcv
virul
within
month
mab
treatment
although
none
examin
patient
develop
pml
studi
larger
cohort
patient
perform
neurofibromatosi
type
tumor
suppressor
protein
induc
proteasomemedi
degrad
jc
viru
tantigen
human
glial
cell
human
polyomaviru
jc
viru
jcv
caus
agent
fatal
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
display
strong
tropism
toward
glial
cell
jcv
typic
replic
immunosuppress
condit
make
viru
threat
aid
patient
undergo
immunomodulatori
therapi
understand
molecular
mechan
respons
viral
replic
pivot
affect
deter
viral
resurg
patient
express
viral
earli
promot
initi
step
viru
life
cycl
lead
product
major
viral
regulatori
protein
tantigen
promot
viral
replic
tantigen
must
hijack
cell
cycl
machineri
host
enhanc
express
jcv
protein
studi
jcv
tantigen
transgen
mice
develop
tumor
resembl
malign
peripher
nerv
sheath
tumor
mpnst
led
identif
neurofibromatosi
type
bind
partner
tantigen
cytoplasm
scaffold
protein
affect
cell
motil
morpholog
tumor
suppressor
properti
also
shown
present
nucleu
found
downregul
express
larg
small
tantigen
protein
activ
jcv
bidirect
promot
upon
character
interact
determin
util
novel
approach
suppress
tantigen
express
wherebi
promot
accumul
matur
tantigen
mrna
proteasom
degrad
tantigen
protein
collect
result
show
neg
regul
jcv
tantigen
express
suggest
novel
role
inhibitor
jcv
reactiv
util
potenti
strategi
block
jcv
replic
glial
cell
discuss
work
support
grant
award
nih
jg
sb
support
nih
ruth
l
kirchstein
nation
research
servic
award
hiv
glycoprotein
impair
fast
axon
transport
axonautonom
mechan
viru
hiv
infect
dsp
character
progress
dyingback
degener
dorsal
root
ganglion
drg
neuron
project
distal
extrem
neurotox
glycoprotein
overproduc
shed
hivinfect
macrophag
link
dsp
pathogenesi
howev
exact
role
play
promot
degener
drg
axon
dsp
remain
uncertain
hypothes
neurotox
might
involv
alter
drg
cytoplasm
test
first
determin
whether
intern
neuron
found
inde
intern
cell
hybrid
cell
line
gener
rat
dorsal
root
ganglion
mous
neuroblastoma
cell
addit
determin
specif
endocyt
pathway
intern
immunoloc
studi
specif
endosom
marker
might
intern
toxic
neuron
sinc
dyingback
neurodegener
link
deficit
fast
axon
transport
fat
hypothes
intracellular
might
affect
fat
test
idea
recombin
perfus
isol
squid
axoplasm
experi
indic
inhibit
fat
nanomolar
concentr
coperfus
pharmacolog
inhibitor
specif
kinas
phosphatas
delin
signal
pathway
mediat
effect
fat
final
role
intern
kinas
activ
also
establish
uniqu
relianc
neuron
fat
mechan
suggest
axonautonom
activ
phosphotransferas
might
repres
critic
pathogen
event
dsp
tat
protein
variant
critic
role
cystein
region
tat
produc
neuron
dysfunct
dead
assay
use
determin
neuron
apoptosi
factin
posit
puncta
spine
count
along
label
neurit
compar
control
examin
neuron
network
integr
tat
protein
induc
signific
apoptosi
network
damag
howev
variant
mutat
cystein
region
induc
neuron
apoptosi
caus
signific
neuron
network
damag
moreov
tat
clade
b
neurotox
wherea
tat
clade
c
detect
effect
neuron
cell
result
indic
highli
conserv
cystein
region
tat
requir
apoptosi
neuron
network
damag
presenceabs
mutat
cystein
region
critic
factor
neurotox
cocain
abus
hasten
neurodegener
often
associ
advanc
infect
mechan
part
revolv
around
neuroinflammatori
process
mediat
chemokin
monocyt
chemotact
understand
factor
modul
turn
facilit
monocyt
extravas
brain
thu
paramount
import
demonstr
cocain
induc
rodent
microglia
transloc
sigma
receptor
lipid
raft
microdomain
plasma
membran
sequenti
activ
src
mitogenactiv
protein
kinas
mapk
kinas
akt
nuclear
factor
kappab
nfkappab
pathway
result
increas
express
furthermor
condit
media
cocaineexpos
microglia
increas
monocyt
transmigr
thu
block
antagonist
sigma
receptor
find
corrobor
demonstr
increas
monocyt
transmigr
mice
expos
cocain
attenu
pretreat
mice
sigma
receptor
antagonist
interestingli
cocainemedi
transmigratori
effect
observ
knockout
mice
conclud
cocainemedi
induct
acceler
monocyt
extravas
across
endothelium
understand
regul
express
function
chang
cocainesigma
receptor
system
may
provid
insight
develop
potenti
therapeut
target
neurocognit
disord
microbi
peptid
other
shown
inhibit
hiv
primari
cell
inhibitori
activ
mediat
cell
receptor
bind
chemokin
eventu
transcript
induct
antiretrovir
cellular
factor
intriguingli
data
show
express
cn
littl
known
role
play
defensin
brain
hypothes
besid
cell
hbd
could
protect
microgli
cell
perivascular
macrophag
product
hiv
infect
data
primari
monocytederiv
macrophag
mdm
use
vitro
model
microgli
cell
show
inhibit
hiv
earli
stage
infect
associ
increas
level
flow
cytometri
analys
show
mdm
express
anoth
share
chemokinedefensin
receptor
although
high
variabl
among
donor
sinc
agonist
antagonist
chemokin
receptor
becom
avail
data
could
lead
develop
new
therapeut
approach
treat
hiv
infect
system
cn
addit
decreas
defensin
product
observ
hivinfect
subject
could
associ
increas
occurr
hivassoci
symptom
rift
valley
fever
viru
rvfv
vectorborn
zoonosi
caus
period
diseas
outbreak
livestock
human
africa
middl
east
human
infect
associ
fever
liver
damag
subset
patient
progress
hemorrhag
fever
enceph
ocular
diseas
death
rvfv
consid
categori
agent
potenti
easili
dissemin
examin
rvfv
infect
intraperiton
aerosol
rout
balbc
mice
intraperiton
infect
led
acut
onset
hepat
lethal
day
postinfect
evid
brain
infect
rout
aerosol
infect
result
differ
cours
infect
hepat
still
observ
less
promin
delay
day
brain
infect
detect
anim
day
postinfect
day
postinfect
mice
develop
sever
enceph
major
neuron
infect
vaccin
balbc
mice
led
protect
infect
upon
intraperiton
challeng
result
less
liver
infect
aerosol
challeng
surprisingli
aerosol
challeng
vaccin
mice
show
enhanc
brain
infect
suggest
depend
rout
challeng
vaccin
may
enhanc
rather
protect
enceph
hivassoci
neurocognit
disord
hand
common
manifest
hiv
infect
afflict
hivposit
individu
peopl
access
antiretrovir
treatment
live
longer
hand
found
increas
segment
popul
risk
chronic
neurodegen
condit
alzheim
diseas
ad
multipl
sclerosi
ms
rais
possibl
brain
diseas
divers
etiolog
may
overlap
util
similar
biolog
pathway
test
proposit
use
metaanalysi
compar
gene
express
signatur
biolog
pathway
brain
tissu
hand
ad
ms
pairwis
threeway
analys
found
surprisingli
larg
number
dysregul
transcript
biolog
process
common
three
diseas
three
diseas
share
upregul
inflammatori
immun
respons
process
downregul
process
implic
signal
transduct
synapt
function
result
obtain
human
metaanalysi
compar
microarray
data
brain
tissu
mice
infect
chimer
hiv
ecohiv
common
downregul
transcript
human
mous
implic
synaps
vesicl
transport
glutam
receptor
learn
memori
process
approach
could
facilit
identif
common
diseas
mechan
complex
neurocognit
disord
ecohivinfect
mice
may
serv
use
system
empir
valid
molecular
physiolog
chang
brain
underli
hand
support
grant
nation
institut
health
us
public
health
servic
nation
neuroaid
tissu
consortium
found
fund
nimh
nind
fill
research
commun
need
wellcharacter
tissu
fluid
hivinfect
individu
nntc
sinc
establish
valuabl
resourc
research
commun
provid
qualiti
pre
ant
mortem
clinic
data
tissu
qualifi
investig
sinc
launch
nntc
continu
refin
structur
process
respons
research
commun
need
expand
scope
avail
clinic
data
implement
bioinformat
platform
standard
data
new
resourc
made
avail
via
nntc
websit
wwwnntcorg
assist
investig
mine
nntc
hold
user
feedback
solicit
user
nntc
resourc
input
nntc
futur
direct
current
nntc
cohort
includ
hiv
posit
particip
contribut
data
longitudin
cohort
current
activ
cohort
deceas
autopsi
addit
bank
data
tissu
hiv
neg
particip
clinic
data
collect
includ
demograph
neuromed
data
neuropsycholog
assess
cognit
diagnos
neuropatholog
prismcidi
clinic
lab
recent
revis
addit
includ
improv
arvconcomit
medic
histori
comorbid
supplement
neuropatholog
nntc
bioinformat
platform
consolid
microarray
bioinformat
data
clinic
annot
provid
integr
view
avail
nntc
resourc
current
snp
gene
array
data
avail
select
case
impact
nntc
demonstr
highli
effect
effici
use
high
qualiti
tissu
data
mani
investig
possibl
nntc
resourc
use
investig
report
journal
public
extern
well
intern
investig
glutam
excitotox
involv
motor
dysfunct
paralysi
follow
infect
human
respiratori
coronaviru
elodi
brison
jacomi
marc
desforg
pierr
talbot
email
elodiebrison
iafinrsca
inrsinstitut
armandfrappi
laval
canada
canada
human
coronavirus
hcov
respiratori
pathogen
report
strain
infect
human
neuron
glial
cell
activ
neuroinflammatori
neurodegen
mechan
thu
possibl
involv
neurolog
diseas
unknown
etiolog
multipl
sclerosi
ms
use
anim
model
report
viral
persistenceassoci
point
mutat
viral
spike
glycoprotein
modifi
neuropatholog
enceph
msrelat
hindlimb
paralysi
viral
cn
infect
may
induc
excitotox
patholog
process
neuron
damag
die
follow
excess
stimul
glutam
neurotransmitt
specif
ionotrop
receptor
ampar
nmdar
previous
shown
paralyt
diseas
induc
mutant
involv
ampar
mediat
glutam
excitotox
given
overactiv
nmethyldaspart
acid
receptor
nmdar
may
also
lead
excitotox
pharmacolog
research
focus
develop
nmdar
antagonist
memantin
one
molecul
modul
glutam
excitotox
wide
use
treatment
human
neurolog
disord
ms
show
low
dose
memantin
bodi
weight
improv
clinic
score
relat
paralyt
diseas
mice
infect
mutant
without
affect
viral
replic
howev
higher
dose
attenu
clinic
score
relat
paralysi
motor
dysfunct
mortal
rate
memantin
attenu
viru
replic
dosedepend
manner
cell
cultur
compar
dizocilpin
anoth
nmdar
antagonist
neither
affect
viru
replic
reduc
mortal
rate
studi
current
underway
investig
mechan
underli
dosedepend
neuroprotect
antivir
activ
memantin
introduct
jc
viru
jcv
regulatori
region
rr
exhibit
sequenc
variabl
determin
viral
pathogen
stabl
archetyp
rr
found
urin
healthi
immunosuppress
individu
convers
rr
found
cn
progress
multifoc
leukoencephalopathi
pml
patient
contain
rearrang
analyz
jcv
rr
sequenc
urin
sampl
pml
patient
differ
clinic
outcom
method
collect
urin
patient
includ
pmlsurvivor
aliv
one
year
diseas
onset
pmlprogressor
deceas
within
one
year
diseas
onset
hiv
patient
two
urin
sampl
collect
mean
month
apart
patient
jcv
dna
quantifi
qpcr
rr
amplifi
posit
sampl
nest
pcr
total
rr
clone
sequenc
rearrang
defin
duplic
within
bp
element
duplic
delet
compar
archetyp
classifi
archetypelik
result
jcv
dna
detect
pml
patient
sampl
median
rang
includ
pmlprogressor
sampl
median
rang
pmlsurvivor
sampl
median
rang
jcv
detect
hiv
sampl
median
archetypelik
rr
found
clone
six
pmlsurvivor
clone
four
pmlprogressor
rr
rearrang
found
clone
one
pmlprogressor
archetyp
rr
found
clone
three
hiv
patient
four
pmlsurvivor
urin
sampl
two
time
point
three
kept
stabl
jcv
rr
archetyp
archetypelik
one
archetypelik
rr
transform
archetyp
conclus
rr
rearrang
found
pml
patient
sampl
clone
archetypelik
jcv
rr
found
frequent
pmlsurvivor
pmlprogressor
data
suggest
minor
alter
archetyp
rr
detriment
surviv
indic
rr
rearrang
may
found
urin
pml
patient
nonmuscl
myosin
lightchain
kinas
mediat
microgli
migrat
induc
hiv
tat
involv
integrin
shilpa
buch
honghong
yao
yao
email
sbuch
unmcedu
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
introduct
hiv
tat
releas
hivinfect
cell
shown
exhibit
chemotact
activ
activ
microglia
hallmark
featur
hivassoci
neurolog
disord
hand
cell
migrat
signal
elicit
hiv
tat
releas
infect
cell
hypothes
microgli
adhesionmigr
mediat
tat
involv
actin
rearrang
activ
upstream
nonmuscl
myosin
light
chain
kinas
mylk
integrin
method
microgli
migrat
assess
boyden
dunn
chamber
role
assess
glisa
factin
polymer
examin
palladin
stain
flow
cytometri
hiv
tat
stereotact
inject
mice
hippocampu
follow
transplant
aavgfp
transduc
mice
microglia
corpu
calloseum
result
intrahippocamp
inject
hiv
mice
result
migrat
aavgfp
transfect
microglia
tatinject
site
molecular
mechan
process
involv
tatmedi
activ
receptor
lead
insideout
activ
mylk
integrin
result
subsequ
outsidein
activ
downstream
src
ultim
culmin
actin
rearrang
ensu
migrat
microglia
conclus
find
first
time
identifi
two
novel
phenomena
rgdindepend
activ
integrin
hiv
tat
b
involv
mylk
tatmedi
microgli
migrat
commun
life
elucid
role
synapt
microrna
chronic
methamphetamin
associ
cn
dysfunct
jame
buescher
howard
fox
gurudutt
pendyala
email
gpendyala
unmcedu
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
drug
abus
notabl
methamphetamin
meth
abus
continu
ravag
unit
state
well
global
damag
individu
user
increas
societ
econom
burden
studi
focu
defin
chronic
meth
abus
apart
lead
neurodegener
array
devast
effect
predispos
individu
stroke
seizur
movement
disord
behavior
chang
importantli
behavior
chang
persist
year
drug
use
discontinu
precipit
relaps
studi
lab
focus
understand
chang
occur
level
synapsekey
structur
involv
neurotransmiss
neuroplast
brain
microrna
emerg
import
regul
synapt
plastic
especi
dendrit
synthesi
protein
wherebi
synapt
stimul
activ
local
translat
mrna
store
close
synaps
preliminari
studi
synaptosom
isol
synaps
contain
pre
post
synapt
compon
autopsi
brain
identifi
set
mirna
enrich
synapt
fraction
hypothes
underli
epigenet
state
gene
crucial
determin
factor
one
key
question
interest
control
format
mainten
distinct
epigenet
state
particular
gene
especi
synaps
importantli
patholog
state
chronic
meth
abus
underli
intracellular
signal
cascad
transduc
initi
drug
action
neurotransmitterreceptor
level
neuron
nucleu
regul
epigenet
state
specif
subset
gene
believ
clue
transcript
epigenet
mechan
chronic
drug
abus
meth
accumul
integr
inform
obtain
posttranscript
translat
posttransl
regul
vital
obtain
complet
understand
chronic
meth
abus
chang
brain
thu
lead
neurodegener
well
behavior
chang
current
landscap
hiv
infect
requir
neuroaid
research
respond
vastli
underserv
realiti
health
dispar
comorbid
medic
condit
press
need
train
investig
fundament
neuroaid
disord
rais
awar
comorbid
preval
hiv
racial
ethnic
minor
rem
commun
end
nimhfund
mount
sinai
institut
neuroaid
dispar
msinad
deploy
train
program
develop
disparitiesfocus
investig
particularli
rem
background
recruit
occur
direct
commun
neuroaid
investig
director
minor
train
program
print
ad
listserv
post
solicit
convent
websit
select
applic
invit
institut
intens
multidisciplinari
didact
seminar
translat
research
experi
individu
career
develop
session
coach
mentor
team
followup
two
year
pilot
grant
msinad
held
institut
sinc
receiv
total
applic
junior
investig
institut
experienc
signific
increas
applic
rem
applic
signific
divers
applic
train
level
disciplin
mdphd
orient
graduat
scholar
persist
neuroaid
dispar
research
great
success
appli
extern
fund
award
fund
eg
pilot
grant
nih
kseri
award
manuscript
publish
submit
review
msinad
provid
innov
comprehens
approach
train
neuroaid
dispar
demonstr
feasibl
sustain
success
develop
junior
investig
particularli
rem
background
cours
fund
cycl
expect
msinad
continu
contribut
divers
new
neuroaid
workforc
stimul
widespread
interest
field
heighten
attent
underserv
popul
condit
antiretrovir
therapi
increas
life
span
hivinfect
individu
preval
neurocognit
impair
increas
infect
individu
live
longer
major
contributor
hivassoci
neurocognit
disord
hand
chronic
neuroinflamm
respons
viral
infect
cn
signific
number
hivinfect
individu
also
drug
abus
hand
mani
individu
often
occur
earlier
time
point
sever
nonabus
infect
popul
drug
abus
includ
cocain
methamphetamin
increas
extracellular
dopamin
cn
hivinfect
drug
abus
increas
cn
accumul
cell
report
chemokin
cell
chemoattract
constitut
express
cn
increas
hiv
infect
hypothes
dopamin
increas
cell
transmigr
across
blood
brain
barrier
bbb
use
vitro
model
human
bbb
show
signific
increas
rest
human
cell
transmigr
respons
dopamin
compar
alon
dopamin
increas
transmigr
alter
cell
express
receptor
determin
flow
cytometri
fac
migratori
phenotyp
cell
respons
detect
actin
tubulin
stain
increas
dopamin
dopamin
receptor
detect
surfac
cell
donor
analyz
fac
significantli
decreas
pha
activ
donor
detect
rest
cell
activ
cell
contribut
specif
dopamin
receptor
rest
well
activ
cell
transmigr
determin
thu
dopamin
may
increas
cell
influx
cn
contribut
increas
neuroinflamm
hivinfect
drug
abus
express
rat
brain
mediat
morphin
abus
withdraw
mainten
lee
campbel
valeriya
avdoshina
italo
mocchetti
email
georgetownedu
georgetown
univers
unit
state
georgetown
univers
unit
state
georgetown
univers
unit
state
intraven
drug
abus
common
practic
observ
hiv
infect
individu
use
opioid
heroin
morphin
caus
distinct
physiolog
state
includ
toler
depend
withdraw
state
may
differenti
effect
chemokin
cytokin
express
therebi
modifi
diseas
progress
relationship
state
may
affect
hiv
neurotox
remain
undefin
address
incorpor
three
morphin
treatment
paradigm
emul
drug
abus
withdraw
mainten
therapi
rat
vivo
express
chemokin
possess
proinflammatori
protect
properti
examin
cortex
striatum
hippocampu
cerebellum
addit
chemoattract
microglia
astrocyt
antibodi
gfap
use
determin
cell
number
morpholog
morphin
abus
paradigm
result
twofold
increas
protein
mrna
express
cortex
striatum
treatment
howev
affect
classic
proinflammatori
cytokin
microglia
astrocyt
number
morpholog
remain
compar
control
morphin
abus
morphin
withdraw
paradigm
result
signific
decreas
express
cortex
return
basal
level
striatum
addit
reduct
gfap
label
astrocyt
within
cortex
observ
morphin
mainten
paradigm
fail
alter
level
induc
glial
respons
final
neurotox
protein
hiv
envelop
inject
striatum
rat
undergo
morphin
abus
paradigm
increas
immunoreact
morphin
treat
anim
compar
control
suggest
potenti
neuron
loss
caus
data
suggest
paradigm
possess
uniqu
profil
glial
respons
may
affect
pathogenesi
hiv
within
cn
jc
viru
load
cerebrospin
fluid
transcript
control
region
rearrang
may
predict
clinic
cours
progress
multifoc
leukoencephalopathi
progress
multifoc
leukoencephalopathi
pml
sever
diseas
central
nervou
system
cn
caus
infect
polyomaviru
jc
viru
jcv
known
treatment
prognost
factor
perform
longterm
studi
focus
mainli
cerebrospin
fluid
csf
sampl
pml
patient
describ
virolog
featur
akin
differ
form
diseas
twentyeight
pml
patient
enrol
patient
classic
pml
cpml
patient
slowli
progress
stabl
neurolog
symptom
benign
pml
asymptomat
patient
patient
csf
urin
blood
sampl
collect
enrol
baselin
everi
six
month
afterward
possibl
jcv
dna
rna
load
determin
jcv
strain
character
baselin
mean
csf
jcv
load
log
copi
ml
cpml
patient
log
copiesml
benign
pml
patient
log
copiesml
asymptomat
pml
patient
log
copiesml
pml
patient
cpml
versu
benign
p
cpml
versu
asymptomat
p
neg
versu
benign
p
organ
jcv
transcript
control
region
tcr
show
unusu
archetyp
structur
longterm
surviv
patient
sequenc
found
commonli
wherea
bind
site
common
cpml
patient
neg
patient
result
suggest
jcv
load
csf
organ
tcr
consid
indic
pml
clinic
outcom
buprenorphin
therapi
opiat
addict
reduc
inflammatori
respons
monocyt
characterist
neuroaid
alter
bbb
human
immunodefici
viru
enter
cn
earli
cours
infect
result
greater
hiv
infect
neurocognit
impair
call
hivassoci
neurocognit
disord
hand
despit
success
antiretrovir
mani
hiv
infect
opiat
abus
increas
inflamm
contribut
hand
buprenorphin
bup
use
treat
opioid
addict
impact
bup
transmigr
hiv
infect
monocyt
across
blood
brain
barrier
bbb
contribut
inflamm
unknown
studi
effect
bup
chemokin
elev
cn
hiv
infect
peopl
junction
protein
human
monocyt
brain
microvascular
endotheli
cell
bmvec
necessari
monocyt
cross
bbb
hypothes
bup
alter
chang
junction
protein
monocyt
bbb
reduc
abil
monocyt
transmigr
cn
across
bbb
show
increas
hiv
infect
monocyt
transmigr
across
bbb
found
increas
jama
phosphoryl
bup
decreas
effect
phosphoryl
associ
migrat
bup
could
decreas
neuroinflamm
induc
chemotaxi
cell
project
monocyt
associ
migratori
phenotyp
bup
decreas
effect
proteom
quantifi
membran
peptid
monocyt
bmvec
show
differ
phosphoryl
leukosialin
respect
bup
treatment
despit
advanc
immun
viral
infect
central
nervou
system
cn
remain
devast
caus
enceph
neurodegener
particularli
young
elderli
immunocompromis
neuron
princip
nonrenew
tradit
mechan
viral
clearanc
employ
peripheri
cytolysi
infect
cell
could
prove
detriment
target
toward
cn
neuron
clear
immun
system
limit
viral
spread
brain
mechan
infect
neuron
respond
inflammatori
environ
creat
immun
infiltr
brain
remain
larg
undefin
interferongamma
interferonbeta
potent
antivir
cytokin
classic
signal
activ
recent
shown
western
blot
basal
level
primari
mous
hippocamp
neuron
drastic
reduc
compar
control
mous
embryon
fibroblast
mef
consequ
phosphoryl
nuclear
local
detect
western
blot
immunofluoresc
substanti
mute
delay
hippocamp
neuron
treat
nevertheless
treatment
protect
primari
neuron
measl
viru
mv
infect
convers
neuron
respons
differ
significantli
mef
howev
inhibitori
effect
mv
replic
neuron
qpcr
analysi
reveal
pattern
interferonstimul
gene
isg
express
neuron
respons
interferon
poli
c
treatment
differ
significantli
mef
data
suggest
neuron
util
distinct
signal
respons
antivir
cytokin
propos
cell
typespecif
differ
type
interferon
respons
play
key
role
abil
neuron
surviv
viral
infect
neurotrop
mous
hepat
viru
mhv
infect
mice
caus
meningoenceph
myeliti
subsequ
axon
loss
demyelin
direct
virusmedi
axon
damag
occur
concurr
independ
demyelin
serv
virusinduc
model
multipl
sclerosi
current
studi
use
isogen
spike
protein
recombin
strain
exhibit
cn
demyelin
involv
mix
popul
inflammatori
cell
predominantli
macrophagesmicroglia
smaller
popul
lymphocyt
evalu
axon
loss
demyelin
spinal
cord
demonstr
neurotrop
mhv
infect
begin
neuron
cell
bodi
propag
centripet
axon
subsequ
axon
degener
demyelin
neurotrop
mhv
strain
also
induc
optic
neuriti
retrograd
spread
brain
optic
nerv
eye
intracrani
inocul
migrat
activ
macrophagesmicroglia
white
matter
optic
nerv
spinal
cord
follow
viral
spread
suggest
recruit
cell
mediat
demyelin
chronic
infect
macrophagesmicroglia
remain
present
within
area
demyelin
ultrastructur
studi
reveal
macrophag
surround
myelin
axon
myelin
unravel
yet
axon
complet
intact
macrophag
cell
membran
intim
contact
outer
portion
myelin
sheath
engulf
myelin
sheath
therefor
one
mechan
demyelin
involv
macrophagemedi
myelin
strip
autophagi
pathway
affymetr
microarray
analysi
mrna
express
mhv
infect
tissu
reveal
upregul
sever
molecul
classic
signal
pathway
regul
autophagi
interferon
ifn
gamma
product
ifngamma
activ
microglia
promot
phagolysom
matur
autophagi
autophag
sequestr
viral
compon
also
fuel
mhc
classii
present
mhv
antigen
regul
product
type
ifn
evid
molecular
pathway
drive
autophagi
mhv
infect
advanc
understand
mechan
viral
induc
demyelin
occur
without
involv
convent
cell
program
neurotox
cofactor
associ
dementia
abrog
induc
neurogli
toxic
vitro
pkc
activ
patient
undergo
antivir
treatment
prolong
infect
develop
associ
neurocognit
disord
hand
neurolog
complic
infect
result
direct
neuron
damag
proinflammatori
product
releas
infect
uninfect
activatedmacrophag
microglia
astrocyt
current
studi
bioplex
array
show
elev
level
signatori
chemokinescytokin
pdegf
cerebrospin
fluid
csf
infect
dement
hivd
patient
infect
nondement
nd
patient
consist
hivinfect
macrophag
astrocyt
treat
induc
signatori
molecul
among
signatori
cytokin
chemokin
distinctli
upregul
activ
astrocyt
infect
macrophag
combin
synergist
enhanc
neuron
toxic
show
chemotact
activ
fold
peripher
blood
mononuclear
cell
pbmc
suggest
intersect
signal
event
impart
bind
respect
surfac
receptor
present
neuron
accord
block
downstream
map
kinas
mapk
signal
pathway
suppress
neurotox
bryostatin
pkc
modul
suppressor
mehla
et
al
confer
neuroprotect
bryostatin
also
suppress
pbmc
chemotaxi
conclus
demonstr
induct
chemokin
cytokin
infect
brain
well
synerg
neuron
toxic
dampen
bryostatin
background
role
neuroinflammatori
genet
marker
hivrel
neurocognit
impair
may
inform
new
pathogen
mechan
method
hiv
individu
age
year
enrol
histor
advanc
diseas
stabl
haart
undetect
plasma
hivrna
underw
standard
neuropsycholog
np
assess
assess
cognit
abil
two
np
summari
score
gener
global
meant
score
captur
overal
neurocognit
perform
global
deficit
score
gd
captur
degre
cognit
impair
npimpair
versu
npnormal
classifi
accord
gd
method
npimpair
dna
extract
saliva
thirteen
snp
genotyp
use
taqman
assay
appli
biosystem
repeat
nontempl
control
includ
run
median
rang
genotyp
success
rate
carriag
minor
allel
snp
compar
neurocognit
score
result
apo
allel
associ
better
overal
neurocognit
perform
p
allel
carrier
slightli
npimpair
vs
allel
allel
carrier
like
npimpair
vs
allel
carrier
ikbl
allel
associ
greater
npimpair
base
gd
allel
carrier
slightli
lower
nadir
allel
carrier
vs
ikbl
allel
carrier
higher
count
vs
p
aidsdefin
ill
p
conclus
involv
apo
minor
allel
consist
increas
risk
cognit
progress
nonhiv
hivdementia
cohort
snp
tnf
adjac
gene
associ
inflammatori
diseas
diabet
asthma
may
link
increas
comorbid
role
hand
pathogenesi
tnf
block
high
linkag
disequilibrium
haplotyp
analys
conduct
role
bim
virusinduc
apoptosi
within
central
nervou
system
penni
clark
john
galvin
smith
leser
kenneth
tyler
email
pennyclark
ucdenveredu
ucdenv
unit
state
ucdenv
unit
state
ucdenv
unit
state
ucdenv
unit
state
reoviru
infect
mous
brain
spinal
cord
provid
classic
model
system
studi
viral
pathogenesi
within
central
nervou
system
cn
reoviru
infect
mous
cn
result
neuron
apoptosi
lead
tissu
injuri
diseas
bax
proapoptot
famili
protein
present
mitochondri
membran
activ
bax
form
homo
baxbax
hetero
baxbak
dimer
creat
pore
mitochondri
membran
proapoptot
factor
includ
cytochrom
c
second
mitochondrialderiv
activ
caspas
smac
releas
recent
shown
bax
activ
brain
follow
reoviru
infect
contribut
viral
pathogenesi
bax
activ
member
homolog
domain
famili
protein
show
famili
protein
bim
interact
mediat
apoptosi
upregul
brain
follow
infect
reoviru
increas
bim
mrna
detect
brain
mice
infect
reoviru
addit
bim
upregul
protein
level
migrat
mitochondri
membran
infect
cell
coloc
bax
bim
also
upregul
brain
mice
infect
west
nile
viru
suggest
upregul
bim
common
pathway
initi
neuron
apoptosi
follow
viru
infect
cn
dopamin
mediat
chang
blood
brain
barrier
neuroinflamm
context
cn
hiv
infect
substanc
abus
jacquelin
cn
complic
due
hiv
infect
persist
even
current
antiretrovir
therapi
hiv
enter
cn
within
two
week
primari
infect
transmigr
infect
monocyt
across
blood
brain
barrier
bbb
cn
cell
produc
viru
neurotox
factor
infect
andor
activ
perivascular
macrophag
microglia
astrocyt
result
neuroinflamm
lead
hivassoci
neurocognit
disord
hand
encompass
cn
abnorm
includ
forget
inabl
follow
direct
impair
decis
make
matur
monocyt
express
permiss
hiv
infect
preferenti
transmigr
across
bbb
mani
drug
abus
higher
monocyt
tcell
infiltr
cn
may
contribut
alter
neurocognit
deficit
drug
abus
methamphetamin
cocain
increas
extracellular
dopamin
cn
addit
chemokin
express
cn
chemotact
tcell
monocyt
also
increas
hiv
infect
lab
demonstr
dopamin
increas
mediat
transmigr
monocyt
across
vitro
bbb
model
hypothes
increas
extracellular
dopamin
cn
hivinfect
drug
abus
increas
mediat
transmigr
monocyt
facilit
entri
hiv
cn
contribut
chronic
neuroinflamm
caus
hand
determin
concentr
dopamin
maxim
transmigr
hiv
infect
uninfect
monocyt
across
tissu
cultur
model
human
bbb
express
dopamin
receptor
monocyt
determin
use
flow
cytometri
qrtpcr
also
examin
brain
microvascular
endotheli
cell
effect
dopamin
junction
protein
jama
occludin
alcam
pecam
maintain
bbb
integr
facilit
transmigr
endoplasm
reticulum
er
stress
cocain
induc
microgli
cell
death
blais
costa
honghong
yao
shilpa
buch
email
bmathiascosta
unmcedu
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
although
well
document
drug
abus
cocain
caus
enhanc
progress
human
immunodefici
viru
hiv
associ
neuropatholog
disord
underli
mechan
mediat
effect
remain
poorli
understood
present
studi
demonstr
exposur
microgli
cell
cell
cocain
result
decreas
cell
viabil
determin
mt
tunel
assay
microgli
toxic
cocain
accompani
increas
express
cleav
demonstr
western
blot
assay
furthermor
increas
microgli
toxic
also
associ
concomit
increas
product
intracellular
reactiv
oxygen
speci
effect
amelior
cell
pretreat
nadph
oxidas
inhibitor
apocynin
thu
underscor
role
oxid
stress
process
novel
find
studi
involv
er
signal
mediat
perk
chop
upregul
cell
expos
cocain
conclus
find
underscor
import
robust
microgli
innat
immun
respons
presenc
cocain
dampen
due
microgli
toxic
understand
link
er
stress
oxid
stress
apoptosi
lead
develop
therapeut
strategi
target
cocainemedi
microgli
deathdysfunct
background
haart
era
collect
longitudin
antiretrovir
medic
arv
histori
hivinfect
individu
becom
increasingli
import
use
technolog
possibl
increas
effici
medic
histori
obtain
summar
method
hiv
neurobehavior
research
program
hnrp
dmi
group
develop
webbas
touchscreenen
ipad
applic
interfac
display
medic
use
report
previou
visit
use
actual
pill
imag
facilit
accur
particip
report
data
subject
realtim
qc
check
account
clinic
unlik
regimen
patient
histori
medic
avail
raw
data
dynam
transform
medic
instanc
mi
uninterrupt
period
use
particular
drug
mi
repres
drug
use
set
overlap
epoch
present
graphic
link
data
neurolog
medic
complic
applic
develop
web
hardwar
softwar
requir
minim
train
time
greatli
reduc
avail
inform
via
web
could
potenti
extend
use
applic
beyond
research
clinic
set
result
develop
applic
complet
exist
arv
data
transform
new
data
structur
data
includ
lifetim
medic
histori
patient
support
studi
applic
current
use
hnrp
replac
tradit
crf
releas
anticip
accuraci
effici
data
collect
improv
dramat
term
time
spent
particip
accuraci
neuromed
assess
data
entri
analysi
pleas
explor
applic
attach
kiosk
visit
http
hnrphivresearchucsdeduarvweb
conclus
use
realtim
data
check
flexibl
data
storag
model
userfriendli
visual
abl
provid
easili
deploy
accur
lowcost
solut
collect
medic
histori
data
matthew
cusick
jane
libbey
robert
fujinami
email
matthewcusick
pathutahedu
univers
utah
unit
state
univers
utah
unit
state
univers
utah
unit
state
viral
infect
central
nervou
system
cn
trigger
antivir
host
defens
cell
initi
inflammatori
cascad
control
viral
replic
dissemin
extent
proinflammatori
respons
cn
time
releas
proinflammatori
cytokin
lead
neuron
excit
tumor
necrosi
factor
tnf
interleukin
il
proinflammatori
cytokin
link
develop
seizur
theiler
murin
encephalomyel
viru
tmev
induc
seizur
model
still
unclear
extent
infiltr
macrophag
vs
resid
cn
cell
contribut
acut
seizur
mani
celltyp
produc
studi
show
significantli
higher
number
microglia
produc
compar
infiltr
macrophag
contrast
infiltr
macrophag
produc
significantli
mice
treat
minocyclin
wogonin
compound
neuroimmunomodulatori
properti
significantli
fewer
macrophag
infiltr
brain
significantli
fewer
seizur
therefor
identifi
infiltr
macrophag
import
immun
cell
contribut
develop
acut
seizur
background
extent
characterist
neurocognit
declin
remain
unclear
viral
suppress
hiv
individu
method
hiv
individu
age
enrol
histor
advanc
diseas
nadir
current
stabl
month
screen
major
neurolog
psychiatr
confound
undetect
plasma
hivrna
across
studi
period
underw
standard
neuropsycholog
np
assess
sensit
hivrel
impair
includ
outcom
measur
baselin
month
followup
individu
regressionbas
summari
chang
score
comput
base
publish
norm
chang
data
four
differ
classif
neurocognit
declin
use
assess
associ
diseas
factor
three
involv
increasingli
stringent
overal
declin
definit
confid
interv
ci
around
norm
regressionbas
summari
chang
score
one
definit
base
outcom
measur
captur
declin
specif
np
measur
result
ci
cutoff
yield
overal
declin
ci
ci
minu
measur
cutoff
yield
declin
among
system
hiv
factor
lower
baselin
associ
declin
definit
p
minu
measur
cutoff
definit
past
cvd
event
includ
abnorm
lipid
valu
hypertens
associ
declin
use
declin
older
age
associ
declin
use
declin
baselin
depress
associ
definit
declin
conclus
despit
viral
suppress
neurocognit
declin
occur
signific
rate
even
milder
form
declin
appear
associ
longterm
immun
dysregul
longer
longitudin
followup
warrant
older
age
longterm
effect
cvd
alreadi
associ
declin
month
declin
data
use
efficaci
tool
clinic
trial
littl
known
relat
pur
famili
member
purgamma
purgamma
three
nucleic
acidbind
amino
acid
domain
puralpha
purgamma
differ
interven
amino
acid
point
differ
pur
protein
cell
function
purgamma
thought
embryon
form
replac
puralpha
postnat
mous
previou
studi
indic
rel
high
express
purgamma
mous
embryogenesi
day
birth
level
declin
famili
member
puralpha
increas
recent
find
purgamma
express
oligodendroglioma
cell
hypothes
protein
might
express
special
circumst
adult
tissu
coimmunoprecipit
experi
reveal
interact
puralpha
purgamma
oligodendroglioma
cell
also
coimmunoprecipit
puralpha
purgamma
astroglioma
cell
line
mg
local
celltyp
specif
howev
sinc
purgamma
mainli
cytoplasm
mg
cell
compar
mainli
nuclear
local
oligodendroglioma
cell
summari
nonembryon
neoplast
cell
display
express
purgamma
least
fraction
interact
puralpha
current
investig
interact
puralpha
purgamma
context
infect
puralpha
known
function
tat
influenc
replic
transcript
hiv
well
replic
jcv
pml
aid
mutat
purgamma
puralpha
allow
us
examin
interact
pur
protein
tat
transcript
regul
cebp
nfat
via
novel
downstream
element
ltr
cell
monocytemacrophag
lineag
depart
microbiolog
immunolog
drexel
univers
colleg
medicin
unit
state
cellular
viral
factor
regul
transcript
bind
dna
element
present
upstream
downstream
transcript
start
site
long
termin
repeat
ltr
transfac
analysi
subtyp
b
lai
ltr
reveal
three
potenti
downstream
ccaat
enhanc
bind
protein
cebp
bind
site
element
present
immedi
downstream
ltr
suggest
may
function
role
regul
product
transcript
analysi
across
subtyp
indic
element
high
degre
conserv
term
nucleotid
sequenc
physic
locat
ltr
interestingli
element
overlap
previous
identifi
element
shown
bind
member
nuclear
factor
activ
tcell
nfat
famili
protein
result
indic
nfat
higher
rel
affin
element
compar
member
cebp
famili
also
observ
element
abl
compet
low
affin
upstream
cebp
bind
site
respect
cebp
bind
suggest
util
nfat
cebp
addit
ltr
contain
singl
point
mutat
c
chang
posit
element
compromis
bind
cognat
factor
show
reduc
transcript
activ
suggest
serv
posit
regul
ltrdirect
transcript
rel
import
nfat
cebp
respect
transcript
identif
relev
isoform
cebp
nfat
current
investig
moreov
extracellular
signal
like
cytokin
exampl
regul
process
modul
express
regulatori
transcript
factor
includ
cebp
especi
cell
monocytemacrophag
lineag
jc
viru
encephalopathi
jcve
newli
describ
gray
matter
diseas
brain
caus
product
infect
cortic
pyramid
neuron
character
full
length
sequenc
jcv
isol
brain
jcve
patient
analyz
distribut
variou
compart
pcr
determin
viral
gene
express
brain
immunohistochemistri
ihc
identifi
novel
jcv
variant
uniqu
bp
delet
agno
gene
encod
truncat
amino
acid
peptid
harbor
archetypelik
regulatori
region
variant
lack
one
three
nuclear
protein
bind
region
agno
gene
predomin
brain
coexist
agnointact
wildtyp
strain
doubl
immunostain
antiagno
antibodi
demonstr
truncat
agno
peptid
present
major
cortic
cell
product
infect
jcv
screen
dna
sampl
brain
csf
pbmc
sampl
pml
patient
hiv
hivcontrol
subject
anoth
jcvcpn
strain
differ
pattern
agnodelet
found
csf
hivpml
patient
also
coexist
wildtyp
agnointact
jcv
find
suggest
novel
tropism
cortic
pyramid
neuron
may
associ
agno
delet
product
lytic
infect
cell
result
fulmin
jcv
encephalopathi
death
may
facilit
coinfect
wildtyp
strain
jcv
previous
report
counteract
retract
neuron
processess
mediat
tnfalpha
also
demonstr
igfi
exert
effect
via
interfer
tnfalphamedi
interact
membran
associ
insulin
receptor
substrat
key
molecul
transmit
signal
intracellular
pathway
show
prevent
neg
effect
tnfalpha
stabil
neuron
process
interact
disintegrin
metalloproteinas
immunohistochem
analysi
demonstr
increas
express
cytoplasm
neuron
enlarg
reactiv
astrocyt
oligodendrocyt
brain
tissu
patient
hiv
enceph
hive
also
coloc
hive
brain
tissu
sampl
longterm
treatment
neuron
cell
tnfalpha
result
loss
dendrit
arbor
accumul
ro
effect
prevent
stimul
presenc
treatment
primari
cortic
neuron
tnfalpha
lead
increas
express
cell
silenc
abrog
induct
interestingli
tnfalpha
combin
treatment
neg
effect
express
silenc
induc
activ
caspas
although
less
cell
treat
suggest
even
moder
amount
inhibit
apoptot
signal
neuron
found
abl
form
protein
complex
immunoprecipit
gst
pull
assay
promot
interact
plasma
membran
neuron
cell
tnfalpha
inhibit
interact
present
result
suggest
new
mechan
sustain
stabil
neuron
process
mediat
signal
work
made
possibl
grant
award
nih
sa
polyomaviru
jc
infect
human
oligodendrocyt
progenitor
cell
dysregul
product
chemokin
alter
differenti
oligodendrocyt
reactiv
human
neurotrop
polyomaviru
cn
result
fatal
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
lytic
destruct
oligodendrocyt
occur
termin
stage
viral
infect
cycl
consid
critic
factor
develop
demyelin
pathogenesi
pml
howev
limit
knowledg
interact
jcv
oligodendrocyt
impact
denud
axon
earli
stage
viral
reactiv
prior
destruct
infect
cell
use
vitro
system
recapitul
differenti
oligodendrocyt
specif
human
neural
progenitor
cell
deriv
fetal
brain
demonstr
jc
viru
delay
progress
oligodendrogli
lineag
jcv
infect
suppress
express
mrna
oligodendrocytespecif
protein
stage
differenti
promin
mrna
specif
matur
oligodendrocyt
particular
plateletderiv
growth
factor
alpah
pdgfralpha
myelin
basic
protein
mbp
plp
concomit
observ
chang
oligodendrocyt
matur
jcv
infect
signific
dysregul
express
sever
chemokin
includ
rant
cxc
ligand
gro
find
jc
virusinduc
delay
progress
oligodendrogli
lineag
provid
evid
differenti
block
oligodendrocyt
progenitor
cell
infect
jcv
may
critic
factor
failur
remyelin
pml
work
made
possibl
grant
award
nih
kk
essenti
function
tyrosinebas
vesicl
sort
signal
agnoprotein
polyomaviru
jc
transit
golgi
plasma
membran
note
sequenc
ysal
correspond
yxxl
consensu
sequenc
tyrosinebas
vesicl
sort
signal
found
near
cterminu
amino
acid
amino
acid
agnoprotein
known
releas
polyomavirus
jcv
cell
occur
without
cell
lysi
like
involv
vesicular
transport
investig
role
agnoprotein
process
mutat
ysal
motif
asav
found
mutat
sever
effect
viral
life
cycl
inhibit
viral
protein
synthesi
dna
replic
introduc
tantigenexpress
svga
cell
primari
astrocyt
conclud
motif
perform
essenti
function
viral
life
cycl
work
made
possibl
grant
award
nih
kk
longact
nanoformul
antiretrovir
drug
neuroprotect
infect
human
mice
brain
background
complianc
escap
immun
surveil
cumul
toxic
underli
treatment
failur
antiretrovir
therapi
art
hiv
diseas
toward
end
laboratori
develop
atazanvir
atv
ritonavir
rtv
nanoformul
refer
nanoart
method
newborn
mice
transplant
human
hematopoiet
stem
cell
infect
age
eight
week
infect
mice
inject
subcutan
sc
weekli
interv
nanoart
mgkg
atvrtv
six
dosag
anim
dosag
six
anim
remain
untreat
control
anoth
set
uninfect
anim
treat
schedul
use
drug
safeti
profil
evalu
anim
sacrif
week
mice
week
mice
postinfect
analysi
tissu
drug
level
viral
load
histopatholog
quantit
immunofluoresc
analysi
conduct
differ
region
thick
brain
section
look
inher
express
neuron
marker
stain
synaptophysin
neurofila
astrocyt
specif
marker
gfap
result
infect
treat
anim
surviv
studi
retain
human
hematopoiesi
week
viral
infect
anim
show
sustain
viral
load
median
valu
x
rna
copiesml
viral
load
level
detect
inject
mice
inject
mice
viral
rebound
observ
week
nanoart
cessat
mice
histopatholog
nanoart
treat
mice
brain
show
signific
increas
express
cerebr
cortex
whisker
barrel
compar
untreat
anim
nanoart
treatment
preserv
damag
human
lymphoid
tissu
prevent
reduct
tcell
conclus
develop
nanoart
current
test
infect
human
mice
demonstr
robust
neuroprotect
outcom
upregul
neuron
hives
lead
decreas
monoamin
oxidas
express
activ
inhibit
amrita
datta
chaudhuri
sowmya
v
yelamanchili
howard
fox
email
adattach
unmcedu
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
microrna
mir
implic
pathogenesi
mani
neurodegen
diseas
investig
role
alter
mir
express
hiv
enceph
hive
determin
upregul
hive
anim
model
simian
immunodefici
viru
enceph
sive
hypothes
express
induc
within
neuron
neuroprotect
respons
hive
sive
first
valid
upregul
sive
brain
hybrid
combin
immunofluoresc
label
reveal
sive
express
within
neuron
second
elucid
downstream
effect
overexpress
creat
stabl
clone
cell
line
express
scrambl
mir
mirnul
compar
differ
global
gene
express
pattern
use
microarray
follow
valid
use
quantit
real
time
pcr
focus
one
gene
found
downregul
express
clone
monoamin
oxidas
maoa
western
blot
analysi
confirm
decreas
maoa
protein
level
clone
well
human
neuron
transduc
clone
also
lower
maoa
enzym
activ
sinc
maoa
bind
site
predict
maoa
must
downstream
direct
target
maoa
transcript
activ
predict
target
western
blot
analysi
reveal
reduct
clone
downregul
could
therefor
lead
observ
decreas
maoa
maoa
necessari
catabol
neurotransmitt
gener
reactiv
oxygen
speci
contribut
cell
death
perform
cell
viabil
assay
clone
three
day
serum
starvat
clone
higher
cell
viabil
implic
neuroprotect
role
chronic
increas
express
thu
uncov
uniqu
mechan
neuroprotect
viral
infect
brain
increas
level
specif
chemiokin
profil
cerebrospin
fluid
patient
affect
leukoencephalopathi
cytokin
chemochin
present
differ
profil
aid
relat
opportunist
infect
accord
differ
pattern
neuroinflammatori
respons
display
neurolog
infect
defin
profil
cytokineschemokin
cerebrospin
fluid
csf
serum
sampl
period
collect
posit
carttreat
patient
affect
two
form
leukoencephalopathi
neg
patient
acut
dissemin
encephalo
myeliti
adem
use
magnet
bead
base
multiplex
immunoassay
qpcr
perform
gag
delbu
et
al
jcv
tag
eurort
polyoma
panel
kit
eurospit
spa
triest
itali
detect
cytokin
measur
pattern
protein
includ
mig
gmcsf
mcsf
constantli
overexpress
posit
patient
compar
neg
patient
note
among
posit
patient
cytokin
pattern
signific
differ
patient
suffer
pml
respect
patient
ndle
particular
chemokin
mig
overexpress
pml
group
chemokin
mcsf
gmcsf
show
significantli
higher
level
ndle
group
focus
attent
cytokineschemokin
profil
pml
patient
respect
ndle
patient
exclud
analysi
patient
affect
adem
two
cytokin
mig
underexpress
ndle
compar
pml
patient
despit
small
size
analyz
sampl
result
pilot
studi
suggest
probabl
coexist
signal
pathway
may
involv
pathogenesi
aidsrel
leukoencephalopathi
may
regul
differ
cascad
cytokin
pilot
studi
show
complex
interplay
chemokin
virus
infect
microgli
cell
emphas
role
immunoregul
aidsrel
neurolog
disord
also
cart
treatment
efficaci
natalizumab
treatment
multipl
sclerosi
ms
patient
high
case
progress
multifoc
leukoencephalopathi
pml
report
worldwid
among
treat
patient
forti
natalizumabtr
ms
patient
femal
ms
patient
femal
treat
convent
therapi
control
enrol
studi
urin
serum
peripher
blood
collect
monthli
monitor
jcv
bkv
herpesvirus
reactiv
viral
load
assay
quantit
realtim
pcr
viral
strain
molecularli
character
mean
number
followup
everi
patient
rang
total
clinic
specimen
analyz
whole
jcv
found
least
urin
patient
control
p
wherea
bkv
found
least
urin
patient
control
p
follow
jcv
urinari
excret
increas
patient
decreas
patient
remain
stabl
patient
bkv
urinari
excret
increas
patient
decreas
patient
remain
stabl
patient
jcv
genom
sporad
detect
serum
peripher
blood
herpesvirus
genom
amplifi
median
viral
load
jcv
follow
log
copiesml
statist
higher
p
median
viral
load
bkv
log
copiesml
jcv
strain
amplifi
urin
archetyp
genotyp
bkv
amplifi
strain
archetyp
ww
high
preval
genotyp
result
show
jcv
bkv
replic
increas
natalizumab
treatment
even
aspect
still
difficult
explain
add
inform
issu
pml
develop
natalizumab
treat
patient
prove
relev
polyomavirus
monitor
urin
latent
viral
infect
young
patient
inflammatori
diseas
treat
biolog
agent
preval
jc
viru
genotyp
object
determin
longterm
effect
biolog
therapi
human
herpesviru
polyomaviru
infect
young
patient
studi
design
one
hundr
eightysix
sampl
urin
serum
peripher
blood
mononuclear
cell
pbmc
patient
year
old
crohn
diseas
ulcer
coliti
juvenil
rheumatoid
arthriti
treat
immunotherapi
convent
therapi
month
test
real
time
pcr
one
hundr
twentyfour
sampl
urin
pbmc
match
healthi
volunt
year
old
includ
control
sequenc
jcv
viral
protein
transcript
control
region
tcr
perform
result
herp
simplex
viru
varicella
zoster
viru
genom
detect
patient
wherea
epsteinbarr
viru
human
cmv
human
genom
detect
patient
respect
jcv
detect
urin
sampl
patient
control
sera
patient
shed
jcv
match
pbmc
signific
associ
infliximab
treatment
excret
jcv
genotyp
discuss
demonstr
subclin
infectionreactiv
jcv
genotyp
young
patient
infliximab
therapi
convers
show
increas
suscept
herpesviru
infect
futur
studi
warrant
investig
effect
jcv
reactiv
health
young
patient
treat
infliximab
effect
methamphetamin
epigenet
regul
human
brain
methamphetamin
meth
highli
addict
psychostimul
abus
worldwid
use
particularli
high
among
person
hiv
infect
interact
meth
hivar
yet
complet
understood
hiv
meth
abus
present
cognit
abnorm
higher
plasma
viral
load
neurolog
damag
nonabus
potenti
hiv
neurodegener
meth
may
mediat
differ
molecular
mechan
includ
calcium
dysregul
oxid
stress
inflamm
moreov
meth
exposur
alter
dna
methyl
histon
acetyl
gene
express
anim
model
dna
methyl
directli
link
regul
latenc
histon
deacetyl
need
sustain
silenc
integr
proviru
goal
studi
investig
effect
meth
epigenet
regul
express
human
brain
studi
postmortem
frontal
cortex
sampl
person
die
hivof
histori
meth
abus
hiv
meth
hiv
meth
analysi
express
qpcr
show
increas
mrna
level
hiv
meth
case
profil
enzym
report
redund
function
adult
brain
show
meth
abus
alter
express
analysi
statu
global
methyl
brain
show
increas
methyl
hiv
meth
group
taken
togeth
result
suggest
methinduc
epigenet
chang
human
brain
might
mediat
increas
express
better
understand
molecular
mechan
govern
infect
brain
context
drug
abus
crucial
design
therapeut
intervent
work
support
pilot
project
grant
pd
translat
methamphetamin
aid
research
center
ig
nih
grant
em
california
neuroaid
tissu
network
ig
activ
latent
herp
simplex
viru
suppress
latand
mirna
trigemin
ganglia
within
timefram
singl
cycl
viral
replic
herp
simplex
viru
replic
oral
genit
mucosa
establish
latent
infect
peripher
neuron
much
pain
miseri
associ
infect
due
lesion
caus
virus
reactiv
latent
infect
neuron
viru
requir
late
protein
introduc
cell
infect
least
protein
initi
transcript
overcom
checkpoint
product
infect
latent
infect
neuron
accumul
long
viral
transcript
lat
viral
mirna
sinc
neither
present
neuron
fundament
question
enabl
viru
reactiv
answer
question
devis
model
viral
reactiv
take
place
within
time
frame
singl
viral
replic
cycl
briefli
mice
infect
corneal
rout
day
infecti
viru
detect
trigemin
ganglia
ganglia
remov
incub
medium
contain
antibodi
ngf
system
viral
mrna
detect
earli
h
excis
amount
increas
h
interv
use
system
report
follow
antingf
antibodi
acceler
reactiv
latent
viru
possibl
induc
strong
stress
respons
contrast
ngf
plu
egf
inhibit
accumul
transcript
period
ii
mrna
transcrib
class
rna
increas
time
even
presenc
cycloheximid
indic
transcript
total
disord
presum
derepress
viral
gene
iii
lat
mirna
decreas
amount
concurr
increas
viral
gene
express
iv
decreas
lat
mirna
level
requir
denovo
transcript
find
challeng
current
model
exit
latenc
requir
prior
express
either
osteopontin
motif
requir
enhanc
replic
osteopontin
opn
cytokinelik
protein
increas
sivand
hivinfect
monocytederiv
macrophag
cerebrospin
fluid
brain
tissu
hivinfect
individu
without
neurocognit
disord
time
littl
known
regard
direct
molecular
mechan
opn
enhanc
replic
ectop
express
opn
surrog
cell
line
produc
protein
endogen
opn
shown
enhanc
infect
replic
pathway
involv
activ
bind
site
within
promot
opn
multifunct
protein
secret
cell
variant
express
exclus
intracellular
fashion
protein
subject
posttransl
modif
includ
glycosyl
phosphoryl
proteolyt
cleavag
opn
aspartaterich
domain
well
integrinand
put
calciumand
domain
studi
use
seri
opn
delet
mutant
well
opn
variant
contain
sitespecif
mutat
target
discret
motif
identifi
region
protein
requir
enhanc
replic
model
system
base
transfect
opn
mutant
express
plasmid
tzmbl
cell
express
endogen
opn
follow
infect
hivgfp
tag
report
viru
quantif
infect
fac
capsid
elisa
cotransfect
opn
mutant
express
plasmid
togeth
hivcatltr
report
promot
vector
use
quantifi
abil
opn
variant
activ
hiv
promot
preliminari
data
suggest
motif
carboxyltermin
portion
opn
requir
enhanc
replic
noncontigu
region
may
also
contribut
phenotyp
impact
morphin
human
immunodefici
viru
type
hepat
c
viru
human
microglia
cell
depend
autophagi
lysosom
pathway
nazira
elhag
email
nelhag
vcuedu
virginia
commonwealth
univers
unit
state
inject
drug
user
idu
remain
import
popul
risk
bloodborn
infect
human
immunodefici
viru
hiv
hepat
c
viru
hcv
opiat
suggest
cofactor
role
immunopathogenesi
viral
diseas
potenti
compromis
host
immun
respons
enhanc
microbi
infect
determin
mechan
opioid
alter
neuropathogenesi
hcv
aim
identifi
potenti
converg
point
opioid
hcv
signal
autophag
pathway
may
one
converg
point
level
autophagi
analyz
primari
human
microglia
infect
neurotrop
strain
cell
culturederiv
hcv
expos
morphin
alon
combin
viru
autophag
protein
detect
western
blot
autophagosom
identifi
use
immunofluoresc
microscopi
flow
cytometri
inhibit
autophagi
microglia
treat
kinas
inhibitor
transfect
autophagyrel
protein
small
interf
rna
proinflammatori
cytokin
quantifi
elisa
increas
level
autophagosom
format
well
autophag
protein
beclin
detect
follow
incub
infecti
hcv
increas
level
detect
cultur
supernat
exposur
morphin
alon
combin
hcv
caus
decreas
autophag
pathway
cytokin
secret
downregul
autophagi
inhibit
earli
stage
replic
microglia
expos
hcv
significantli
reduc
induct
suggest
product
microglia
occur
induct
autophagi
conclus
infect
microglia
hcv
induc
autophagi
machineri
microgli
activ
exposur
morphin
decreas
autophagi
pathway
disrupt
host
immun
respons
role
agnogen
delet
archetypelik
regulatori
region
jcv
strain
isol
brain
patient
jcv
encephalopathi
jcve
background
jc
viru
cortic
pyramid
neuron
jcvcpn
isol
brain
individu
jcv
encephalopathi
jcve
post
mortem
analysi
show
product
infect
cortic
pyramid
neuron
jcvcpn
contain
agnogen
delet
nucleotid
archetypelik
regulatori
region
rr
object
goal
understand
effect
jcvcpn
agnogen
delet
rr
type
replic
differ
cell
line
jcv
infect
neuron
newli
observ
phenomenon
jcvcpn
first
patientisol
strain
larg
agnogen
delet
method
compar
replic
jcvcpn
prototyp
monkey
kidney
human
neuroblastoma
svg
human
fetal
glial
cell
line
chimer
virus
jcvcpn
gener
exchang
rr
agnogen
level
dna
replic
mrna
express
determin
use
qpcr
qrtpcr
respect
result
jcvcpn
replic
viral
dna
svg
cell
lesser
degre
cell
jcvcpn
earli
late
mrna
express
decreas
compar
cell
introduct
jcvcpn
rr
delet
agnogen
result
decreas
level
dna
replic
mrna
express
introduct
rr
full
length
agnogen
jcvcpn
partial
rescu
decreas
level
dna
replic
mrna
express
delet
complet
agnogen
caus
decreas
dna
replic
prevent
agnoprotein
express
addit
stop
codon
effect
conclus
agnogen
delet
archetypelik
rr
jcvcpn
contribut
lower
replic
compar
kidney
cell
jcvcpn
replic
advantag
neuron
cell
interestingli
agnogen
delet
phenotyp
caus
loss
agnogen
dna
rather
absenc
agnoprotein
focus
beam
microwav
irradi
measur
neural
metabolit
murin
model
neuroaid
introduct
biomark
discoveri
provid
mechanist
link
immun
activ
neuropathogenesi
hiv
infect
proton
magnet
reson
spectroscopi
previous
identifi
nacetyl
aspart
naa
glutamateglutamin
creatin
biomark
earli
chronic
stage
hivassoci
neurocognit
disordo
hand
infect
human
studi
siv
infect
nonhuman
primat
replic
signatur
laboratori
shown
murin
model
hand
naa
reduct
cho
elev
found
cerebr
cortex
expand
upon
observ
use
liquid
chromatographi
mass
spectrometri
lcmsm
detect
broad
array
metabolit
lcmsm
metabolom
studi
brain
region
would
expand
signific
find
restrict
due
post
mortem
tissu
metabol
focus
beam
microwav
irradi
fbmi
preserv
brain
tissu
metabolit
quench
brain
enzymat
activ
brain
tissu
prepar
fbmi
allow
metabolom
studi
subregion
parallel
histolog
analysi
describ
neural
biochem
respons
associ
hiv
induc
neuropatholog
method
brain
bisect
parallel
immunohistochemistri
ihc
lcmsm
analys
nine
amino
acid
myoinositol
quantifi
lcmsm
ultraperform
liquid
chromatographi
uplc
system
coupl
q
hybrid
quadrupol
linear
ion
trap
mass
spectromet
result
fbmi
protocol
optim
mous
brain
preserv
effect
valid
compar
preand
postfbmi
level
metabolit
lactat
naa
addit
metabolit
measur
dissect
brain
tissu
lcmsm
degrad
assay
metabolit
homogen
brain
tissu
demonstr
stabil
fbmi
treat
tissu
test
amino
acid
except
glutamin
half
hour
lcmsm
analysi
frontal
middl
cortic
region
combin
demonstr
myoinostitol
reduct
hiv
infect
hiv
infect
human
astrocyt
disrupt
bloodbrain
barrier
integr
gap
junction
depend
mechan
eliseo
eugenin
joan
berman
email
eliseoeugenin
einsteinyuedu
public
health
research
institut
phri
depart
microbiolog
molecular
genet
newark
nj
usa
unit
state
albert
einstein
colleg
medicin
unit
state
hiv
infect
human
astrocyt
disrupt
blood
brain
barrier
integr
gap
junction
depend
mechan
eugenin
berman
depart
microbiolog
albert
einstein
colleg
medicin
bronx
ny
public
health
research
institut
phri
depart
microbiolog
molecular
genet
newark
nj
usa
hiv
infect
central
nervou
system
cn
earli
event
primari
infect
result
neurolog
complic
signific
number
individu
despit
antiretrovir
therapi
main
cell
infect
hiv
within
cn
macrophagesmicroglia
small
fraction
astrocyt
role
infect
astrocyt
pathogenesi
neuroaid
examin
extens
demonstr
despit
fact
astrocyt
becom
infect
hiv
gap
junction
channel
allow
toxic
intracellular
signal
spread
neighbor
uninfect
astrocyt
demonstr
hiv
infect
astrocyt
compromis
blood
brain
barrier
bbb
integr
misguid
astrocyt
end
feet
dysregul
astrocyt
signal
suggest
import
role
infect
astrocyt
neuroaid
alter
bbb
structur
integr
induc
hiv
infect
astrocyt
gap
junction
perhap
hemichannel
connexinpannexin
atp
receptor
depend
block
channel
protect
bbb
compromis
disrupt
depend
arachidon
acid
activ
lipoxigenasecycloxigenas
well
bk
channel
activ
find
describ
novel
mechan
bbb
toxic
within
brain
trigger
low
number
hivinfect
astrocyt
amplifi
gap
junction
contribut
pathogenesi
neuroaid
identif
intracellular
toxic
signal
requir
bystand
kill
gap
junction
hiv
infect
astrocyt
uninfect
astrocyt
eliseo
eugenin
joan
berman
email
eliseoeugenin
einsteinyuedu
public
health
research
institut
phri
depart
microbiolog
molecular
genet
newark
nj
usa
unit
state
albert
einstein
colleg
medicin
unit
state
hiv
entri
central
nervou
system
cn
earli
event
infect
result
neurolog
dysfunct
signific
number
individu
peopl
aid
live
longer
preval
cognit
impair
increas
despit
antiretrovir
therapi
mechan
mediat
cn
dysfunct
still
well
understood
postul
combin
inflamm
viral
infect
andor
replic
addit
mechan
recent
demonstr
hiv
infect
astrocyt
mediat
surviv
hiv
infect
cell
bystand
kill
surround
uninfect
cell
mechan
gap
junction
depend
character
mechan
hiv
mediat
protect
infect
astrocyt
emphasi
mitochondri
dysregul
identif
intracellular
factor
mediat
bystand
kill
uninfect
cell
find
describ
novel
mechan
hiv
maintain
surviv
hiv
infect
astrocyt
identifi
calcium
cytochrom
c
key
signal
involv
bystand
kill
uninfect
cell
contact
hiv
infect
astrocyt
gap
junction
depend
mechan
thu
data
provid
novel
mechan
hiv
surviv
toxic
current
neuroaid
era
viral
replic
major
compon
due
effect
antiretrovir
treatment
find
identifi
new
potenti
therapeut
target
reduc
devast
consequ
neuroaid
lack
neuroimag
biomark
hiv
associ
neurocognit
disord
hand
purpos
studi
analyz
magnetoencephalographi
meg
data
patient
hiv
diseas
riskgroup
appropri
control
determin
meg
frequenc
profil
rest
state
stabil
week
also
set
access
neuron
function
connect
measur
identifi
hivassoci
chang
brain
function
individu
hiv
hiv
complet
neurobehavior
evalu
minut
restingst
meg
acquisit
repeat
week
later
hivcontrol
lost
followup
rel
meg
power
delta
hz
theta
hz
alpha
hz
beta
low
gamma
hz
band
comput
predefin
sensor
group
baselin
eye
close
data
analyz
use
mutual
inform
mi
pair
meg
sensor
median
stabil
restingst
rel
power
eye
close
eye
open
rel
gamma
power
right
occipit
p
r
right
frontal
p
region
associ
serostatu
effect
age
delta
power
greater
seroposit
subject
seroneg
subject
individu
high
thetatogamma
ratio
tend
lower
cognit
test
perform
regardless
serostatu
permut
test
p
one
network
planar
gradiomet
meg
sensor
right
anterior
region
connect
left
posterior
region
relat
hiv
serostatu
signific
mean
mi
valu
distinguish
serostatu
group
one
error
p
rel
stabil
wideband
meg
frequenc
profil
week
support
util
meg
biomark
measur
function
connect
may
possibl
distinguish
hivinfect
uninfect
individu
jc
viru
jcv
etiolog
agent
human
brain
demyelin
diseas
progress
multifoc
leukoencephalopathi
nonproduct
infect
multipotenti
human
neural
progenitor
cell
upon
seruminduc
differenti
infect
progenitor
cell
astrocyt
jcv
commenc
earli
gene
express
follow
dna
replic
late
gene
express
thu
measur
chang
gene
express
cours
astrocyt
differenti
provid
insight
factor
requir
transcript
replic
jcv
use
affymetrix
microarray
determin
express
gene
multipl
time
astrocyt
differenti
neural
progenitor
cell
express
approxim
gene
chang
day
differenti
rna
astrocyt
marker
glial
fibrillari
acid
protein
gfap
secret
protein
acid
rich
cysteineslik
astrocyt
specif
glutam
transport
upregul
within
hour
differenti
remain
upregul
confirm
ident
cell
astrocyt
specif
increas
express
orthodenticl
homeobox
identifi
glia
pattern
midforebrain
phenotyp
therefor
system
astrocyt
differenti
jcv
infect
use
investig
glial
differenti
cellular
factor
involv
jcv
replic
ten
gene
upregul
one
hour
serum
addit
remain
upregul
throughout
differenti
includ
inhibitor
dna
bind
id
famili
member
astrocyt
differenti
transcript
factor
nuclear
factor
ia
nfia
downregul
nfix
upregul
previous
shown
demonstr
reproduc
differenti
chang
coincid
increas
jcv
suscept
differenti
ad
evid
observ
nfia
repress
jcv
nfix
enhanc
infect
model
astrocyt
differenti
jcv
infect
may
lead
identif
number
protein
import
jcv
pathogenesi
michael
ferenczi
shannon
steinberg
lesli
marshal
peter
jensen
eugen
major
email
michaelferenczi
nihgov
clonal
cell
line
select
origin
svg
cell
cultur
exhibit
variabl
level
permiss
jcv
replic
clone
show
reduc
viral
growth
express
low
level
nerv
growth
factor
ngf
high
level
glial
cell
linederiv
neurotroph
factor
gdnf
clone
highli
permiss
jcv
express
dna
replic
express
high
level
ngf
low
level
gdnf
addit
level
nuclear
factor
ia
transcript
factor
known
reduc
jcv
gene
express
lower
cell
furthermor
cell
support
persist
stabl
jcv
infect
month
cultur
thu
svgderiv
cell
line
provid
system
investig
cell
type
differ
jcv
pathogen
cell
provid
reproduc
quantit
viral
biolog
platform
drug
discoveri
studi
demonstr
accumul
extracellular
human
immunodefici
viru
type
vpr
serum
cerebrospin
fluid
patient
direct
correl
viral
load
diseas
progress
late
stage
patient
also
suffer
differ
inflammatori
condit
manifest
excess
intracellular
oxid
condit
may
potenti
escal
lead
irrevers
fatal
effect
sever
protein
tat
nef
found
differ
bodili
fluid
littl
known
downstream
effect
vpr
one
approach
examin
role
extracellular
vpr
diseas
progress
demonstr
recombin
vpr
decreas
level
glutathion
gsh
atp
pool
cultur
astrocyt
caus
oxid
stress
base
result
aforement
clinic
manifest
hypothes
correl
enhanc
extracellular
vpr
cn
declin
astrocyt
level
gsh
atp
diseas
progress
result
demonstr
declin
level
atp
gsh
unrel
due
vprinduc
decreas
gapdh
activ
therebi
affect
glycolyt
pathway
addit
exposur
extracellular
vpr
promot
caspasedepend
apoptosi
astrocyt
along
secret
proinflammatori
cytokin
chemoattract
mif
furthermor
excess
astrocyt
gsh
oxid
lower
extracellular
level
gsh
suppli
cystein
neuron
affect
gsh
synthesi
within
neuron
compart
cascad
event
within
astrocyt
compart
thu
led
oxid
stress
within
neuron
popul
impair
surviv
partial
rescu
effect
obtain
upon
supplement
antioxid
compound
nacetylcystein
result
support
role
extracellular
vpr
deregul
neuronalastrocyt
network
possibl
acceler
diseas
progress
also
offer
therapeut
approach
aim
target
one
caus
agent
astrocyticneuron
network
disrupt
alter
neuron
ferritin
heavi
chain
express
hiv
envelop
protein
inflammatori
cytokin
ferritin
ubiquit
protein
involv
iron
sequestr
storag
compos
two
differ
subunit
heavi
chain
fhc
light
chain
flc
recent
evid
identifi
novel
role
fhc
neg
regul
chemokin
receptor
lab
previous
demonstr
receptor
agonist
includ
morphin
upregul
fhc
protein
level
neuron
result
inhibit
prosurviv
signal
mediat
vivo
data
indic
greater
express
fhc
inhibit
ser
phosphoryl
index
activ
brain
tissu
hivposit
drug
abus
compar
hivcontrol
aim
studi
investig
potenti
compon
hiv
infect
could
contribut
upregul
fhc
neuron
data
indic
inflammatori
cytokin
tumor
necrosi
factoralpha
beta
well
hiv
envelop
glycoprotein
preferenti
upregul
fhc
protein
express
flc
neuron
furthermor
although
trend
toward
upregul
fhc
seen
neuron
cultur
without
glia
treat
studi
perform
presenc
glia
suggest
potenti
role
cell
effect
cytokin
contrari
previou
studi
suggest
mechan
may
involv
morphineinduc
ferritin
regul
thu
differ
potenti
addit
mechan
may
respons
fhc
chang
caus
opiateshiv
infect
hypothesi
also
support
preliminari
studi
morphinetr
sivinfect
nonhuman
primat
overal
studi
suggest
opiat
hiv
synergist
act
fhc
depriv
neuron
import
neuroprotect
action
driven
antiretrovir
drug
activ
neuron
unfold
protein
respons
promot
amyloidogen
process
app
primari
neuron
advent
antiretrovir
therapi
art
mainstay
hiv
treatment
led
signific
reduct
incid
hivassoci
dementia
sever
motorcognit
disord
afflict
aid
patient
howev
preval
hivassoci
neurocognit
disord
hand
spectrum
hivrel
cn
dysfunct
rang
mild
cognit
deficit
continu
escal
postart
era
addit
hivassoci
neuropatholog
evolv
subacut
subcort
encephalit
condit
prolong
cortic
neurodegen
diseas
increas
longev
hivinfect
popul
thought
contribut
alter
hand
patholog
risk
factor
peripher
toxic
art
potenti
central
effect
link
enhanc
amyloidogenesi
age
remain
unexplor
previou
work
shown
art
toxic
peripher
nervou
system
vivo
well
dorsal
root
ganglion
neuron
vitro
explor
artmedi
neuron
toxic
vitro
treat
primari
rat
cortic
cultur
commonli
prescrib
art
compound
two
class
nucleosid
revers
transcriptas
inhibitor
nrti
hiv
proteas
inhibitor
pi
studi
suggest
pi
lead
signific
loss
cours
day
treatment
wherea
nrti
induc
loss
given
known
role
pi
activ
unfold
protein
respons
upr
macrophag
hepatocyt
explor
cellular
stress
pathway
primari
neuron
potenti
mechan
toxic
found
concentr
pi
nrti
approxim
plasma
cmax
level
induc
er
stress
lead
phosphoryl
enhanc
translat
enzym
addit
observ
ritonavirmedi
amyloidogen
app
process
increas
ab
secret
cho
cell
stabli
express
human
app
furthermor
antiretrovir
administ
rat
sivinfect
macaqu
result
neuron
damag
cn
implic
drug
potenti
mediat
neurodegener
neurolog
consequ
hiv
infect
major
health
issu
especi
among
hivposit
drug
abus
despit
effect
antiretrovir
therapi
hiv
infect
individu
use
drug
show
chang
develop
hivassoci
neurolog
disord
hand
may
due
elev
cn
dopamin
level
mediat
addict
reinforc
effect
mani
drug
abus
hypothes
dopamin
exacerb
develop
hand
increas
hiv
infect
alter
function
macrophag
primari
target
hiv
cn
show
previous
high
level
dopamin
significantli
increas
viral
replic
macrophag
increas
number
macrophag
infect
hiv
also
shown
macrophag
express
subtyp
dopamin
receptor
dopamin
relat
protein
current
data
demonstr
dopamin
enhanc
hiv
entri
cell
activ
differ
subtyp
macrophag
dopamin
receptor
also
examin
effect
dopamin
macrophag
cytokin
product
cell
import
regul
neuroinflamm
dopamin
significantli
alter
secret
cytokin
macrophag
macrophag
treat
lp
model
inflammatori
environ
dopamin
modul
secret
well
dopamin
mediat
modul
potenti
hiv
infect
defin
mechan
dopamin
effect
viral
entri
cytokin
product
specif
examin
hiv
infect
alter
mechan
regul
product
data
suggest
dopamin
mediat
chang
macrophag
increas
cn
viral
infect
exacerb
neuroinflamm
alter
develop
hand
dopamin
may
common
mechan
drug
abus
exacerb
hand
hiv
infect
drugabus
support
nida
rna
dna
nntc
brain
specimen
correl
neurocognit
impair
relationship
hiv
replic
brain
hivassoci
neurocognit
disord
hand
remain
elucid
hiv
gagpol
rna
dna
measur
brain
specimen
nation
neuroaid
tissu
consortium
nntc
archiv
correl
analysi
neuropsycholog
test
perform
within
six
month
autopsi
undertaken
dna
rna
extract
freshfrozen
dorsolater
prefront
cortex
viral
rna
dna
measur
use
revers
transcriptas
qpcr
standard
qpcr
nntc
neurocognit
test
batteri
given
perform
score
normal
educ
age
race
gender
overal
spearman
correl
high
hiv
rna
concentr
low
composit
score
signific
p
analysi
use
brain
hiv
dna
statist
signific
overal
p
conclus
high
level
replic
hiv
brain
relat
wors
neuropsycholog
test
perform
cliniconeurovirolog
correl
rel
specif
replic
hiv
hiv
dna
correl
brain
function
significantli
hiv
latenc
viral
dna
cach
human
brain
postintegr
dna
highest
specimen
obtain
prior
haart
enrich
white
matter
erad
latent
hiv
reservoir
cn
amount
postintegr
hiv
dna
pidna
neuroanatom
cach
effect
highli
activ
antiretrovir
therapi
haart
must
elucid
twostep
alugag
assay
use
measur
proport
pihiv
dna
human
brain
specimen
least
copi
total
hiv
dna
per
gram
wet
weight
frontal
neocortex
totdna
sampl
contain
specimen
collect
prior
haart
era
pidna
detect
specimen
use
singl
replic
specimen
less
totdna
usual
requir
multipl
replic
proport
pidna
rel
tothiv
dna
deced
die
era
haart
least
twice
posthaart
deced
pair
demograph
equival
concentr
totdna
pair
wilcoxon
sign
rank
test
p
proport
pidna
significantli
highest
white
matter
compar
either
neostriatum
neocortex
conclus
postintegr
hiv
dna
brain
concentr
white
matter
form
largest
pool
size
human
brain
volum
fact
specimen
obtain
prior
era
haart
significantli
higher
proport
pidna
resembl
clinic
vitro
data
use
hivinfect
lymphocyt
treat
haart
brain
contain
rel
larg
pool
pidna
must
address
attempt
erad
latent
hiv
dna
bodi
erad
latent
hiv
reservoir
cn
system
cellular
cach
postintegr
hiv
dna
bodi
must
account
construct
wholebodi
organ
map
latent
hiv
dna
three
subject
activ
hiv
replic
time
death
includ
one
subject
hiv
enceph
total
dna
extract
vari
anatom
site
postintegr
hiv
dna
pidna
assay
use
twostep
alugag
assay
total
hiv
dna
totdna
measur
use
qpcr
hiv
gagpol
rank
totdna
concentr
highest
lowest
spleen
plasma
intestin
lung
liver
kidney
heart
skelet
muscl
deep
peron
nerv
dorsal
root
ganglion
tissu
contain
high
concentr
totdna
gener
abund
pidna
rank
alway
congruou
totdna
subject
hiv
enceph
pool
size
central
nervou
system
rel
larg
includ
compon
pituitari
gland
choroid
plexu
leptomening
one
patient
rel
larg
cach
colon
two
patient
rel
larg
cach
lung
tissu
conclus
postintegr
hiv
dna
present
virtual
organ
extent
subject
activ
hiv
replic
patient
harbor
specif
cach
nonlymphoid
tissu
tissu
map
guid
effort
find
erad
cach
latent
hiv
dna
studi
patient
low
viru
replic
rate
ongo
determin
extent
residu
pool
latent
hiv
dna
replic
compet
secret
solubl
insulin
receptor
human
neuron
cell
expos
cerebrospin
fluid
hivseroposit
women
correl
cognit
perform
yamil
gerena
sebastian
perez
giovanna
ramirez
claudia
hilera
javier
sierra
joyc
velez
avindra
nath
among
hivinfect
individu
previous
show
associ
high
csf
solubl
insulin
receptor
sir
level
hand
howev
possibl
high
glucos
factor
present
csf
hivinfect
individu
may
influenc
secret
sir
human
neuron
cell
remain
elucid
method
csf
collect
hivinfect
women
hand
normal
cognit
hiv
control
without
histori
diabet
neuron
cell
line
cell
cellswel
cultur
emem
medium
presenc
patient
csf
high
glucos
mm
concentr
hour
secret
sir
fulllength
quantifi
use
specif
fluorescentirelisa
membran
intracellular
ir
determin
flow
cytometri
result
signific
increas
observ
sir
level
secret
neuron
cell
expos
csf
hivinfect
patient
p
compar
hiv
control
increas
sir
secret
cell
associ
sever
p
hand
signific
differ
observ
secret
sir
fulllength
level
cell
expos
high
normal
glucos
level
high
glucos
decreas
significantli
membranebound
ir
level
increas
significantli
p
intracellular
ir
level
compar
normal
glucos
expos
cell
conclus
secret
sir
neuron
cell
influenc
csf
compon
hivinfect
women
correl
sever
hand
effect
high
glucos
neuron
cell
relat
downregul
membranebound
ir
increas
intern
macrophagecoloni
stimul
factor
mcsf
believ
play
promin
role
aid
progress
develop
hivassoci
neurocognit
disord
hand
addit
increas
hiv
infect
viru
product
monocyt
mcsf
increas
monocyt
frequenc
circul
express
cell
phenotyp
similar
macrophag
accumul
cn
hiv
enceph
hive
believ
contribut
pathogenesi
hand
therefor
mcsf
may
viabl
therapeut
target
treat
prevent
hand
report
sever
tyrosin
kinas
inhibitor
tki
mcsf
receptor
activ
reduc
frequenc
andor
express
mcsf
monocyt
mcsf
treat
peripher
blood
mononuclear
cell
pbmc
interestingli
data
suggest
proprietari
tki
report
exclus
decreas
frequenc
fmslike
tyrosin
kinas
receptor
tyrosin
kinas
express
monocyt
believ
interact
exclus
ligand
fl
mcsftreat
pbmc
show
increas
frequenc
monocyt
without
chang
express
level
mcsf
elev
cerebr
spinal
fluid
csf
patient
hive
may
alter
express
cn
examin
cn
tissu
relev
anim
model
hivrel
cn
diseas
siv
infect
rhesu
macaqu
express
studi
show
greater
express
cn
siv
macaqu
even
greater
express
seen
enceph
sive
compar
seroneg
anim
observ
increas
number
cell
well
degre
express
find
suggest
signal
may
involv
regul
andor
ligand
modul
may
potenti
adjunct
therapi
addit
target
therapeut
strategi
treat
prevent
hand
background
progress
multifoc
leukoencephalopathi
pml
opportunist
diseas
aid
patient
immunosuppress
patient
caus
reactiv
jc
viru
sinc
advent
combin
antiretrovir
therapi
often
confront
patient
develop
pml
set
immun
reconstitut
inflammatori
syndrom
iri
studi
character
progress
multifoc
leukoencephalopathi
pml
lesion
contrastenhanc
mri
evalu
metabol
use
proton
magnet
reson
spectroscopi
set
iri
method
pml
patient
underw
clinic
evalu
well
brain
mri
baselin
month
later
presenc
iri
determin
base
clinic
laboratori
criteria
ratio
nacetylaspart
naa
cholin
cho
myoinositol
mi
lipidlact
creatin
cr
measur
correl
presenc
contrast
enhanc
ce
pml
lesion
result
iri
occur
pml
survivor
pml
pml
progressor
pmlp
lesion
pmliri
patient
show
significantli
higher
chocr
micr
p
lower
naacr
ratio
compar
pml
patient
iri
elev
chocr
ratio
associ
ce
within
voxel
lipid
cr
ratio
elev
pmliri
lesion
independ
ce
follow
month
pml
onset
show
persist
elev
micr
ratio
lesion
pmliri
patient
ratio
combin
presenc
ce
yield
probabl
iri
compar
absenc
criteria
conclus
valuabl
tool
recogn
track
iri
pml
may
prove
use
clinic
manag
patient
hivinfect
monocytederivedmacrophag
hivmdm
primari
cn
reservoir
promot
neurodegener
induct
neuroinflamm
neurotoxin
releas
neurotoxin
includ
small
kda
heatstabl
proteaseresist
molecul
excit
nmethyldaspart
nmda
receptor
excitotoxin
glutam
quinolin
acid
quin
correl
degre
neurolog
impair
hivinfect
individu
although
antiretrovir
therapi
art
improv
clinic
outcom
preval
associ
morbid
hand
remain
high
thu
adjunct
neuroprotect
therapi
address
patholog
process
persist
arttreat
individu
need
shown
hiv
infect
alter
macrophag
antioxid
respons
ar
pharmacolog
induct
ar
attenu
hiv
replic
neurotox
hypothes
hiv
infect
mdm
alter
compon
glutam
quin
biosynthesi
induc
ar
attenu
hiv
neurtox
modul
neurotoxin
pathway
method
monocyt
mdm
obtain
pbmc
human
volunt
hivmdm
infect
cellfre
rt
activ
assay
determin
viral
replic
supernat
ar
activ
determin
western
blot
cellbas
elisa
determin
neuron
surviv
signific
defin
p
use
anova
student
ttest
result
demonstr
hiv
replic
reduc
express
heme
oxygenas
key
compon
ar
also
alter
compon
glutam
quin
biosynthesi
pathway
induc
ar
decreas
neurotoxin
product
even
without
alter
hiv
replic
hiv
mdm
conclus
result
suggest
induc
antioxid
respons
therapeut
potenti
hand
suppress
hiv
replic
neurotoxin
product
mdm
reduct
neurotoxin
product
may
work
alter
biosynthet
pathway
glutam
quin
studi
ongo
defin
mechan
modul
neurotoxin
product
impact
tat
puralpha
mediat
regul
dendrit
rhoa
signal
puralpha
essenti
protein
brain
develop
local
specif
dendrit
play
role
translat
neuron
rna
puralpha
also
bind
partner
tat
protein
shown
upregul
tarmedi
viral
transcript
examin
two
rho
gtpase
rhoa
play
oppos
role
neurit
outgrowth
critic
dendrit
matur
brain
develop
presenc
absenc
puralpha
puralpha
development
regul
mous
brain
express
increas
third
week
postnat
develop
rhoa
level
analyz
western
blot
rapidli
fluctuat
wildtyp
mous
brain
howev
absenc
puralpha
delay
cycl
rhoa
regul
observ
lead
reduc
basal
level
rhoa
day
postnat
immunohistochemistri
brain
tissu
puralpha
knockout
mice
display
reduc
rhoa
level
loss
perinuclear
cytoplasm
label
level
remain
rel
stabl
chang
subcellular
local
seen
absenc
puralpha
absenc
puralpha
appear
affect
activ
rhoa
howev
express
tat
increas
activ
fraction
rhoa
neuron
cell
time
decreas
activ
similar
effect
seen
rhoa
basal
level
find
suggest
puralpha
regul
rhoa
multipl
level
includ
basal
protein
level
subcellular
compartment
well
turnov
activ
rhoa
order
promot
dendrit
matur
tat
dysregul
neuron
homeostasi
simultan
induc
rhoa
inactiv
lead
retract
thu
neurotox
effect
tat
may
work
rhoa
target
puralpha
induc
neuron
loss
work
support
grant
nih
jg
sa
reduc
effect
nrti
azt
astrocyt
implic
neurocart
lachlan
gray
gilda
tachedjian
burnet
institut
australia
background
penetr
central
nervou
system
cn
lead
hivassoci
dementia
macrophag
microglia
major
site
product
infect
cn
astrocyt
undergo
restrict
infect
astrocyt
becom
infect
vivo
often
lead
astrocyt
dysfunct
loss
neuron
support
onset
infect
astrocyt
repres
viral
reservoir
longliv
cell
presum
target
antiretrovir
arv
prevent
establish
infect
astrocyt
pool
may
benefici
delay
andor
prevent
viru
erad
strategi
sought
determin
effect
arv
use
neurocart
inhibit
infect
astrocyt
method
arv
includ
use
neurocart
abc
azt
efv
nvp
lpv
ral
assess
abil
inhibit
infect
astrocyt
gener
singl
round
hiv
luciferas
report
virus
pseudotyp
vsvg
envelop
facilit
effici
viru
entri
astrocyt
viru
ad
svg
astrocyt
cell
line
primari
fetal
astrocyt
pfa
cell
presenc
titrat
amount
arv
luciferas
assay
perform
data
use
gener
inhibit
curv
calcul
valu
result
except
arv
test
inhibit
viral
infect
svg
pfa
cell
dose
depend
manner
howev
azt
reduc
potenc
pfa
valu
greater
known
csf
drug
concentr
respect
conclus
reduc
effect
azt
pfa
suggest
neurocart
regimen
contain
drug
may
achiev
suboptim
viral
inhibit
astrocyt
data
potenti
import
implic
use
neurocart
suggest
astrocyt
infect
may
remain
untarget
regimen
potenti
lead
poorer
neurolog
outcom
patient
chaojiang
gu
alejandra
borjabad
wei
chao
hongxia
jin
suh
bruce
polski
mari
jane
potash
david
j
current
avail
antiretrovir
treatment
art
highli
success
control
hiv
replic
progress
immunodefici
develop
form
frank
aid
howev
immun
restor
art
alway
complet
nervou
system
diseas
hivneurocognit
disord
larg
unrespons
treatment
moreov
even
clinic
effect
treatment
infectioncompet
hiv
persist
integr
dna
within
cellular
reservoir
describ
system
establish
studi
hiv
reservoir
immunocompet
host
model
hivinfect
person
success
art
inocul
chimer
mousetrop
hiv
ecohiv
convent
mice
caus
acut
product
infect
peak
day
chronic
infect
last
month
hiv
genom
integr
macrophag
within
hour
viru
inocul
integr
viru
persist
macrophag
spleen
cell
year
level
viral
circular
dna
splice
vif
rna
viral
encod
protein
declin
sever
month
infect
level
genom
rna
macrophag
antigag
antibodi
fluctuat
throughout
follow
period
suggest
stochast
viru
reactiv
form
hiv
genom
infect
mice
compar
similar
form
peripher
blood
cell
hivinfect
person
infect
athym
mice
result
extend
effici
ecohiv
express
confirm
role
adapt
immun
control
chimer
hiv
infect
mice
reservoir
integr
provir
dnawer
found
lymphoid
tissu
macrophag
bone
marrow
brain
reservoir
contain
replicationcompet
viru
shown
spread
ecohiv
macrophag
athym
recipi
cell
ecohivinfect
mice
result
establish
anim
model
studi
reservoir
infecti
hiv
vivo
support
grant
nation
institut
health
us
public
health
servic
vpr
induc
neuron
apoptosi
mediat
part
differenti
regul
inflammatori
molecular
network
infect
target
cell
debjani
guha
pruthvi
nagilla
carri
reding
alagarsami
srinivasan
gerald
schatten
velpandi
ayyavoo
email
velpandi
pittedu
induc
neuron
dysfunct
secret
host
cellular
factor
cytokineschemokin
viral
protein
includ
vpr
releas
infect
macrophagesmicroglia
determin
factor
mechan
involv
vpr
induc
neuron
dysfunct
util
monocytederiv
macrophag
mdm
infect
either
wild
type
vpr
delet
mutant
model
presenc
vpr
differenti
regul
sever
proinflammatori
molecul
includ
signific
upregul
mdm
transcript
andor
protein
level
upregul
inflammatori
factor
mediat
vpr
induc
phosphoryl
sapkjnk
block
sapkjnk
prevent
vpr
mediat
elev
level
mdm
confirm
involv
sapk
jnk
proinflammatori
cytokin
product
vpr
induc
indirect
effect
neuron
apoptosi
proinflammatori
cytokin
examin
expos
primari
neuron
cultur
supernat
mock
infect
mdm
supernat
infect
mdm
contain
elev
level
well
viral
protein
show
enhanc
neurotox
compar
mock
infect
mdm
supernat
reduct
neuron
death
presenc
antibodi
impli
vpr
mediat
neuron
cell
death
part
mediat
releas
inflammatori
factor
collect
result
demonstr
abil
vpr
impair
neuron
surviv
indirectli
dysregul
multipl
cytokin
infect
target
cell
primari
monocytederiv
microvesicl
intern
human
neural
cell
novel
mechan
hivhcv
associ
neurotox
archana
gupta
cyru
calos
bing
sun
han
rempel
sonia
navasmartin
lynn
pulliam
email
drexeledu
coinfect
hiv
hepat
c
viru
hcv
associ
mild
cognit
impair
despit
hiv
viral
suppress
art
propos
monocyt
activ
exposur
hivhcv
peripheri
cross
blood
brain
barrier
shed
microvesicl
mv
taken
neural
cell
neuropathogen
consequ
microvesicl
mv
small
membran
enclos
sac
releas
varieti
cell
type
normal
well
patholog
state
mv
contain
select
packag
cellular
protein
nucleic
acid
includ
mrna
microinterf
mi
rna
host
cell
interestingli
mv
capabl
transfer
cellular
inform
cell
differ
lineag
influenc
physiolog
environmentin
support
hypothesi
show
human
monocytederiv
mv
intern
primari
neuron
astrocyt
addit
mv
releas
hcv
core
proteintr
monocyt
induc
abnorm
neuron
aggreg
suggest
mv
cargo
deriv
monocyt
expos
viral
product
associ
neurotox
examin
rna
content
monocytederiv
mv
hcv
hivhcvinfect
subject
rtpcr
analysi
reveal
numer
differenti
express
mirna
potenti
could
dysregul
neural
cell
function
also
detect
mv
posit
strand
hcv
indic
mv
may
vehicl
transport
hcv
nervou
system
result
suggest
monocyt
mvmediat
mechan
hcv
entri
cn
well
modul
neural
cell
function
may
result
cognit
impair
substanc
abus
infect
sever
impact
global
health
crise
although
drug
abusehiv
known
caus
neurolog
disord
independ
drug
abus
acceler
progress
neuroaid
elus
multifacet
mechan
describ
underli
mechan
malnutrit
drug
energi
wast
infect
intersect
point
neuroaid
daili
ip
inject
methamphetamin
meth
mgkg
mice
caus
inflamm
hemorrhag
stroke
week
brain
capillari
anim
show
massiv
oxid
damag
impair
angiogenesi
inflamm
glucos
transport
dysfunct
activ
via
vegfsign
respons
degrad
bbb
basement
protein
neurolog
diseas
impair
angiogenesi
due
reduct
promot
infiltr
infect
cell
brain
demonstr
infus
label
macrophag
via
common
carotid
arteri
cathet
implant
observ
infect
microglia
amass
limit
suppli
glucos
methinduc
malnutrit
energi
wast
process
promot
oxid
stress
inflamm
neurotox
progress
neuroaid
combin
therapeut
prevent
methinduc
malnutrit
energi
wast
hivinfect
novel
approach
mitig
neuroaid
among
drug
abus
sadli
uniqu
anatom
featur
bbb
restrict
skull
caviti
hinder
cure
neuroaid
newli
discov
neurotoxin
drug
travers
bbb
effect
erad
infect
neuroimmun
cell
evid
show
treatment
acetyllcarnitin
alc
antioxid
stabil
energi
oxid
drug
abl
mitig
malnutrit
hivinfect
energi
wast
thu
induct
hemorrhag
stroke
trigger
activ
mmp
degrad
bbb
compon
impair
vascular
wound
heal
vascular
oxid
injuri
glucos
relat
malnutrit
prevent
alc
drug
effect
erad
hivinfect
macrophagemicroglia
protect
neuron
astrocyt
human
immunodefici
viru
infect
cn
associ
neuron
injuri
includ
dendrit
prune
synaps
loss
cell
death
cognit
declin
patient
dementia
correl
dendrit
damag
hypothes
dendrit
prune
excitatori
synaps
loss
cope
mechan
enabl
neuron
decreas
excess
excitatori
input
cell
infect
shed
viral
protein
includ
transactiv
transcript
tat
tat
bind
lowdens
lipoprotein
receptorrel
protein
lrp
intern
induc
overactiv
nmethyldaspart
receptor
nmdar
subsequ
loss
excitatori
synaps
overal
network
excit
determin
balanc
excitatori
inhibitori
synapt
connect
increas
excitatori
synapt
activ
result
reciproc
increas
inhibitori
synapt
activ
maintain
network
stabil
use
live
cell
confoc
imag
transfect
neuron
find
exposur
tat
ngml
caus
mark
upregul
inhibitori
synaps
number
hour
nmdar
antagonist
dizocilpin
lrp
antagonist
rap
block
tatinduc
increas
inhibitori
synaps
number
indic
nmdar
activ
necessari
tatinduc
gain
inhibitori
synaps
inhibitor
prevent
tatinduc
loss
excitatori
synaps
block
ubiquitin
fail
prevent
tatinduc
upregul
inhibitori
synaps
indic
chang
inhibitori
synapt
transmiss
induc
tat
secondari
chang
excitatori
drive
result
suggest
inhibitori
synaps
might
increas
maintain
network
equilibrium
specul
increas
inhibitori
synaps
part
neuroprotect
mechan
gone
awri
pharmacolog
manipul
inhibitori
synapt
transmiss
could
pronounc
effect
synapt
network
alter
exposur
protein
find
could
provid
viabl
target
design
new
therapi
treat
patient
host
innat
immun
respons
particularli
type
interferon
ifn
system
serv
first
line
defens
pathogen
includ
hiv
exogen
type
ifn
effect
block
hiv
infect
vitro
particularli
macrophag
studi
cultur
indic
hiv
evolv
mechan
disrupt
induct
cellular
ifn
respons
also
suggest
observ
dysregul
ifnrespons
gene
lymph
node
peripher
cell
brain
tissu
hivinfect
patient
howev
direct
demonstr
role
type
ifn
control
hiv
infect
vivo
lack
end
compar
hiv
infect
neuropathogenesi
pair
set
wildtyp
wt
type
ifn
receptor
knockout
ifnrko
mice
genet
background
mice
infect
modifi
mousetrop
hiv
ecohiv
follow
intraperiton
ip
inocul
ecohiv
ifnrko
mice
show
significantli
higher
hiv
express
spleen
periton
macrophag
greater
viru
infiltr
brain
wt
mice
although
ipinfect
wt
ifnrko
mice
asymptomat
brain
patholog
ifnrko
mice
show
greater
global
gene
dysregul
brain
facilit
studi
hiv
neuropathogenesi
system
ecohiv
inocul
directli
brain
intracerebr
inject
result
uniformli
high
hiv
burden
brain
caus
gross
neuropatholog
chang
includ
lesion
infiltr
macrophag
cell
microgli
activ
astrocytosi
extens
gene
dysregul
includ
upregul
inflammatori
cytokin
chemokin
detect
qpcr
analysi
affect
brain
tissu
paramet
hiv
neuropathogenesi
includ
hiv
express
microgliamacrophag
significantli
pronounc
ifnrko
wt
mice
result
show
directli
function
type
ifn
respons
import
insuffici
control
hiv
infect
pathogenesi
brain
support
nih
background
modern
antiretrovir
therapi
art
substanti
extend
surviv
hiv
infect
person
later
year
rais
possibl
agerel
organ
chang
includ
neurodegen
cerebrovascular
chang
might
amplifi
hiv
effect
brain
studi
investig
effect
age
hiv
vascular
metabol
marker
neurocognit
nc
function
method
hiv
particip
charter
studi
hivparticip
hnrp
select
analysi
subject
receiv
comprehens
neuromed
neurocognit
laboratori
assess
logist
regress
use
examin
effect
age
hiv
vascular
metabol
marker
global
domain
specif
cognit
function
interact
age
hiv
diseas
vascular
marker
also
model
analys
hiv
particip
result
hiv
case
perform
wors
hivin
domain
global
p
signific
age
x
hiv
interact
older
hiv
perform
increment
wors
work
memori
learn
global
nc
function
captur
global
deficit
score
gd
p
exploratori
analys
hiv
diseas
vascular
metabol
marker
show
age
interact
aid
diagnosi
systol
blood
pressur
sbp
bmi
cholesterol
predict
wors
gd
multivari
model
aid
sbp
bmi
cholesterol
individu
age
interact
term
predict
gd
show
aid
interact
age
aid
interact
age
cholesterol
relat
wors
gd
current
nadir
art
statu
plasma
viral
load
relat
gd
conclus
result
show
disproportion
reduct
neurocognit
perform
hiv
person
age
sever
hiv
diseas
indic
vascular
metabol
chang
link
vascular
diseas
age
may
play
role
amplifi
effect
bind
directli
hiv
ltr
associ
nuclear
matrix
protein
repress
hiv
transcript
astrocyt
astrocyt
gener
restrict
hiv
replic
certain
trigger
support
product
hiv
infect
given
astrocyt
make
brain
cell
even
lowlevel
infect
may
contribut
significantli
hivassoci
neuropathogenesi
furthermor
although
astrocyt
harbor
hiv
rest
condit
level
infect
suffici
transmit
hiv
infiltr
lymphocyt
previous
establish
inhibit
signal
via
knockdown
treatment
trigger
product
hiv
replic
astrocyt
also
determin
knockdown
transcript
partner
enhanc
dock
elongationcompet
rna
polymeras
ii
suggest
repress
hiv
level
transcript
directli
assess
impact
hiv
transcript
evalu
whether
associ
directli
hiv
ltr
identifi
four
novel
bind
site
ltr
locat
transcript
initi
site
strongest
bind
observ
site
chromatin
immunoprecipit
confirm
dock
ltr
remov
site
delet
furthermor
delet
mutat
bind
site
combin
knockdown
enhanc
basal
hiv
ltr
activ
astrocyt
stabli
express
ltrluciferas
construct
effect
tatmedi
transactiv
show
nuclear
matrix
bind
protein
tether
ltr
region
coprecipit
suggest
interact
may
render
region
inaccess
transcript
machineri
disrupt
complex
astrocyt
may
account
permiss
state
hiv
product
replic
work
support
ljh
la
inhibit
process
withhold
attenu
action
thought
central
import
regul
behavior
abil
function
daili
life
deficit
inhibit
key
featur
hiv
methamphetamin
meth
depend
play
critic
role
highrisk
behavior
associ
drug
use
diseas
transmiss
although
hiv
infect
meth
exposur
associ
cognit
dysfunct
neurotox
combin
effect
factor
examin
comprehens
variou
domain
inhibit
hyperact
noveltyseek
persever
assess
rodent
quantifi
activ
openfield
test
similar
measur
appli
human
subject
neurolog
infect
group
recent
establish
human
openfield
paradigm
human
behavior
pattern
monitor
hbpm
motor
activ
behavior
quantifi
room
contain
furnitur
engag
novel
object
task
directli
base
model
rodent
explor
project
assess
inhibit
human
particip
hiv
infect
meth
depend
compar
mous
model
hiv
transgen
mice
expos
chronic
meth
treatment
hypothes
combin
effect
hiv
express
meth
exposur
speci
would
induc
greater
inhibitori
deficit
humanrod
openfield
test
either
factor
alon
human
subject
comorbid
hiv
infect
meth
depend
exhibit
greatest
motor
activ
first
sever
minut
hbpm
rel
comparison
group
trend
toward
elev
multipl
object
interact
express
protein
significantli
impact
locomot
mous
openfield
chronic
meth
administr
increas
noveltyseek
includ
time
spent
novel
object
studi
demonstr
util
crossspeci
paradigm
use
elucid
hiv
neuropatholog
assess
inhibitori
dysfunct
associ
comorbid
substanc
use
la
cross
viru
lacv
member
california
serogroup
orthobunyavirus
major
caus
pediatr
enceph
asept
mening
midwestern
southern
unit
state
consid
emerg
human
pathogen
laboratori
recent
identifi
lacv
fusion
peptid
hypothes
region
critic
determin
neuroinvas
test
hypothesi
gener
panel
recombin
lacv
rlacv
contain
mutat
fusion
peptid
vitro
test
recombin
virus
confirm
rlacv
target
chang
fusion
peptid
region
decreas
replic
fusion
phenotyp
yet
remain
neurotox
primari
rat
neuron
cultur
system
data
suggest
lacv
fusion
peptid
associ
properti
neuroinvas
growth
high
titer
muscl
cell
robust
fusion
phenotyp
necessarili
neurovirul
extend
studi
establish
murin
model
lacv
enceph
mirror
mani
featur
human
diseas
includ
agedepend
suscept
determin
neuroinvas
neuropathogen
phenotyp
mutant
rlacv
suckl
mice
suscept
peripher
challeng
lacv
inocul
subcutan
rlacv
fusion
peptid
domain
mutant
deceler
rate
diseas
progress
howev
rlacv
retain
abil
mediat
sever
neurolog
diseas
without
significantli
slow
surviv
kinet
inocul
directli
central
nervou
system
adult
mice
tissu
titrat
histolog
studi
progress
character
vivo
consequ
chang
lacv
fusion
peptid
importantli
high
conserv
fusion
peptid
domain
among
bunyavirida
make
find
applic
bunyavirus
includ
also
caus
neurolog
diseas
interferon
mediat
effect
activ
though
shown
level
primari
mous
neuron
drastic
reduc
compar
control
fibroblast
despit
abil
ifn
gamma
ifng
protect
neuron
viral
infect
moreov
mvpermiss
defici
mice
primari
hippocamp
neuron
explant
mice
absenc
restrict
abil
host
respons
mediat
viral
clearanc
identifi
princip
signal
transduct
pathway
ifng
signal
neuron
assess
activ
two
altern
signal
molecul
associ
ifng
signal
akt
erk
follow
ifng
stimul
rapid
activ
akt
erk
signal
pathway
distinct
delay
weaker
respons
made
fibroblast
respons
expect
influenc
express
gene
typic
associ
pathway
despit
fact
respons
gene
remain
quiescent
follow
ifng
stimul
sinc
mani
molecul
prosurviv
gene
next
ask
whether
ifng
confer
protect
advantag
treat
neuron
inde
apoptot
effect
staurosporin
significantli
blunt
addit
ifng
though
pharmacolog
block
akt
erk
pathway
negat
protect
effect
interestingli
pauciti
avail
cytoplasm
may
chang
access
signal
molecul
ifng
receptor
sinc
ko
mef
show
similarli
enhanc
akt
erk
respons
profil
follow
ifng
stimul
propos
receptor
occup
model
natur
pauciti
cytoplasm
neuron
allow
signal
transduc
access
ifng
receptor
trigger
altern
pathway
pathway
result
induct
gene
afford
protect
nonrenew
cell
condit
viral
infect
epidemiolog
evid
support
role
matern
infect
risk
factor
autism
schizophrenia
alter
brain
morpholog
function
condit
propos
result
direct
influenc
infecti
agent
immun
activ
induc
neuron
prolifer
migrat
behavior
histopatholog
imag
studi
autism
schizophrenia
suggest
involv
hippocamp
structur
use
mous
model
wherein
matern
inflamm
induc
viral
rna
mimic
polyinosinicpolycytidyl
acid
poli
c
test
whether
prenat
immun
activ
alter
neurogenesi
dentat
gyru
offspr
hippocampu
previou
work
model
use
vitro
assay
indic
dramat
reduct
intermedi
progenitor
cell
prolifer
increas
neuron
apoptosi
offspr
also
show
deficit
prepuls
inhibit
abnorm
locomotor
learn
memori
function
effect
observ
wildtyp
j
mice
pretreat
nonsteroid
antiinflammatori
drug
assess
role
hippocamp
neurogenesi
abnorm
poli
c
brdu
administ
pregnant
wildtyp
mice
gestat
day
prenat
poli
c
exposur
associ
markedli
reduc
number
brduposit
granul
cell
dentat
gyru
offspr
postnat
day
exposur
poli
c
alon
gestat
day
also
show
reduc
densiti
granul
cell
dentat
gyru
postnat
week
poli
c
effect
granul
cell
densiti
diminish
week
find
indic
late
prenat
inflamm
affect
genesi
migrat
neuron
dentat
gyru
may
help
explain
pathogenesi
behavior
deficit
mous
model
infectionrel
neurodevelopment
disord
despit
sever
clinic
ill
neuropatholog
rabi
rel
bland
mild
inflammatori
chang
degen
neuron
chang
led
concept
underli
abnorm
neuron
dysfunct
precis
mechan
remain
uncertain
evalu
cvsinfect
transgen
mice
express
yellow
fluoresc
protein
found
evid
neuron
process
degener
involv
dendrit
axon
use
adult
rodent
dorsal
root
ganglion
drg
cultur
evalu
structur
chang
axon
cvsinfect
cultur
vitro
infect
drg
neuron
permiss
infect
show
promin
axon
swell
associ
immunostain
marker
lipid
peroxid
oxid
stress
good
viabil
neuron
ciliari
neurotroph
factor
activ
highli
neuroprotect
cvsinfect
neuron
reduc
number
puncta
peptid
inhibitor
cv
infect
addit
effect
produc
axon
swell
indic
neuroprotect
western
immunoblot
show
increas
express
infect
drg
neuron
fluoresc
signal
subunit
quantit
evalu
nucleu
cytoplasm
drg
neuron
hr
signific
increas
nucleu
cytoplasm
ratio
wherea
hr
significantli
reduc
nuclear
local
cv
infect
cv
infect
kreb
cycl
enzym
citrat
synthas
malat
dehydrogenas
activ
normal
wherea
activ
electron
transport
chain
complex
iv
significantli
increas
vs
mock
infect
neuron
dysfunct
rabi
associ
structur
chang
involv
neuron
process
mediat
oxid
stress
rabi
viru
inhibit
nuclear
activ
mitochondri
dysfunct
like
play
role
increas
product
reactiv
oxygen
speci
ro
increas
activ
complex
may
lead
ro
overproduct
due
revers
electron
transfer
postul
drug
abus
may
act
combin
hiv
lead
increas
neurotox
neurocognit
impair
mechanist
hiv
drug
abus
converg
mesocorticolimb
dopamin
da
system
contain
two
main
receptor
subtyp
dopamin
receptor
strong
cortic
bia
express
human
brain
wide
implic
cognit
function
dopamin
receptor
strongli
link
reward
use
manhattan
hiv
brain
bank
popul
hiv
individu
evalu
polymorph
gene
relat
opioid
cocain
depend
found
three
two
polymorph
significantli
associ
p
use
regress
analysi
next
examin
polymorph
associ
neuropsycholog
perform
amongst
seven
cognit
domain
motor
speed
inform
process
verbal
fluenci
learn
memori
abstractionexecut
function
work
memori
factor
opioid
cocain
depend
motor
domain
observ
trend
level
associ
singl
polymorph
two
polymorph
p
similar
observ
also
seen
work
memori
domain
signific
associ
found
singl
polymorph
trend
level
associ
singl
polymorph
p
domain
direct
effect
differ
substanc
use
group
opioid
cocain
depend
individu
direct
correl
opposit
seen
subject
without
substanc
depend
conclud
polymorph
strongli
correl
substanc
depend
trait
account
analysi
weaker
associ
emerg
restrict
number
cognit
domain
result
highlight
import
dopaminerg
system
substanc
depend
cognit
perform
hiv
individu
introduct
plasma
gelsolin
pgsn
secretori
postul
modul
inflammatori
respons
express
independ
regul
central
nervou
system
peripheri
base
experi
use
gsnmous
model
postul
modul
pgel
express
might
benefici
inhibit
acut
inflamm
increas
chronic
inflamm
previous
work
reveal
reduc
level
pgsn
csf
individu
advanc
neurocognit
impair
due
hiv
infect
brain
express
brain
parenchyma
infect
unknown
result
vitro
experi
show
infect
macrophag
secret
pgsn
support
immunohistochemistri
studi
section
siv
infect
monkey
brain
show
accumul
pgsn
macrophag
nodul
indic
increas
level
pgsn
present
local
milieu
thu
impact
overal
net
decreas
concentr
pgsn
csf
infect
subject
accumul
clearanc
pgsn
within
macrophag
nodul
elsewher
regul
mmp
pgsn
substrat
moreov
studi
show
accumul
pgsn
around
neuron
postul
major
produc
pgsn
brain
preliminari
data
show
exposur
uninfect
macrophag
pgsn
lead
secret
proinflammatori
cytokin
tnfa
find
exposur
control
infect
macrophag
pgsn
lead
transient
inhibit
phosphoryl
chang
level
provid
mechanist
clue
perspect
work
hypothesi
pgsn
contribut
persist
low
level
neuroinflamm
within
around
macrophag
nodul
support
work
support
part
nih
grant
vzv
infect
human
brain
vascular
adventiti
fibroblast
downregul
stat
mrna
express
inhibit
transloc
pstat
nucleu
stephani
jame
igor
traktinskiy
alexand
choe
gilden
maria
nagel
email
ucdenveredu
univers
colorado
school
medicin
unit
state
univers
colorado
school
medicin
unit
state
univers
colorado
school
medicin
unit
state
univers
colorado
school
medicin
unit
state
univers
colorado
school
medicin
unit
state
primari
varicella
zoster
viru
vzv
infect
caus
varicella
chickenpox
viru
becom
latent
ganglion
neuron
advanc
age
declin
cellmedi
immun
vzv
lead
viru
reactiv
manifest
zoster
shingl
zoster
may
complic
vzv
vasculopathi
tia
stroke
caus
product
viru
infect
arteri
within
first
year
zoster
increas
risk
stroke
vzv
vasculopathi
month
zoster
viral
antigen
abund
leukocyt
subset
found
understand
mechan
vzv
persist
despit
robust
immun
respons
focus
jakstat
pathway
commonli
activ
viral
infect
uninfect
cell
type
interferon
specif
bind
interferon
receptor
result
autophosphoryl
jak
protein
turn
phosphoryl
one
stat
protein
pstat
pstat
complex
interferon
regulatori
factor
irf
complex
transloc
nucleu
transloc
pstat
upregul
transcript
multipl
antivir
protein
rnase
l
protein
kinas
r
scidhu
xenograft
model
vzvinfect
skin
cell
decreas
amount
pstat
transloc
nucleu
uninfect
bystand
cell
herein
show
vzvinfect
primari
human
cerebrovascular
adventiti
fibroblast
express
mrna
downregul
compar
mockinfect
fibroblast
contrast
jak
mrna
unaffect
vzv
infect
immunostain
reveal
pstat
transloc
nucleu
vzvinfect
cell
seen
nucleu
uninfect
bystand
cell
well
mockinfect
cell
overal
vzv
infect
cerebr
adventiti
fibroblast
block
transloc
pstat
nucleu
find
provid
potenti
mechan
transcript
antivir
protein
downregul
vzv
turn
lead
viral
persist
vascular
remodel
potenti
stroke
involv
antioxid
respons
pathway
neurogli
neuron
astrocyt
cultur
expos
antiretrovir
compound
brigid
jensen
cagla
akay
kathryn
lindl
kelli
jordansciutto
email
jensenb
mailmedupennedu
univers
pennsylvania
unit
state
univers
pennsylvania
unit
state
univers
pennsylvania
unit
state
univers
pennsylvania
unit
state
despit
restor
immun
function
due
effect
viral
suppress
antiretrovir
arv
therapi
hivposit
patient
suffer
neurolog
impair
vari
sever
collect
term
hivassoci
neurocognit
disord
hand
persist
inflamm
viral
reservoir
tout
sourc
continu
oxid
damag
central
nervou
system
individu
hand
arv
arv
drug
induc
er
oxid
stress
reactiv
oxygen
speci
ro
cell
death
sever
nonneur
cell
type
furthermor
shown
arv
drug
induc
ro
subsequ
mitochondri
depolar
eventu
neuron
toxic
cortic
neurogli
cultur
nonneur
cell
oxid
stress
induc
endogen
antioxid
respons
ear
activ
transcript
factor
upregul
express
protect
enzym
thu
hypothes
ear
activ
neurogli
cultur
respons
arv
compound
alter
cellular
functionsurviv
primari
rat
cortic
neurogli
enrich
astrocyt
enrich
neuron
cultur
treat
arv
drug
zidovudin
ritonavir
saquinavir
ear
induc
tertbutyl
hydroperoxid
tbhp
hour
assay
ro
dihydroethidium
stain
well
stabil
express
target
qpcr
immunoblot
find
show
rapid
ro
accumul
neurogli
enrich
neuron
cultur
result
stabil
follow
effector
protein
induct
compar
neurogli
cultur
ro
accumul
enrich
neuron
cultur
begin
earlier
lead
damagedeath
hour
ro
accumul
ear
activ
seen
astrocyt
cultur
rather
begin
hour
arv
compound
tbhp
show
reduct
ro
astrocyt
buffer
ro
via
constitut
high
glutathion
level
may
account
ro
reduct
observ
data
suggest
ear
transient
activ
respons
arv
target
sustain
increas
ear
activ
may
promot
surviv
neuron
expos
arv
possibl
hiv
induc
oxid
stress
tori
johnson
karan
patel
peter
calabresi
avindra
nath
email
toryjohnson
nihgov
nih
nind
unit
state
nih
nind
unit
state
john
hopkin
school
medicin
depart
neurolog
unit
state
nih
nind
unit
state
background
immun
reconstitut
inflammatori
syndrom
iri
character
deterior
clinic
statu
initi
antiretrovir
therapi
may
involv
cn
even
absenc
opportunist
infect
result
sever
tcell
mediat
enceph
death
method
result
immunohistochem
analysi
brain
section
patient
cnsiri
demonstr
presenc
tcell
cell
hivtat
absenc
antigen
henc
determin
extracellular
tat
could
activ
tcell
isol
tcell
normal
human
donor
expos
tat
protein
gene
express
determin
microarray
analysi
cytokin
array
select
cytokin
confirm
elisa
tattreat
tcell
releas
granzym
b
dosedepend
manner
tcell
activ
block
inhibit
tcell
receptor
tcr
signal
tat
abl
activ
tcell
ovaspecif
mice
indic
novel
tcr
independ
mechan
tcell
activ
tat
cellular
uptak
visual
imagestream
analysi
shown
depend
clatharinmedi
endocytosi
interestingli
tat
caus
prolifer
tcell
determin
tritat
thymidin
incorpor
tatmedi
tcell
activ
depend
upon
upregul
vegfc
result
autocrin
activ
use
pharmacolog
inhibitor
cascad
found
involv
activ
kinas
mtor
cdk
independ
pkc
hiv
capabl
infect
activ
tcell
therefor
examin
extracellular
tat
activ
tcell
enhanc
hiv
infect
tat
stimul
enabl
hiv
increas
histon
acetyl
modifi
chromatin
structur
allow
viral
integr
conclus
hiv
tat
protein
activ
tcell
novel
antigen
independ
manner
lead
alter
chromatin
state
increas
gene
transcript
releas
cytokin
cytox
granul
enhanc
viral
infect
mechan
tcell
activ
open
new
avenu
therapeut
intervent
hivassoci
iri
chronic
inflamm
irf
protein
becom
recogn
independ
class
transcript
factor
regul
critic
cellular
gene
express
pathway
respons
extern
threat
littl
known
irf
activ
neuron
glial
cell
cn
especi
neuroaid
cell
patholog
affect
infect
data
present
indic
infect
cn
elicit
irf
respons
noninfect
neuron
glial
cell
respons
subvert
protein
tat
tat
contain
region
amino
acid
highli
conserv
among
clade
cy
c
residu
recent
xray
crystallograph
data
tat
bound
cyclin
show
tat
requir
cyclin
coordin
two
zn
atom
manner
stabil
tat
structur
enabl
bind
rna
anoth
wellcharacter
tatbind
partner
contain
domain
c
residu
sever
aa
homolog
cyclin
mutat
tat
crich
region
inhibit
bind
cyclin
interferon
regulatori
factor
irf
redirect
cellular
local
tat
coloc
tat
irf
contain
c
domain
homolog
cyclin
gsttat
pulldown
lysat
mg
glial
cell
show
tat
bind
confoc
laser
microscopi
togeth
gsttat
pulldown
reveal
tat
bind
phosphoryl
ie
activ
nonphosphoryl
form
tat
target
cytoplasm
nonphosphoryl
proteolyt
degrad
remain
phosphoryl
dimer
coloc
tat
nuclear
structur
result
reveal
novel
irfmedi
pathway
potenti
intervent
tat
activ
support
nih
divis
neurovirolog
depart
neurolog
boston
novarti
cambridg
simian
viru
famili
polyomavirida
caus
fatal
demyelin
cn
diseas
analog
progress
multifoc
leukoencephalopathi
pml
caus
jc
viru
jcv
immunosuppress
human
recent
demonstr
jcv
may
infect
cerebellar
granul
cell
neuron
cortic
pyramid
neuron
immunosuppress
peopl
addit
passag
neurotrop
isol
infect
neuron
inocul
intraven
two
shivinfect
rhesu
examin
whether
neuron
infect
occur
spontan
immunosuppress
macaqu
analyz
archiv
brain
specimen
sivinfect
rhesu
aid
brain
infect
addit
white
matter
distribut
classic
demyelin
pml
monkey
exhibit
mening
subpial
neocortex
periventricular
viru
distribut
pattern
correspond
broader
viral
tropism
neuron
infect
case
case
neuron
posit
larg
tantigen
tag
case
exhibit
neuron
posit
suggest
case
restrict
neuron
infect
tag
product
neuron
infect
tag
neuron
detect
pariet
occipit
tempor
cortic
hippocampu
thalamu
brain
stem
presenc
dna
cortic
sampl
verifi
pcr
sequenc
mutat
agnoprotein
detect
case
neuron
infect
may
impact
tag
transcript
observ
confirm
spontan
neuron
infect
occur
immunosuppress
macaqu
parallel
jcvneuron
infect
immunosuppress
peopl
neuron
infect
appear
import
aspect
jcv
pathogenesi
respect
host
prevent
repair
hivassoci
brain
injuri
marcu
kaul
email
mkaul
sanfordburnhamorg
sanfordburnham
medic
research
institut
unit
state
infect
often
devast
immun
nervou
system
combin
antiretrovir
therapi
cart
extend
life
expect
hiv
patient
fail
prevent
hivassoci
neurocognit
disord
hand
therefor
addit
neuroprotect
strategi
urgent
need
hivinfect
individu
progress
aid
neuroaid
suggest
protect
host
factor
mechan
exist
may
har
prevent
repair
hivassoci
brain
injuri
hand
chemokin
major
hiv
coreceptor
virusassoci
solubl
envelop
glycoprotein
interact
conjunct
lead
infect
andor
cellular
signal
howev
natur
ligand
import
compon
antivir
immun
respons
possess
neuroprotect
properti
therefor
group
studi
potenti
role
promot
prevent
hivassoci
brain
injuri
use
vitro
vivo
approach
aid
patient
mice
express
transgen
brain
share
distinct
neuropatholog
featur
decreas
number
neurit
synaps
pronounc
astrocytosi
activ
microglia
recent
gener
character
cross
mice
microarray
analysi
brain
tissu
show
affect
express
gene
presenc
gene
absenc
ligand
express
increas
brain
independ
presenc
absenc
howev
quantit
fluoresc
deconvolut
microscopi
indic
knockout
larg
abrog
neuron
injuri
microgli
activ
trigger
viral
astrocytosi
altogeth
appear
host
factor
contribut
hivassoci
microgli
activ
neuron
injuri
thu
provid
therapeut
target
limit
hiv
infect
also
protect
possibl
repair
brain
inocul
mice
mousetrop
hiv
ecohiv
establish
chronic
system
infect
remain
mostli
host
immun
control
similar
hivinfect
individu
despit
control
low
level
viru
mild
neuropathogen
chang
found
brain
infect
mice
explor
patholog
cognit
consequ
infect
inocul
ecohiv
directli
mous
striatum
examin
viru
replic
brain
tissu
patholog
cellular
gene
chang
mous
behavior
radial
arm
water
maze
ecohiv
use
mlvenvelop
place
viru
entri
infecti
mlv
use
control
mous
pathogen
ecohiv
mlv
induc
extens
brain
lesion
contain
infiltr
macrophag
b
cell
caus
pronounc
astrocyt
macrophag
microglia
activ
brain
parenchyma
ecohiv
mlv
express
brain
hiv
replic
document
detect
viral
genom
dna
rna
circl
presenc
splice
viral
rna
speci
synthesi
viral
hiv
found
mostli
macrophagemicroglia
neuron
infiltr
lymphocyt
also
posit
ecohiv
mlvinfect
mous
brain
show
signific
chang
express
select
cellular
gene
involv
hiv
neuropathogen
hivinfect
peopl
includ
tnfalpha
importantli
ecohiv
mlvinfect
mice
exhibit
signific
learn
memori
deficit
radial
arm
water
maze
test
thu
intracerebr
infect
immunocompet
mice
chimer
hiv
lack
hiv
recapitul
mani
featur
advanc
hand
result
indic
hiv
replic
essenti
patholog
express
hiv
dispens
anim
model
describ
permit
experiment
analysi
link
hiv
replic
brain
express
individu
viral
protein
behavior
neurocognit
deficit
support
nih
varicellazost
viru
isol
obtain
patient
zoster
complic
postherpet
neuralgia
induc
signific
increas
sodium
current
densiti
neuron
cell
line
varicellazost
viru
vzv
caus
chickenpox
varicella
primari
infect
follow
becom
latent
sensori
ganglia
reactiv
caus
herp
zoster
shingl
import
complic
zoster
postherpet
neuralgia
phn
caus
sever
chronic
dermatom
pain
extrem
refractori
treatment
host
factor
age
immunosuppress
import
develop
phn
viral
factor
may
also
import
therefor
hypothes
phnassoci
nonphnassoci
vzv
isol
could
induc
alter
neuron
sodium
ion
channel
activ
sinc
latter
known
associ
neuropath
pain
twenti
vzv
isol
studi
blind
phn
sampl
nonphn
sampl
subject
virus
propag
mewo
cell
line
cellfre
viru
harvest
hr
plate
onto
neuroblastoma
cell
line
latter
show
constitut
express
exogen
nav
endogen
nav
gene
encod
sodium
channel
known
associ
neuropath
pain
singl
cell
sodium
ion
channel
record
infect
control
cell
perform
hr
voltageclamp
found
phnassoci
vzv
isol
significantli
increas
sodium
current
amplitud
cell
line
compar
nonphn
vzv
wildtyp
duma
vaccin
vzv
strain
poka
merck
gsk
sodium
current
increas
unaffect
acyclovir
pretreat
abolish
expos
infect
cell
line
tetrodotoxin
ttx
block
ttxsensit
fast
channel
na
v
ttxresist
slow
na
channel
therefor
phnassoci
vzv
sodium
current
increas
mediat
part
nav
sodium
channel
report
play
role
neuropath
pain
knowledg
first
report
painassoci
vitro
effect
induc
vzv
inocul
mice
mousetrop
hiv
ecohiv
establish
chronic
system
infect
peripher
lymphocyt
macrophag
low
level
viru
mild
neuropathogenesi
brain
begin
investig
basi
ecohiv
neurotrop
mice
examin
ecohiv
infect
mous
mix
brain
cell
cultur
enrich
popul
neuron
astrocyt
bone
marrowderiv
macrophag
bmm
vitro
use
cell
mice
test
infect
clade
b
clade
ecohivndk
virus
hiv
infect
score
measur
hiv
dna
rna
qpcr
detect
green
fluoresc
protein
gfp
ecohiv
indic
virus
detect
viral
immunohistochemistri
elisa
ident
infect
cell
determin
doublestain
cell
lineag
marker
mix
brain
cell
cultur
ecohiv
infect
viru
dosedepend
manner
microgli
cell
neuron
neglig
fraction
astrocyt
ecohivndk
infecti
cell
suscept
cell
attribut
higher
express
ecohiv
receptor
mice
similar
mous
microglia
murin
bmm
highli
suscept
ecohiv
progeni
viru
produc
cell
could
passag
uninfect
bmm
interestingli
exposur
enrich
neuron
cultur
ecohiv
result
neurotox
without
express
viral
protein
conclud
ecohiv
use
ecotrop
mlv
receptor
cellular
entri
reproduc
hiv
tropism
human
cnsderiv
cell
preferenti
infect
mous
microglia
macrophag
molecular
basi
observ
resist
mous
neuron
astrocyt
ecohiv
express
investig
similar
hiv
infect
phenotyp
human
mous
cn
cell
suggest
ecohiv
suitabl
studi
hiv
neuropathogenesi
mice
support
nih
prolin
rich
fusion
domain
mous
hepat
viru
spike
protein
involv
neuron
cell
fusion
induct
axon
loss
concurr
demyelin
neurotrop
mous
hepat
viru
infect
mice
caus
meningoenceph
myeliti
demyelin
axon
loss
infect
mice
demyelin
strain
contain
wildtyp
spike
gene
caus
axon
loss
concurr
macrophagemedi
demyelin
mimic
certain
patholog
human
demyelin
diseas
multipl
sclerosi
contrast
infect
nondemyelin
strain
contain
spike
gene
genom
show
rare
earli
axon
degener
axon
loss
demyelin
occur
due
direct
viral
attack
mechan
mediat
demyelin
axon
loss
depend
spikemedi
axon
transport
viral
particl
gray
matter
white
matter
mhv
spike
protein
synthes
kda
glycosyl
precursor
posttransl
cleav
two
kda
subunit
receptor
bind
domain
respons
initi
attach
mhv
cell
surfac
receptor
bind
event
trigger
conform
chang
spike
allow
cleavag
initi
fusion
host
membran
candid
fusion
peptid
domain
identifi
within
homolog
model
demonstr
despit
high
sequenc
ident
two
fusion
peptid
fusion
peptid
uniqu
contain
two
consecut
prolin
residu
comparison
one
insert
extra
prolin
residu
sequenc
central
loop
region
fusion
peptid
uniqu
structur
conform
could
respons
fusion
viru
neural
cell
membran
pathogen
evalu
role
two
consecut
prolin
residu
membran
fusion
compar
put
domain
spike
protein
spike
protein
design
target
rna
recombin
swap
domain
confirm
put
domain
respons
membran
fusion
subsequ
demyelin
vpr
regul
select
inhibit
pathway
numer
studi
report
vpr
alter
signal
variou
cell
howev
find
larg
conflict
report
stimulatori
inhibitori
effect
vpr
aim
investig
role
vpr
signal
myeloid
cell
address
controversi
develop
field
result
show
vpr
express
intracellularli
inhibitori
extracelluar
vpr
may
opposit
stimulatori
effect
consist
notion
report
vpr
inhibitori
effect
specif
pathway
affect
lp
pathway
suggest
differenti
target
vpr
may
exist
regul
identifi
vprbp
one
possibl
cellular
compon
vpr
regul
respons
stimul
identifi
role
instead
seem
inhibit
vpr
function
final
find
suggest
regul
vpr
influenc
presenc
compon
within
infect
cell
chronic
infect
cell
knockdown
construct
vpr
unexpectedli
less
respons
data
suggest
vpr
may
serv
import
role
vivo
select
inhibit
immun
activ
stimul
mediat
viral
product
infect
tcell
myeloid
cell
oncogen
potenti
mcsf
receptor
cfm
note
thirti
year
howev
current
studi
focus
role
receptor
aml
clinic
trial
aml
sunitinib
found
hold
efficaci
treat
diseas
author
hypothes
primari
therapeut
target
sunitinib
aml
kinas
howev
inhibit
alon
shown
recapitul
effect
sunitinib
vitro
drug
known
cross
reactiv
potenti
oncogen
receptor
well
studi
treat
three
myeloid
cell
line
monomac
sunitinib
small
molecul
cfmsi
optim
cfm
inhibitori
activ
test
anticanc
effect
treatment
observ
monomac
cell
diminish
prolifer
vitro
monomac
cell
inhibit
erk
result
cfm
inhibit
show
dose
depend
increas
cfm
express
sunitinib
cfmsi
result
suggest
potenti
cfm
import
target
sunitinib
similar
drug
aml
either
independ
combin
therapeut
altern
cfm
may
marker
differenti
aml
may
link
respons
certain
therapeut
case
futur
studi
cfm
may
produc
target
therapeut
approach
may
suitabl
tool
develop
person
medicin
aml
cocain
remain
among
commonli
abus
drug
worldwid
pose
substanti
health
econom
burden
imag
studi
postmortem
microarray
data
human
cocain
abus
reveal
signific
deficit
white
matter
wm
integr
myelinrel
gene
discret
brain
region
includ
nucleu
accumben
nac
underli
mechan
remain
larg
unknown
wm
abnorm
like
contribut
cognit
motor
psycholog
deficit
commonli
afflict
cocain
abus
furthermor
human
studi
indic
abstin
cocain
allow
recoveri
cognit
function
gray
matter
densiti
interestingli
wm
densiti
appear
recov
patient
indic
longterm
potenti
irrevers
damag
result
repeat
cocain
exposur
human
studi
often
confound
polydrug
abus
comorbid
condit
vivo
anim
model
need
delin
pathway
contribut
wm
loss
highlight
potenti
treatment
avenu
context
uncov
new
paradigm
chronic
cocain
treatment
significantli
decreas
express
wm
protein
nac
adult
mice
furthermor
demonstr
wm
loss
inhibit
andor
revers
administr
antibiot
ceftriaxon
period
cocain
withdraw
mice
expos
chronic
cocain
paradigm
mgkg
daili
day
follow
day
cocain
withdraw
challeng
dose
display
signific
decreas
myelin
basic
protein
proteolipid
protein
myelinoligodendrocyt
glycoprotein
myelinassoci
glycoprotein
nac
moreov
chang
inhibit
administr
ceftriaxon
mgkg
daili
withdraw
effect
wm
loss
observ
mice
treat
ceftriaxon
cocain
treatment
vehicl
day
withdraw
prior
challeng
observ
identifi
cocainemedi
myelin
loss
adult
mous
model
highlight
potenti
pharmacolog
intervent
revers
andor
prevent
cocaineinduc
wm
loss
mount
evid
suggest
potenti
link
cocain
abus
disrupt
hypothalamicpituitarythyroid
hpt
axi
signal
neuroplast
molecular
mechan
remain
unknown
neurogranin
ng
gene
contain
thyroid
hormon
respons
element
tre
within
first
intron
involv
synapt
plastic
transcript
activ
requir
heterodimer
thyroid
hormon
receptor
tr
retinoid
x
receptor
rxr
bound
respect
ligand
triiodothryonin
acid
ra
subsequ
bind
complex
tre
ng
gene
studi
character
effect
chronic
cocain
abus
ng
express
euthyroid
hypothyroid
mice
cocainetr
mice
decreas
ng
express
observ
absenc
chang
level
th
hpt
signal
factor
therefor
hypothes
cocain
decreas
ng
express
via
alter
avail
trrxr
signal
support
hypothesi
significantli
decreas
brain
cocainetr
mice
main
enzym
respons
neuron
ra
degrad
significantli
increas
result
studi
provid
first
evid
direct
effect
cocain
abus
trrxr
signal
ra
metabol
transcript
regul
ng
gene
essenti
adult
synapt
plastic
addit
role
pml
numer
studi
demonstr
transform
abil
jcv
earli
protein
tantigen
associ
human
cancer
jcv
infect
like
occur
childhood
hypothes
latent
viru
maintain
within
bone
marrow
harbor
cell
mani
lineag
addit
hematopoiet
compon
recent
shown
nonhematopoet
bone
marrowderiv
mesenchym
stem
cell
also
known
marrow
stromal
cell
msc
infect
jc
viru
undergo
oncogen
transform
mediat
jc
viru
tantigen
induc
neurallik
tumor
anim
msc
heterogen
cell
partial
origin
neural
crest
shown
capabl
traffick
potenti
multilineag
differenti
msc
isol
bone
marrow
jcv
tantigen
transgen
mice
cultur
condit
typic
mesenchym
cell
select
popul
tantigen
neg
cell
express
neural
crest
marker
jcv
tantigen
posit
cell
aros
cell
cultur
neural
condit
express
ie
neural
crest
characterist
jcv
tantigen
posit
neural
crestderiv
bone
marrow
cell
exhibit
nestin
posit
could
success
cultur
longterm
maintain
neural
crest
characterist
conclud
jcv
tantigen
stabli
express
within
neural
crest
popul
bone
marrow
find
suggest
appropri
popul
within
bone
marrow
jcv
establish
latenc
cell
may
critic
understand
jcv
reactiv
distribut
data
provid
excel
experiment
model
system
stud
celltyp
specif
jcv
tantigen
express
role
bone
marrowderiv
stem
cell
pathogenesi
jcvrelat
diseas
central
role
cytochrom
tobaccomedi
oxid
stress
maccrophag
astrocyt
implic
pathogenesi
neuroaid
santosh
kumar
anusha
and
namita
sinha
carol
mcarthur
email
kumarsa
umkcedu
univers
missourikansa
citi
unit
state
univers
missourikansa
citi
unit
state
univers
missourikansa
citi
unit
state
univers
missourikansa
citi
unit
state
tobacco
consumptionsmok
highli
preval
hiv
person
known
increas
replic
perhap
aidsneuroaid
develop
progress
hypothes
cytochrom
play
central
role
nicotin
tobacco
major
constitu
mediat
oxid
stress
lead
increas
replic
monocytesmacrophag
astrocyt
known
metabol
nicotin
activ
nicotineder
nitrosamin
keton
nnk
caus
oxid
stress
mediat
liver
toxic
lung
cancer
howev
noth
known
role
set
monocytesmacrophag
secondari
target
viral
replic
major
viral
reservoir
also
infiltr
brain
caus
neuroaid
astrocyt
minor
target
replic
upon
activ
known
caus
neuron
damag
test
hypothesi
use
invitro
model
monocyt
macrophag
svga
astrocyt
cell
line
human
primari
macrophag
result
show
predominantli
express
monocytesmacrophag
total
cyp
astrocyt
total
cyp
subsequ
use
newli
develop
highli
sensit
lcm
ms
method
show
nicotin
metabol
cotinin
nnk
produc
reactiv
oxygen
speci
result
suggest
nicotin
metabol
increas
oxid
stress
may
respons
replic
process
test
hypothesi
measur
replic
nicotinetr
primari
human
monocytesmacrophag
astrocyt
final
recruit
healthi
smoker
hiv
hiv
smoker
cameroon
africa
isol
monocytesmacrophag
lymphocyt
subject
preliminari
result
show
posit
correl
smoke
increas
replic
level
neg
correl
smoke
express
level
antioxid
enzym
studi
open
new
cyp
pathway
may
respons
smokingmedi
pathogenesi
neuroaid
support
nih
although
hivassoci
impair
neuromotor
neurocognit
function
hallmark
infect
cn
remain
pauciti
evid
direct
relationship
chang
dopamin
da
avail
well
rna
level
region
impair
perform
neurocognit
function
object
investig
impact
statu
da
postmortem
brain
tissu
frontocort
fc
basal
ganglia
bg
region
individu
die
hivaid
determin
relationship
da
metabolit
homovanil
acid
hva
avail
well
region
local
rna
level
perform
neuropsycholog
np
function
evalu
life
result
among
brain
region
investig
decreas
da
avail
found
putamen
caudat
substantia
nigra
brain
region
hiv
aid
case
compar
hivneg
decreas
da
putamen
sn
correl
perform
memori
learn
inform
process
verbal
fluenci
chang
hva
level
correl
motor
function
inform
process
attentionwork
memori
rna
fc
caudat
gp
invers
influenc
motor
function
learn
attentionwork
memori
conclus
find
studi
suggest
hiv
invas
cn
profoundli
disrupt
region
da
avail
fc
bg
region
individu
hivaid
may
import
contribut
factor
impair
perform
differ
np
function
ariel
kurzweil
swati
sath
email
ariellekurzweil
nyumcorg
new
york
univers
school
medicin
unit
state
new
york
univers
school
medicin
unit
state
object
report
case
recurr
mening
patient
aid
initi
cryptococcu
infect
subsequ
asept
background
even
patient
hivaid
recurr
mening
unusu
evid
recurr
cryptococc
mening
cm
result
persist
origin
infect
strain
recurr
mening
symptom
follow
haart
therapi
may
relat
immun
reconstitut
rather
reinfect
method
clinic
present
laboratori
radiolog
studi
man
year
review
review
literatur
perform
result
patient
present
twice
headach
neck
stiff
fever
count
respect
viral
load
copiesml
time
csf
grew
cryptococcu
neoforman
treat
amphotericinflucytosin
follow
fluconazol
csf
treatment
neg
cryptococcu
haart
maintain
howev
complianc
fluconazol
haart
unreli
count
remain
date
sinc
present
sever
time
meningit
symptom
csf
reveal
lymphocyt
pleocytosi
elev
protein
mgdl
low
glucos
level
mgdl
without
evid
viral
hsv
cmv
vzv
toxoplasmosi
fungal
bacteri
infect
atyp
cell
cryptococc
antigen
ca
alway
posit
blood
except
last
admiss
viral
load
copiesml
treat
presum
cryptococcu
tubercul
mening
receiv
treatment
brain
mri
persist
show
mening
enhanc
especi
around
brainstem
mri
show
progress
hydrocephalu
ventriculoperiton
shunt
place
conclus
number
recurr
cm
patient
make
case
unusu
well
later
persist
csf
mri
abnorm
punctuat
episod
clinic
worsen
without
identifi
agent
possibl
immun
reconstitut
play
role
later
present
yet
exact
etiolog
remain
elus
cyclindepend
kinas
serinethreonin
protein
kinas
activ
neuronspecif
activ
truncat
form
activ
essenti
mani
postmitot
process
neuron
activ
neuron
migrat
develop
neurit
outgrowth
howev
deregul
associ
link
patholog
neurodegen
diseas
alzheim
diseas
amyotroph
later
sclerosi
vivo
studi
util
hippocampu
wild
type
tg
mice
tg
mice
increas
activ
compar
wild
type
mice
express
tg
mice
significantli
lower
higher
mark
popul
newli
born
dentat
granul
neuron
retroviru
express
green
floresc
protein
gfp
stereotax
inject
dentat
gyru
mice
dendrit
analysi
threedimension
reconstruct
entir
dendrit
process
neuron
made
use
confoc
imag
twodimension
project
imag
trace
nih
imagej
elabor
dendrit
tree
tg
mice
seen
comparison
wild
type
mice
week
post
inject
retroviru
dendrit
length
branch
number
increas
tg
mice
furthermor
sholl
analysi
demonstr
greater
dendrit
complex
neuron
tg
mice
thu
initi
dendrit
develop
aberrantli
acceler
newli
gener
adult
hippocamp
neuron
tg
mice
cultur
npcderiv
neural
progeni
expos
recombin
protein
hr
immunolabel
antibodi
neuron
marker
tubulin
reveal
treatment
result
aberr
outgrowth
neurit
taken
togeth
studi
demonstr
abnorm
activ
mediat
result
abnorm
dendrit
develop
may
therapeut
target
rang
studi
associ
ubiquit
human
herpesviru
neurolog
diseas
includ
multipl
sclerosi
ms
biolog
surround
infect
larg
unknown
though
consid
neurotrop
investig
infect
common
marmoset
cjacchu
unlik
rodent
express
receptor
viral
entri
marmoset
inocul
intraven
exhibit
neurolog
symptom
gener
robust
virusspecif
serum
igm
igg
respons
light
work
lab
suggest
olfactori
pathway
rout
entri
also
inocul
marmoset
intranas
n
interestingli
marmoset
inocul
intranas
fail
gener
virusspecif
serum
igm
igg
experiment
autoimmun
encephalomyel
eae
common
anim
model
ms
research
recapitul
tcell
mediat
cn
inflammatori
demyelin
virus
may
act
trigger
ms
ask
marmoset
previous
inocul
intranas
exhibit
alter
eae
diseas
cours
compar
marmoset
observ
eae
marmoset
exhibit
clinic
symptom
includ
weight
loss
physic
disabl
earlier
aggress
eae
alon
marmoset
marmoset
also
exhibit
sever
radiolog
diseas
mri
increas
white
matter
lesion
load
leukocort
lesion
brain
post
mortem
mri
spinal
cord
ongo
previou
marmoset
eae
studi
correl
seroposit
immunogen
myelin
protein
mog
overt
clinic
eae
detect
increas
level
serum
antimog
igg
marmoset
compar
eae
alon
moreov
follow
eae
induct
detect
virusspecif
serum
igm
one
intranas
marmoset
suggest
synergi
viral
infect
autoimmun
trigger
immunohistochem
analys
cn
tissu
flow
cytometrybas
analys
cellular
immun
respons
mog
ongo
anim
model
may
help
elucid
role
virus
process
autoimmun
pathogenesi
ms
longitudin
analysi
interact
effect
host
genotyp
stimul
use
hiv
statu
upon
neurocognit
function
hivassoci
neurocognit
impair
highli
preval
among
infect
individu
unit
state
put
caus
includ
chronic
neuroinflamm
mediat
larg
cytokin
activ
loss
dysfunct
dopaminerg
neuron
investig
examin
genet
suscept
loci
within
cytokin
dopaminerel
gene
may
increas
risk
neurocognit
impair
especi
among
user
drug
affect
dopaminerg
system
method
longitudin
studi
util
gener
linear
model
examin
interact
effect
hiv
statu
stimul
use
host
genotyp
upon
neurocognit
function
data
obtain
hiv
uninfect
individu
enrol
multicent
aid
cohort
studi
approxim
stimul
user
cocain
andor
methamphetamin
data
obtain
prior
use
avoid
confound
effect
highli
activ
antiretrovir
therapi
statist
model
control
marijuana
use
alcohol
use
depress
hepat
c
nadir
practic
effect
neurocognit
domain
examin
work
memori
learn
memori
motor
execut
process
speed
fals
discoveri
rate
use
correct
multipl
comparison
result
interact
found
refit
signific
interact
found
comt
gene
indic
influenc
comt
genotyp
learn
abil
time
affect
hiv
statu
stimul
use
interact
gene
indic
execut
function
time
influenc
genotyp
hiv
statu
final
interact
across
mani
model
indic
hiv
result
declin
motor
function
process
speed
lesser
extent
stimul
use
improv
motor
worsen
work
memori
function
time
conclus
find
suggest
genet
suscept
loci
within
dopamin
cytokinerel
gene
interact
hiv
statu
andor
stimul
use
impact
cours
neurocognit
function
domainspecif
manner
emerg
evid
show
human
cerebr
ec
part
bloodbrain
barrier
bbb
also
play
import
role
immunolog
regul
gain
insight
innat
immun
cerebr
ec
viral
infect
studi
immun
activ
human
cerebr
microvascular
endotheli
cell
found
polyi
c
treatment
effect
ifn
express
transfect
significantli
upregul
express
ifnbeta
ifnlambda
mrna
protein
level
rigi
activ
also
moder
increas
ifnbeta
ifnlambda
express
cell
immunofluoresc
studi
show
transfect
induc
polyi
c
cell
ifnbeta
ifnlambda
induct
polyi
c
stimul
could
inhibit
disrupt
function
well
rigi
sirna
investig
mechan
reveal
polyi
c
stimul
induc
nuclear
transloc
studi
function
signific
brain
ec
activ
appli
supernat
sn
polyi
cstimul
cultur
hivinfect
macrophag
observ
signific
inhibit
hiv
replic
sn
polyi
cstimul
cultur
induc
express
phosphoryl
jnk
erk
mapk
kinas
activ
trigger
express
isg
inhibitori
activ
sn
could
neutral
antibodi
ifnbeta
confirm
ifnbeta
ifnlambda
key
factor
sn
respons
antihiv
activ
result
thu
demonstr
signal
activ
human
cerebr
ec
term
ifn
induct
first
time
show
newli
identifi
ifnlambda
involv
activ
observ
indic
hcmec
may
key
regulatori
bystand
play
crucial
role
brain
innat
immun
hiv
infect
use
ifnbeta
ifnlambdadepend
mechan
human
endogen
retrovirus
herv
genom
sequenc
retrovir
origin
believ
integr
germlin
chromosom
million
year
ago
although
mostli
defect
inact
herv
may
activ
certain
physiolog
patholog
condit
one
herv
hervk
intact
genom
structur
may
preserv
capabl
make
viral
particl
hervk
activ
detect
plasma
brain
patient
infect
suggest
exogen
retrovirus
may
regul
hervk
express
hypothes
protein
tat
rev
may
directli
upregul
express
hervk
examin
brain
tissu
patient
infect
hervk
revers
transcriptas
rt
express
found
immunostain
densiti
hervk
rt
significantli
higher
infect
patient
hervk
rt
higher
posit
brain
compar
neg
brain
infect
patient
studi
hervk
activ
vitro
construct
plasmid
encod
hervk
consensu
genom
confirm
express
viral
particl
product
hela
cell
cotransfect
hervk
plasmid
significantli
increas
hervk
env
pol
mrna
level
unlik
transactiv
protein
identifi
hervk
genom
howev
found
tat
significantli
upregul
hervk
express
rev
also
increas
hervk
express
addit
effect
togeth
tat
hervk
rec
rev
equival
significantli
activ
hervk
express
delet
mutant
rec
margin
effect
less
effect
rev
also
addit
effect
togeth
tat
conclus
tat
rev
significantli
upregul
hervk
express
could
mechan
hervk
activ
infect
patient
astrocyt
critic
reservoir
human
brain
human
astrocyt
express
receptor
express
coreceptor
dcsign
endocytosi
propos
pathway
entri
astrocyt
howev
infect
astrocyt
consid
nonproduct
challeng
current
dogma
although
found
cellfre
hiv
infect
rare
human
astrocyt
obstacl
replic
cell
viral
particl
continu
releas
extracellular
medium
day
follow
either
infect
vsvg
pseudotyp
transfect
provir
dna
could
also
replic
continu
astrocyt
infect
strain
cellfre
virus
follow
treatment
either
lysosomotrop
agent
chloroquin
tat
peptid
destabil
membran
endosomeslysosom
viru
releas
astrocyt
chronic
infect
day
could
success
transmit
lymphocyt
cell
line
electron
microscopi
confirm
process
endocytosi
hiv
gain
entri
compart
endosomeslysosom
astrocyt
addit
persist
infect
astrocyt
probabl
speciesspecif
siv
strain
share
receptor
coreceptor
hiv
could
establish
persist
infect
astrocyt
despit
treatment
chloroquin
observ
indic
endocytosi
major
pathway
hiv
entri
astrocyt
infect
limit
trap
hiv
particl
endosomeslysosom
viru
escap
lysosom
form
persist
infect
cell
thu
chloroquin
lysosomotrop
agent
use
caution
patient
hiv
infect
hiv
infect
human
astrocyt
role
hiv
latenc
brain
strengthen
cumul
vivo
evid
shown
occur
predominantli
perivascular
region
brain
infect
astrocyt
cellfre
hiv
ineffici
vitro
found
signific
infect
could
easili
establish
cocultiv
human
astrocyt
lymphocyt
infect
report
viru
confirm
use
sever
hivinfect
lymphocyt
cell
line
cemss
jurkattat
hivinfect
peripher
blood
mononuclear
cell
multipl
mode
interact
astrocyt
infect
lymphocyt
especi
jurkattat
observ
video
microscopi
electron
microscopi
includ
partial
invagin
infect
lymphocyt
astrocyt
format
virolog
synaps
format
larg
interfac
cell
membran
two
cell
interdigit
long
filopodia
aris
cell
type
form
bridgelik
structur
viral
particl
concentr
interfac
cell
along
bridg
also
observ
villuslik
synapt
structur
stretch
onto
astrocyt
hiv
particl
appear
space
within
structur
infect
lymphocyt
place
upper
chamber
transwel
decreas
infect
astrocyt
observ
infect
astrocyt
infect
lymphocyt
could
significantli
inhibit
monoclon
antibodi
pharmacolog
inhibitor
antidc
sign
integrin
antibodi
conclus
infect
astrocyt
easili
establish
cellcel
contact
hivinfect
lymphocyt
critic
receptor
mediat
transmiss
studi
indic
cellcel
transmiss
might
play
critic
role
hiv
infect
astrocyt
brain
laboratori
develop
novel
drug
deliveri
system
carri
antiretrovir
therapi
art
cell
tissu
site
infect
although
nanoformul
art
nanoart
test
uptak
releas
antiretrovir
efficaci
complex
approach
need
determin
drug
biodistribut
therapeut
efficaci
address
small
magnetitecontain
art
smart
polym
nanoparticl
system
develop
combin
art
superparamagnet
iron
oxid
particl
hydrophob
core
polym
particl
util
hydrophil
shell
ensur
stabil
prepar
smart
flash
nanoprecipit
hydrophob
magnetit
nanoparticl
amphiphil
poli
ethylen
oxideblactid
copolym
art
effect
high
supersatur
kinet
control
aggreg
result
smart
particl
narrow
size
distribut
polydispers
indic
administ
smart
macrophag
observ
result
chang
transvers
relax
importantli
smart
ingest
within
eight
hour
human
monocytederiv
macrophag
mdm
final
smart
inject
ip
ritonavir
rtv
concentr
ngkg
reticuloendotheli
system
mice
weight
map
mri
acquir
preinject
hour
later
result
indic
liver
spleen
contain
greatest
concentr
smart
particl
commensur
postmortem
tissu
rtv
concentr
determin
ultra
perform
liquid
chromatographi
posit
flash
precipit
develop
smart
particl
permit
simultan
studi
drug
biodistribut
measur
therapeut
efficaci
antiretrovir
drug
posit
smart
serv
platform
screen
nanoart
biodistribut
therapeut
endpoint
screen
capabl
would
permit
analys
multipl
differ
formul
system
would
speed
translat
work
laboratori
bench
patient
provid
theranost
develop
theranost
develop
small
magnetit
antiretrovir
therapi
smart
laboratori
develop
novel
drug
deliveri
system
carri
antiretrovir
therapi
art
cell
tissu
site
infect
although
nanoformul
art
nanoart
test
uptak
releas
antiretrovir
efficaci
complex
approach
need
determin
drug
biodistribut
therapeut
efficaci
address
small
magnetitecontain
art
smart
polym
nanoparticl
system
develop
combin
art
superparamagnet
iron
oxid
particl
hydrophob
core
polym
particl
util
hydrophil
shell
ensur
stabil
prepar
smart
flash
nanoprecipit
hydrophob
magnetit
nanoparticl
amphiphil
poli
ethylen
oxideblactid
copolym
art
effect
high
supersatur
kinet
control
aggreg
result
smart
particl
narrow
size
distribut
polydispers
indic
administ
smart
macrophag
observ
result
chang
transvers
relax
importantli
smart
ingest
within
eight
hour
human
monocytederiv
macrophag
mdm
final
smart
inject
ip
ritonavir
rtv
concentr
mgkg
result
ngkg
mous
reticuloendotheli
system
weight
map
mri
acquir
preinject
hour
later
result
indic
liver
spleen
contain
greatest
concentr
smart
particl
commensur
tissu
rtv
concentr
determin
ultra
perform
liquid
chromatographi
posit
flash
precipit
develop
smart
particl
permit
simultan
studi
drug
biodistribut
measur
therapeut
efficaci
antiretrovir
drug
posit
smart
serv
platform
screen
nanoart
biodistribut
therapeut
endpoint
screen
capabl
would
permit
analys
multipl
differ
formul
system
would
speed
translat
work
laboratori
bench
patient
bedsid
new
field
theranost
microglia
activ
result
proinflammatori
respons
play
crucial
role
pathogenesi
neurocognit
disord
studi
identif
specif
target
control
microglia
activ
result
neurotox
activ
imper
increas
evid
indic
voltageg
k
kv
channel
involv
regul
microglia
function
hypothes
tat
activ
microgli
channel
result
neurotox
activ
test
hypothesi
investig
role
kv
channel
tatinduc
neurotox
primari
rat
microglia
cultur
brain
slide
result
reveal
incub
microglia
tat
ngml
markedli
increas
level
mrna
protein
express
block
margtoxin
mgtx
specif
channel
blocker
heat
inactiv
tat
alter
level
mrna
protein
express
wholecel
patch
record
show
tat
enhanc
microglia
current
dosedepend
manner
examin
associ
tat
enhanc
current
microgliainduc
neurotox
detect
microglia
cytokin
nitric
oxid
product
elisa
microgliainduc
neuron
injuri
via
tunel
elisa
analysi
show
tattreat
microglia
produc
higher
amount
untreat
microglia
tunel
stain
reveal
k
channel
block
mgtx
pap
attenu
apoptot
neuron
induc
tatactiv
microglia
respect
knockdown
gene
transfect
abrog
neurotox
mediat
tattreat
microglia
suggest
involv
tat
induc
microgli
neurotox
activ
similar
result
obtain
brain
slide
blockad
channel
express
mgtx
pap
brain
slide
significantli
inhibit
microglia
activ
result
neuron
injuri
taken
togeth
data
suggest
brain
infect
induc
microgli
cytotox
activ
via
microgli
could
potenti
target
develop
therapeut
strategi
integr
role
tantigen
ctcf
bori
mediat
noncanon
endoplasm
reticulumdepend
death
pathway
trigger
erchron
stress
mous
medulloblastoma
distinct
molecular
pathway
could
constitut
activ
mous
tantigen
posit
tantigen
neg
medulloblastoma
cell
line
contribut
phenotyp
differ
well
cellular
respons
cell
cycl
progress
cell
death
surviv
divers
respons
might
due
distinct
activ
ctcf
bori
protein
respons
alter
network
signal
evok
tag
presenc
provid
evid
support
role
tantigen
caus
chronic
endoplasm
reticulum
er
stress
aberr
express
activ
subsequ
drive
massiv
cell
death
like
select
cell
higher
malign
phenotyp
also
observ
endoplasm
stress
either
chronic
caus
tag
transient
induc
glucos
depriv
accompani
format
complex
retinoblastoma
relat
protein
chromatin
insul
ccctcbind
factor
ctcf
ctcfparalogu
bori
abstract
present
first
evid
support
role
tantigen
inducingmaintain
chronic
erstress
well
indic
role
ctcf
bori
potenti
mediat
noncanon
erdepend
death
pathway
mous
medulloblastoma
andrew
maclean
nicol
renner
hope
sans
andrew
lackner
email
amaclean
tulaneedu
tulan
univers
unit
state
tulan
univers
unit
state
tulan
univers
unit
state
tulan
univers
unit
state
hiv
infect
report
includ
increas
vegf
serum
although
curious
csf
hiv
protein
tat
bind
receptor
vegf
induc
angiogenesi
kaposi
sarcoma
spindl
cell
hypothes
hiv
tat
may
increas
induc
vegfr
express
brain
endotheli
cell
ec
astrocyt
vegf
associ
decreas
tight
junction
protein
express
hypothes
vegfr
express
would
correl
activ
ec
tat
tempor
spatial
test
hypothesi
examin
brain
tissu
macaqu
infect
neuropathogen
strain
siv
express
increas
astrocyt
macaqu
siv
enceph
upregul
restrict
ec
mechan
upregul
confirm
use
primari
cultur
ec
astrocyt
deriv
control
macaqu
result
demonstr
increas
express
depend
focal
adhes
kinas
activ
use
highli
select
inhibitor
express
astrocyt
brain
macaqu
detect
viru
situ
hybrid
result
provid
proofofconcept
hypothesi
bbb
disrupt
hiv
mediat
least
part
vegf
receptor
express
neurosteroidmedi
regul
brain
innat
immun
hivaid
dhea
suppress
neurovirul
neurosteroid
repres
network
cholesterolderiv
molecul
synthes
within
brain
exert
trophic
protect
action
infect
human
hiv
felin
fiv
immunodefici
virus
caus
neuroinflamm
neurodegener
secret
neuroinflammatori
host
viral
factor
activ
glia
infiltr
leukocyt
compris
princip
neuropathogen
mechan
although
impact
neurosteroid
neurolog
infect
unknown
herein
investig
interact
neurosteroidmedi
effect
lentiviru
infect
outcom
analys
hivinfect
uninfect
person
brain
disclos
reduct
express
neuron
hivinfect
person
neuron
expos
supernat
hivinfect
macrophag
exhibit
suppress
express
without
reduc
cellular
viabil
p
hivinfect
macrophag
treat
sulphat
dhea
dhea
show
suppress
inflammatori
gene
express
p
fivinfect
anim
treat
dhea
demonstr
reduct
inflammatori
gene
transcript
gfap
brain
p
blood
tcell
level
increas
dhea
treat
fivinfect
anim
p
dhea
treatment
also
prevent
neurobehavior
deficit
neuron
loss
among
fivinfect
anim
compar
vehicletr
anim
p
reduc
neuron
neurosteroid
express
accompani
lentiviru
infect
treatment
dhea
limit
inflamm
neurobehavior
deficit
neurosteroidderiv
therapi
might
effect
treatment
virusor
inflammationmedi
neurodegener
two
member
w
famili
human
endogen
retrovirus
hervw
relat
multipl
sclerosi
ms
msrv
msassoci
retroviru
releas
cell
ms
patient
viruslik
particl
element
produc
env
protein
vitro
anim
model
msrvenv
caus
neuroinflamm
neurodegener
alter
immun
stress
respons
also
ebv
epstein
barr
viru
propos
ms
cofactor
unknown
mechan
past
monitor
ms
patient
variou
tempor
clinic
stage
case
strike
parallel
ms
behaviour
msrvhervw
presenceload
found
express
msrvenv
peripher
blood
mononuclear
cell
pbmc
msrv
volunt
ms
patient
astrocyt
studi
discriminatori
envspecif
rtpcr
flow
cytometri
clarifi
whether
msrv
differenti
express
b
nk
monocyt
subset
separ
immunospecif
adsorpt
magnet
bead
monocyt
also
differenti
macrophag
mdm
altern
hervwenvspecif
immunostain
monitor
flow
cytometri
pbmc
sort
marker
cell
subset
similar
studi
carri
astrocyt
result
show
basal
express
occur
monocyt
nk
b
cell
one
third
astrocyt
surfac
hervwenv
uneven
express
pbmc
amplifi
cell
ms
patient
dramat
reduc
therapi
cell
expos
protein
msrvenv
activ
b
cell
monocyt
mdm
cell
highli
express
nk
cell
latter
cell
cell
activ
proinflammatori
cytokin
conclud
vitro
interact
among
two
propos
mscofactor
hervw
ebv
occur
cell
blood
brain
like
might
occur
also
vivo
src
domain
contain
protein
tyrosin
phosphatas
shp
regul
chemokin
express
human
astrocyt
implic
hiv
neuropathogenesi
chronic
inflamm
initi
infect
brain
via
releas
cytokineschemokin
import
factor
neuropathogenesi
hivassoci
dementia
one
first
chemokin
found
brain
upregul
brain
cerebrospin
fluid
csf
infect
individu
suggest
potenti
role
hivassoci
neuroinflamm
major
contributor
pool
known
astrocyt
interleukin
il
activ
astrocyt
exhibit
signific
upregul
mechan
involv
elucid
present
studi
investig
underli
intracellular
signal
pathway
lead
product
astrocyt
activ
proinflammatori
stimuli
primari
human
astrocyt
show
decreas
mrna
protein
level
pretreat
pharmacolog
inhibitor
srchomolog
domain
contain
protein
tyrosin
phosphatas
shp
mitogenactiv
protein
kinas
mapk
activ
transfect
astrocyt
overexpress
plasmid
led
increas
rna
protein
level
wherea
correspond
domin
neg
mutant
cs
effect
basal
level
howev
treatment
inhibitor
overexpress
astrocyt
abrog
overexpress
show
increas
level
suggest
act
upstream
mapk
transfect
effici
confirm
phosphatas
vitro
kinas
assay
also
show
phosphoryl
activ
transfect
astrocyt
result
show
nonreceptor
tyrosin
phosphatas
import
role
express
astrocyt
inflamm
also
directli
indirectli
modul
mapk
signal
cascad
lead
product
studi
provid
insight
detail
understand
mechan
involv
product
neuroinflamm
human
tcell
leukemia
viru
type
etiolog
agent
two
immunolog
distinct
diseas
adult
tcell
leukemia
atl
myelopathytrop
spastic
paraparesi
hamtsp
although
cytotox
cell
respons
seen
pathogen
state
actual
signific
prevent
viral
load
control
diseas
progress
remain
question
util
newli
standard
dendrit
cell
cell
polychromat
antibodi
cocktail
investig
immun
activ
cell
patient
cohort
jamaica
includ
seroneg
control
asymptomat
carrier
ac
atl
hamtsp
extens
immun
profil
reveal
cell
hamtsp
atl
patient
sampl
demonstr
function
respons
albeit
much
lesser
extent
respons
seen
ac
furthermor
dc
individu
exhibit
alter
matur
adhes
phenotyp
compar
ac
express
inhibitori
molecul
ligand
upregul
ctl
dc
respect
diseas
group
compar
match
provir
load
flow
cytometri
result
identifi
uniqu
immun
signatur
distinguish
ac
atl
hamtsp
patient
collect
result
suggest
modul
dc
cell
andor
blockad
pathway
may
use
therapeut
intervent
atl
andor
hamtsp
tripleedg
sword
prion
protein
prp
agent
receptor
innat
protector
amyloid
escap
artist
human
cjd
sheep
scrapi
tse
agent
repres
tip
iceberg
undiscov
hidden
virus
environ
initi
contribut
lateonset
neurodegener
recent
studi
demonstr
brain
prp
destroy
without
loss
infecti
titer
underscor
prp
host
receptor
foreign
environment
agent
transmiss
wt
mice
geograph
bse
kuru
kcjd
agent
addit
clone
k
scrapi
agent
also
reveal
vastli
differ
agent
doubl
time
ti
rang
day
gt
cell
uniqu
tse
agent
show
ti
day
remark
chang
strongli
indic
complex
anim
recognit
control
tse
agent
replic
clearanc
innat
immun
molecul
document
earli
pre
prpre
stage
brain
infect
gt
cell
also
display
innat
protect
mechan
limit
maxim
agent
titer
strain
depend
fashion
kcjd
rapidli
induc
high
prpre
produc
fold
lower
titer
fucjd
agent
slowli
induc
less
total
prpre
thu
prp
protect
role
tse
agent
found
hiv
infecti
agent
howev
tse
agent
induc
prpre
cascad
amyloid
product
continu
even
infecti
agent
elimin
like
neurodegen
diseas
includ
subset
alzheim
diseas
initi
environment
infecti
agent
suppress
longer
present
host
inflammasom
protein
complex
activ
upregul
proinflammatori
cytokin
four
wellcharacter
inflammasom
ipaf
induc
endotoxin
lipopolysaccharid
lp
previous
show
lpsinduc
serum
level
significantli
greater
transgen
rat
control
rat
studi
compar
express
key
gene
involv
inflammasom
function
spleen
rat
control
anim
without
lp
treatment
adult
male
rat
randomli
assign
receiv
either
lp
salin
ip
two
hour
follow
treatment
anim
sacrif
spleen
collect
total
spleen
rna
isol
real
time
pcr
use
rat
inflammasom
pcr
array
express
gene
examin
compar
spleen
rat
given
salin
indic
gene
express
four
known
inflammasom
alter
presenc
viral
protein
gene
express
inflammasom
proinflammatori
cytokin
chemokin
downstream
signal
molecul
includ
upregul
rat
respons
lp
magnitud
upregul
much
greater
rat
except
lpsinduc
upregul
greater
spleen
rat
greater
rat
convers
lpsinduc
upregul
greater
spleen
rat
greater
rat
data
suggest
may
addit
mechan
inflammasom
product
underli
lpsinduc
upregul
spleen
rat
nih
slc
jcv
persist
kidney
b
cell
precursor
bone
marrow
persist
neurovirul
control
regul
gene
express
variabl
sequenc
viral
noncod
control
region
nccr
promoterenhanc
sequenc
within
nccr
differ
among
site
persist
diseas
within
singl
individu
importantli
nccr
sequenc
found
viru
kidney
archetyp
conserv
viral
sequenc
isol
brain
pml
patient
contain
uniqu
variat
usual
contain
tandem
repeat
sequenc
variat
includ
addit
delet
promot
element
inhibitori
sequenc
transcript
factor
bind
site
spib
transcript
factor
bind
cellular
promot
affect
transcript
activ
develop
b
cell
harbor
persist
jcv
infect
repres
jcv
nccr
glial
cell
support
earli
viral
gene
express
novel
spib
bind
site
identifi
nccr
sequenc
obtain
varieti
pml
patient
tissu
pmlderiv
nccr
insert
frame
earli
late
gene
start
site
plasmid
contain
entir
pml
genom
pmlderiv
nccr
permit
increas
earli
viral
gene
express
compar
kidneyassoci
archetyp
mutat
analysi
show
elimin
spib
bind
subset
site
significantli
impair
earli
viral
gene
express
preliminari
studi
demonstr
spib
upregul
develop
b
cell
respons
natalizumab
therapi
ms
patient
known
risk
factor
pml
therefor
case
spib
propos
natur
occur
jcv
sequenc
variat
cellular
chang
induc
drug
treatment
may
synerg
creat
environ
suit
increas
viral
multipl
develop
pml
human
brain
slice
expos
hiv
show
impair
neural
progenitor
cell
renew
acceler
differenti
invad
brain
earli
infect
lead
spectrum
neurolog
abnorm
mild
cognit
dysfunct
dementia
effect
may
attribut
direct
interact
viral
protein
neural
cell
could
result
inflammatori
process
accompani
viral
infect
investig
infect
cn
develop
vitro
two
cultur
system
use
human
fetal
brain
slice
expos
chronic
produc
iiib
j
neurosci
meth
brain
slice
incub
day
neural
progenitor
cultur
medium
expos
uninfect
show
midlin
nestin
neural
progenitor
antigen
midlin
paramidlin
glial
fibrillari
acid
acid
protein
gfap
slice
cultur
medium
extens
coloc
gfap
nestin
antigen
suggest
renew
neural
progenitor
cell
slice
gfap
express
dens
coloc
nestin
suggest
differenti
progenitor
astrocyt
coloc
signal
protein
phosphoryl
gfap
investig
progenitor
mainten
differenti
slice
expos
analyz
mrna
express
pattern
seven
day
exposur
slice
express
fold
higher
level
mrna
gene
associ
neuron
structur
compar
slice
cultur
medium
alon
slice
expos
uninfect
cell
gfap
mrna
level
approxim
tenfold
higher
day
slice
compar
slice
thu
gfap
mrna
express
day
predict
increas
gfap
antigen
day
mrna
transcript
associ
progenitor
cell
renew
nestin
fold
lower
slice
compar
slice
cultur
medium
alon
data
suggest
infect
associ
inflamm
impair
neuroepitheli
progenitor
mainten
potenti
acceler
astrocyt
differenti
apolipoprotein
e
genotyp
influenc
neurofilamentlight
express
differenti
neuroepitheli
cell
expos
apolipoprotein
e
apo
identifi
genet
factor
influenc
suscept
neuron
injuri
alzheim
diseas
cerebrovascular
diseas
neurodegen
diseas
addit
allel
associ
increas
risk
dementia
peripher
neuropathi
infect
individu
faster
diseas
progress
homozyg
allel
vitro
neural
progenitor
cell
nep
allow
differenti
presenc
supernat
differenti
inhibit
neuron
fail
thrive
character
rel
decreas
neurofilamentlight
nfl
express
depend
apolipoprotein
e
apo
genotyp
cultur
cell
show
rel
reduc
nfl
express
upon
exposur
differenti
cell
martinez
et
al
j
neurovirolog
addit
recombin
differenti
cultur
result
decreas
nfl
express
upon
exposur
compar
mocktreat
cultur
decreas
compar
cultur
ad
thu
mimick
phenotyp
cultur
underscor
detriment
effect
neural
antigen
express
extens
neurit
elabor
complex
block
apo
receptor
lactoferrin
led
decreas
express
nfl
exposur
pattern
depend
lactoferrin
concentr
mrna
express
nfl
day
viral
exposur
predict
protein
express
pattern
observ
day
incub
data
suggest
apo
phenotyp
may
factor
influenc
suscept
neurolog
abnorm
observ
individu
infect
function
proteom
analys
support
role
macrophag
depot
longact
antiretrovir
drug
nanoformul
andrea
martinezskinn
ram
veerubhotla
shantanu
balkundi
han
liu
howard
fox
huangui
xiong
larisa
poluektova
joellyn
mcmillan
howard
gendelman
email
amartinezskinn
unmcedu
access
medicin
malabsorbt
drug
toxic
poor
pharmacokinet
pharmacodynam
complianc
limit
benefit
antiretrovir
therapi
art
treat
human
immunodefici
viru
hiv
infect
peopl
combat
limit
laboratori
develop
longact
nanoformul
commonli
use
crystallin
art
use
food
drug
administr
approv
excipi
art
drug
includ
ritonavir
rtv
atazanavir
atv
efavirenz
efv
packag
nanoparticl
target
macrophag
cell
carriag
deliveri
cellbas
deliveri
system
result
cell
tissu
depot
releas
drug
slowli
day
week
result
reduct
viral
replic
limit
system
toxic
despit
benefit
littl
known
particlemacrophag
interact
effect
carriag
function
migratori
capac
could
facilit
drug
administr
optim
art
bioavail
end
proteom
approach
system
biolog
use
evalu
effect
art
nanoparticl
carriag
human
monocytederiv
macrophag
mdm
puls
stabl
isotop
label
amino
acid
cell
cultur
psilac
use
evalu
global
proteom
chang
mdm
nanoparticl
exposur
result
broad
rang
activationlink
protein
includ
free
radic
scaveng
antigen
present
cell
mobil
phagocytosi
cellular
differenti
develop
well
affect
lipid
metabol
data
indic
enhanc
abil
macrophag
establish
nanoparticl
art
depot
moreov
data
also
coincid
electrophysiolog
chang
macrophag
outward
k
current
indic
cell
activ
taken
togeth
data
demonstr
nanoparticl
artmacrophag
interact
promot
drug
load
enhanc
function
migratori
capac
macrophag
facilit
role
cell
drug
depot
futur
clinic
develop
bnzgamma
peptid
potenti
therapeut
agent
associ
myelopathi
raya
massoud
steven
jacobson
yoshimi
enoseakahata
yutaka
tagaya
nazli
azimi
unsong
oh
email
rayamassoud
nihgov
first
exogen
retroviru
identifi
pathogen
human
major
infect
subject
remain
lifelong
asymptomat
carrier
develop
relentlessli
progress
inflammatori
myelopathi
term
associ
myelopathi
tropic
spastic
paraparesi
hamtsp
precis
mechan
hamtsp
pathogenesi
remain
unclear
howev
mani
find
suggest
activ
infect
lymphocyt
peripher
circul
lead
enhanc
migrat
cn
compart
seem
preferenti
expans
infect
cell
compartment
interact
virusspecif
tcell
virusinfect
lymphocyt
lead
bystand
damag
neural
tissu
spontan
prolifer
sp
abil
infect
lymphocyt
prolifer
vitro
without
antigen
stimul
thought
surrog
marker
lymphocyt
activ
condit
function
particularli
depend
induct
stimulatori
cytokin
loop
cytokin
share
common
chain
receptor
gamma
chain
offer
potenti
therapeut
target
ham
tsp
peptid
bind
receptor
select
block
bind
downstream
signal
earli
stage
evalu
effect
peptid
vitro
immunolog
marker
hamtsp
demonstr
abl
suppress
sp
quantifi
radioact
thymidin
incorpor
patient
show
signific
suppress
also
show
suppress
express
lymphocyt
activ
marker
express
phosphoryl
tcell
studi
effect
phenotyp
function
marker
effector
memori
tcell
might
clinic
translat
interest
background
hiv
associ
neurocognit
disord
hand
common
manifest
hiv
infect
confer
worsen
morbid
mortal
affect
individu
despit
adequ
antiretrovir
therapi
art
undetect
viral
load
optim
tlymphocyt
adult
gener
immun
dysregul
independ
tlymphocyt
suppress
may
contribut
neuropathogenesi
howev
similar
mechan
examin
adolesc
context
still
develop
neurolog
immun
system
physiolog
pubert
neuroendocrin
fluctuat
object
determin
relationship
activ
tlymphocyt
nk
cell
countfunct
function
neuropsychiatr
outcom
behaviorallyinfect
hiv
adolesc
method
secondari
analysi
prospect
collect
data
examin
behaviorallyinfect
hiv
adolesc
enrol
reach
excel
adolesc
care
health
reach
cohort
nicdhnih
site
unit
state
flow
cytometri
measur
activ
cell
nk
cell
count
nk
cell
function
activ
lytic
unit
per
nk
cell
per
pbmc
examin
comparison
function
outcom
depress
anxieti
grade
school
use
multivari
logist
regress
model
gener
estim
equat
repeat
measur
intraindividu
result
adolesc
mean
age
year
boy
year
girl
includ
studi
follow
year
rang
year
subject
femal
african
american
subject
pregnant
immedi
postpartum
exclud
enrol
cohort
absolut
count
viral
load
qualifi
aid
diagnosi
antiretrovir
therapi
art
data
follow
poster
conclus
project
provid
preliminari
data
understand
role
immun
dysregul
develop
hand
hiv
adolesc
rick
meeker
jeff
liner
kevin
robertson
email
meekerr
neurologyuncedu
univers
north
carolina
unit
state
univers
north
carolina
unit
state
univers
north
carolina
unit
state
improv
penetr
antiretrovir
compound
central
nervou
system
need
control
hiv
infect
also
carri
risk
toxic
effort
target
antiretrovir
compound
cn
balanc
risk
potenti
gain
hamper
incomplet
inform
potenti
neurotox
begin
assess
potenti
neurotox
perform
vitro
studi
primari
neuron
expos
relev
concentr
major
class
antiretrovir
compound
dendrit
bead
prune
process
calcium
destabil
use
sensit
indic
neural
damag
found
wide
rang
toxic
median
toxic
concentr
rang
ngml
toxic
concentr
overlap
concentr
current
seen
csf
level
toxic
typic
modest
compar
challeng
mimic
hivassoci
neuropathogenesi
greatest
neural
damag
associ
abacavir
efavarenz
etravirin
nevaripin
atazanavir
lowest
seen
darunavir
emtracitabin
tenofovir
maraviroc
provid
index
potenti
risk
log
minimum
vitro
toxic
concentr
divid
log
plasma
csf
concentr
previous
report
patient
undergo
therapi
eleven
compound
show
tangibl
risk
five
compound
minim
risk
base
criterion
antiretrovir
combin
use
clinic
show
addit
damag
case
show
less
damag
would
predict
base
individu
toxic
toxic
predict
depolar
mitochondria
acut
toxic
effect
neuron
calcium
regul
data
provid
initi
evid
identifi
potenti
risk
antiretrovir
compound
cn
illustr
need
close
examin
mechan
toxic
help
guid
ration
select
antiretrovir
regimen
minim
risk
neurotox
support
aid
research
refer
reagent
program
still
preval
art
treat
patient
minor
cognit
impair
glycoprotein
use
chemokin
receptor
coreceptor
entri
target
cell
chemokin
receptor
promot
neurotox
glycoprotein
bind
wherea
other
neuroprotect
effect
chemokin
express
neuronsglia
aberr
activ
neurotoxin
affect
synaptogenesi
promot
apoptosi
inflamm
chemokin
coloc
ncam
merino
et
al
cell
adhes
involv
neurogenesi
memori
format
understand
mechan
chemokin
regul
ncam
level
cn
would
lead
novel
therapeut
strategi
neuroaid
aim
materi
method
proantinflammatori
cytokin
beta
tgf
beta
chemokin
fractalkin
cell
adhes
molecul
ncam
solubl
quantifi
elisa
subset
infect
patient
monitor
week
art
treatment
compar
control
base
line
characterist
art
nnrti
non
analog
nucleosid
revers
transcriptas
inhibitor
durat
year
nadir
viral
load
log
mean
increment
week
cell
patient
show
undetect
viral
load
copiesml
log
addit
studi
whether
chemokin
nm
fractalkin
nm
might
prevent
neurotox
pm
promot
dendrit
branch
psancam
depend
level
cortic
neuron
div
result
conclus
infect
increas
fractalkin
solubl
psancam
level
reduc
art
week
treatment
suggest
use
predict
art
efficaci
infect
patient
addit
ncam
act
target
iii
beta
neurotox
cortic
neuron
div
interestingli
prevent
iii
beta
cell
death
increas
psancam
level
vitro
natalizumab
monoclon
antibodi
therapi
treat
relaps
remit
form
multipl
sclerosi
ms
crohn
diseas
block
migrat
inflammatori
cell
brain
gut
natalizumab
howev
associ
risk
jc
viru
jcv
induc
progress
multifoc
leukoencephalopathi
pml
incid
emerg
jcv
pathogenesi
set
chang
pml
rare
diseas
mostli
seen
hiv
infect
individu
signific
complic
patient
receiv
immunomodulatori
treatment
treatment
baselin
regular
interv
month
cours
administr
total
eightyeight
blood
sampl
twentysix
natalizumabtr
patient
drawn
comparison
plasma
progenitorcel
blymphocyt
sort
blood
sampl
via
flow
cytometri
quantit
jcv
dna
qpcr
patient
longitudin
studi
timepoint
virem
least
one
compart
plasma
fiftyeight
percent
detact
viral
dna
three
compart
singl
blood
sampl
also
collect
patient
greater
natalizumab
infus
twentynin
percent
singl
timepoint
patient
show
viremia
least
one
compart
plasma
four
singl
timepoint
patient
test
seroneg
virem
cd
bone
marrow
site
jcv
latenc
natalizumab
augment
migrat
bone
marrow
fold
result
demonstr
jcv
dna
detect
provid
potenti
mechan
increas
incid
pml
ms
patient
treat
natalizumab
diana
moral
summer
acevedo
richard
skolaski
email
dmmoral
stupsmedu
ponc
school
medicin
puerto
rico
southern
texa
univers
unit
state
jonh
hopkin
univers
unit
state
hivassoci
neurocognit
disord
hand
continu
neurolog
complic
hiv
infect
increas
morbid
mortal
era
combin
antiretrovir
therapi
cart
hippocamp
function
alter
associ
infect
tradit
assess
use
morri
water
maze
mwm
rodent
neuropsycholog
np
test
human
howev
method
may
compar
memori
island
mi
test
virtual
realitybas
comput
program
test
hippocampusdepend
spatial
learn
memori
resembl
mwm
mi
may
better
bridg
gap
rodent
model
hand
human
hand
use
mi
test
understand
effect
infect
apolipoprotein
e
apo
allel
statu
csf
apo
protein
level
spatial
learn
memori
singl
visit
hivseroposit
women
control
n
evalu
neurolog
exam
neuropsycholog
np
test
mi
test
csf
apo
assay
csf
total
apo
protein
level
lower
nonhiv
control
howev
level
correl
biolog
neurocognit
perform
measur
observ
significantli
reduc
learn
delay
memori
perform
mi
test
hivseroposit
group
compar
control
hivseroposit
group
stratifi
cognit
perform
impair
group
perform
wors
abil
learn
task
delay
memori
trial
addit
signific
differ
found
np
test
mi
carrier
noncarri
suggest
confound
factor
consid
futur
studi
find
suggest
mi
test
sensit
detect
spatial
deficit
hivseroposit
women
hand
sinc
result
human
hand
patient
mi
test
resembl
find
previous
report
rodent
hiv
model
mwm
propos
mi
test
serv
translat
instrument
studi
hand
success
combin
antiretrovir
diminish
sever
form
hand
one
earliest
neurolog
alter
found
progress
infect
prior
obviou
cognit
deficit
disrupt
brainstem
auditori
evok
potenti
indic
deficit
sensori
gate
studi
prepuls
inhibit
ppi
auditori
startl
respons
asr
oper
measur
sensorimotor
gate
two
anim
model
either
via
inject
protein
tat
use
transgen
rat
express
gene
intrahippocamp
inject
tat
disrupt
ppi
evidenc
leftward
peak
shift
inhibit
function
compar
control
anim
use
apomorphin
challeng
suggest
enhanc
inhibit
across
isi
ms
peak
asr
amplitud
neonat
dose
increas
implic
alter
dopamin
da
system
function
preliminari
data
suggest
similar
leftward
peak
shift
effect
occur
transgen
rat
effect
persist
month
age
observ
sensorimotor
gate
deficit
anim
model
occur
absenc
wast
alter
growth
rate
use
behavior
measur
asr
ppi
detect
earli
neurolog
alter
may
instrument
predict
develop
later
obviou
cognit
deficit
hand
thu
determin
appropri
cours
treatment
addit
find
add
grow
bodi
evid
transgen
rat
model
may
great
util
studi
hand
cerebr
small
vessel
diseas
examin
clinic
hiv
cohort
variabl
implic
hivassoci
demograph
metabol
risk
studi
human
brain
examin
relationship
cerebr
arteriolar
wall
thick
hivassoci
well
metabol
variabl
accordingli
measur
mean
arteriolar
thick
sclerot
index
si
diameterout
diamet
deep
white
matter
brain
hiv
hiv
manhattan
hiv
brain
bank
bivari
correl
si
perform
gener
medic
variabl
age
gender
race
hypertens
htn
hyperlipidemia
diabet
obes
cirrhosi
hepat
c
viru
infect
hcv
herp
viru
infect
cmv
hsvor
vzv
hivassoci
variabl
hiv
infect
statu
hiv
risk
count
plasma
hiv
load
antiretrovir
therapi
arv
time
death
gener
variabl
age
htn
race
hcv
cirrhosi
associ
si
hivassoci
variabl
arv
death
address
colinear
prior
multipl
regress
partial
correl
run
hcv
cirrhosi
htn
race
htn
age
hcv
control
cirrhosi
lost
signific
htn
control
age
lost
signific
accordingli
entir
sampl
hcv
black
race
htn
enter
multivari
analysi
account
varianc
si
p
independ
associ
si
hcv
largest
effect
beta
hcv
htn
black
race
p
hiv
sampl
inclus
arv
model
increas
hcv
htn
arv
remain
signific
trend
level
beta
hcv
arv
htn
p
valu
respect
conclud
hcv
infect
constitut
signific
independ
risk
factor
cerebrovascular
thicken
recent
demonstr
cerebr
endotheli
infect
hcv
implic
cerebr
vasculatur
hcv
neuropathogenesi
studi
shown
hivinfect
patient
develop
neurocognit
disord
character
neuron
dysfunct
lack
product
infect
neuron
hiv
suggest
viral
cellular
protein
neurotox
activ
releas
infect
target
cell
caus
neuron
deregul
viral
protein
r
protein
encod
shown
alter
express
variou
import
cytokin
inflammatori
protein
infect
uninfect
cell
howev
mechan
involv
remain
unclear
use
human
neuron
cell
line
found
vpr
taken
neuron
caus
ideregul
calcium
homeostasi
iiendoplasm
reticulumcalcium
releas
iiiactiv
oxid
stress
pathway
ivmitochondri
dysfunct
vsynapt
retract
search
cellular
factor
involv
perform
microrna
gene
array
assay
use
human
neuron
primari
cultur
cell
line
treat
recombin
vpr
protein
interestingli
vpr
deregul
level
sever
microrna
eg
target
gene
eg
creb
could
lead
neuron
dysfunct
therefor
conclud
vpr
play
major
role
neuron
dysfunct
deregul
microrna
target
gene
phenomenon
could
lead
develop
neurocognit
disord
loretta
mulcar
bob
connor
swati
sath
email
robertdconnor
gmailcom
nyu
unit
state
nyu
unit
state
nyu
unit
state
object
describ
cours
progress
multifoc
leukoencephalopathi
year
old
femal
congenit
hiv
infect
background
year
old
femal
congenit
hiv
present
bellevu
hospit
left
side
clumsi
admit
noncompli
antiretrovir
examin
disclos
left
hemibodi
sensori
loss
left
hemiataxia
left
babinski
sign
result
count
hiv
viral
load
copiesml
csf
acellular
glucos
protein
concentr
normal
jc
viru
dna
concentr
copiesml
hsv
vzv
ebv
bk
dna
detect
pcr
mr
reveal
multipl
foci
abnorm
compat
diagnosi
pml
patient
hospit
treat
antiretrovir
three
week
later
patient
neurolog
examin
deterior
count
hiv
viremia
improv
csf
jc
viru
dna
concentr
increas
copiesml
mr
demonstr
expans
previous
note
hyperintens
without
contrast
enhanc
time
write
patient
remain
hospit
neurolog
servic
sever
debilit
conclus
patient
pml
may
deterior
despit
adequ
virolog
respons
haart
inflammatori
immunolog
reconstitut
often
mechan
pmliri
therefor
often
defin
neurolog
deterior
despit
increas
count
decreas
viral
load
consider
clinic
heterogen
exist
within
broad
definit
immunolog
reconstitut
may
account
everi
case
take
absenc
contrast
enhanc
increas
csf
concentr
jc
viru
dna
evid
patient
deterior
spite
rather
reconstitut
immun
system
clinic
profil
may
suggest
progress
jv
virusinduc
oligodendrocyt
injuri
oppos
maladapt
immun
reconstitut
background
neurocognit
impair
nci
frequent
observ
peopl
hiv
complic
connect
wors
daili
function
poor
qualiti
life
also
difficulti
clinic
manag
develop
studi
find
brief
use
method
screen
nci
patient
hiv
method
seven
hospit
barcelona
catalonia
spain
particip
crosssect
studi
comprehens
neuropsycholog
batteri
includ
computer
paperbas
test
use
cover
recommend
neurocognit
area
hour
durat
nci
defin
perform
least
standard
deviat
mean
least
area
consid
gold
standard
data
comparison
roc
curv
sensit
specif
calcul
perform
compar
differ
combin
test
result
total
patient
hiv
includ
although
complet
studi
assess
subject
mostli
middleag
year
men
undetect
plasma
viral
load
median
educ
level
year
cell
count
nadir
cell
count
nci
seen
patient
report
cognit
complaint
accord
easi
total
time
durat
combin
test
better
sensit
specif
detect
nci
compris
tmta
tmtb
cowa
test
respect
combin
appli
overal
less
minut
impli
easi
instruct
applic
correct
call
neu
screen
conclus
neu
screen
rapidli
detect
nci
peopl
hiv
addit
show
high
sensit
specif
properti
method
may
help
initi
stage
diagnosi
hivassoci
neurocognit
disord
consid
use
comprehens
neuropsycholog
batteri
next
step
background
sever
brief
method
propos
screen
neurocognit
impair
nci
peopl
hiv
studi
compar
properti
method
valid
usa
recent
tool
propos
europ
neu
screen
method
neu
screen
suggest
method
detect
rapidli
nci
peopl
infect
hiv
tool
includ
paperbas
measur
character
show
high
statist
sensit
specif
properti
compar
neu
anoth
screen
method
valid
usa
similar
properti
brief
neurocognit
screen
bnc
elli
et
al
combin
measur
offer
hiv
neurobehavior
research
center
hnrc
carey
et
al
use
gold
standard
exist
nci
determin
comprehens
neuropsycholog
batteri
includ
test
cover
recommend
neurocognit
area
result
origin
studi
sensit
specif
show
bnc
hnrc
method
respect
case
neu
screen
howev
americanpopulationbas
method
replic
european
sampl
patient
subject
sensit
specif
detect
nci
bnc
hnrc
regard
easi
time
durat
characterist
method
similar
although
consid
applic
bnc
neu
appear
feasibl
hnrc
due
paperbas
use
conclus
screen
tool
nci
detect
hiv
infect
appear
present
distinct
statist
properti
probabl
due
cultur
discrep
cohort
differ
countri
west
european
popul
neu
screen
appear
offer
optim
characterist
although
confirm
larger
cohort
peopl
infect
hiv
persist
humor
immun
respons
cn
limit
recoveri
reactiv
murin
cytomegaloviru
manohar
mutnal
shuxian
hu
jame
lokensgard
email
umnedu
univers
minnesota
unit
state
univers
minnesota
unit
state
univers
minnesota
unit
state
background
experiment
infect
mous
brain
murin
cmv
mcmv
elicit
neuroimmun
respons
termin
acut
infect
simultan
prevent
extens
bystand
damag
previou
studi
determin
lymphocyt
requir
restrict
acut
product
mcmv
infect
within
central
nervou
system
cn
studi
investig
contribut
humor
immun
respons
control
mcmv
brain
infect
methodologyprincip
find
util
mcmv
brain
infect
model
investig
blymphocytelineag
cell
assess
role
control
recoveri
reactiv
viru
latentlyinfect
brain
tissu
brain
infiltr
leukocyt
first
phenotyp
use
marker
indic
blymphocyt
plasma
cell
result
obtain
studi
show
steadi
increas
recruit
blymphocytelineag
cell
brain
throughout
timecours
viral
infect
mcmvspecif
antibodi
secret
cell
asc
detect
within
infiltr
leukocyt
popul
use
elispot
assay
immunohistochem
studi
brain
section
reveal
coloc
cell
either
igg
igm
addit
immunohistochem
stain
mcmv
earli
antigen
report
marker
viral
latenc
neuron
confirm
express
brain
latent
infect
final
use
bcell
defici
jh
mice
demonstr
b
lymphocyt
control
recoveri
reactiv
viru
latentlyinfect
brain
tissu
significantli
higher
rate
reactiv
viru
recov
brain
jhmice
compar
wt
anim
conclus
taken
togeth
result
demonstr
mcmv
infect
trigger
accumul
persist
blymphocytelineag
cell
within
brain
produc
antibodi
play
signific
role
control
reactiv
viru
immun
repertoir
varicella
zoster
viru
vzv
vasculopathi
associ
vzvinduc
cerebrovascular
remodel
vzv
human
viru
proven
replic
cerebr
arteri
caus
transient
ischem
attack
stroke
vzv
vasculopathi
analyz
cerebr
arteri
earli
late
vzv
vasculopathi
identifi
immunolog
featur
help
diagnosi
point
mechan
vzvinduc
cerebrovascular
remodel
normal
vzvinfect
tempor
cerebr
arteri
two
subject
earli
week
late
month
vzv
vasculopathi
examin
histolog
immunohistochemistri
use
antibodi
direct
vzv
leukocyt
tcell
subset
b
cell
activ
macrophag
neutrophil
natur
killer
mast
cell
earli
vzv
vasculopathi
vzv
antigen
present
adventitia
corrobor
previou
report
adventitia
initi
site
vzv
infect
late
vzv
vasculopathi
vzvantigen
found
media
also
support
spread
viru
outsidein
earli
late
vzv
vasculopathi
cell
macrophag
rare
b
cell
present
adventitia
thicken
intima
earli
vzv
vasculpathi
distinguish
abund
neutrophil
adventitia
inflamm
associ
intim
thicken
late
vzv
vasculopathi
distinguish
presenc
viral
antigen
without
inflamm
media
provid
first
evid
human
viru
immunoprivileg
site
neutrophil
abund
adventitia
earli
vzv
vasculopathi
play
signific
role
cardiopulmonari
vascular
remodel
studi
primari
human
brain
vascular
adventiti
fibroblast
braf
infect
vzv
vitro
compar
uninfect
braf
increas
mrna
protein
neutrophil
chemoattract
vzvinfect
braf
condit
medium
vzvinfect
braf
attract
neutrophil
transwel
assay
thu
earli
step
vzvinduc
cerebrovascular
remodel
may
involv
secret
recruit
neutrophil
turn
secret
factor
contribut
vascular
remodel
persist
inflamm
stroke
canon
signal
regul
express
hundr
gene
involv
cell
differenti
commun
apoptosissurviv
prolifer
signal
particularli
robust
astrocyt
contribut
restrict
state
hiv
replic
cell
signal
disrupt
signal
allevi
restrict
hiv
replic
astrocyt
evalu
cellular
consequ
disrupt
signal
progenitorderiv
astrocyt
pda
knockdown
kd
express
target
sirna
impact
sever
gene
involv
glutam
transport
network
includ
glutamin
synthetas
find
prompt
us
evalu
impact
express
glutam
transport
also
known
excitatori
amino
acid
transport
predomin
glutam
transport
express
astrocyt
respons
major
glutam
transport
adult
brain
kd
pda
result
inhibit
mrna
protein
level
approxim
respect
kd
also
inhibit
promot
activ
assess
promot
link
luciferas
report
gene
convers
express
constitut
activ
construct
led
dramat
induct
mrna
protein
promot
activ
collect
gain
loss
function
studi
demonstr
posit
regul
express
first
time
identifi
target
gene
signal
find
relev
hiv
neuropathogenesi
suggest
model
inflammatori
mediat
eg
ifn
repress
signal
astrocyt
repress
lead
dramat
reduct
consequ
glutam
accumul
culmin
neuron
toxic
turn
set
stage
inflammatori
process
lead
patholog
cn
carli
ninemir
howard
fox
email
cninemir
unmcedu
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
neurodegen
diseas
associ
decreas
autophagi
thu
maintain
normal
enhanc
activ
system
becom
common
theme
protect
neurodegen
diseas
activ
immun
respons
neuroinflamm
induc
hiv
infect
brain
creat
harsh
environ
cellular
homeostasi
lab
demonstr
decreas
neuron
autophagi
neuroaid
use
vivo
vitro
system
cytokin
drive
inflammatori
process
myriad
effect
brain
specif
neuron
meanwhil
drug
abus
also
affect
brain
neuron
creat
comorbid
scenario
therefor
hypothes
autophagi
process
neuron
hinder
signal
pathway
releas
cytokin
immun
glial
cell
brain
hiv
infect
autophagi
modul
commonli
use
drug
abus
methamphetamin
examin
hypothesi
studi
effect
cytokin
autophagi
neuron
cell
cultur
model
combin
cytokin
treatment
methamphetamin
perform
conjunct
use
number
chemic
probe
defin
effect
autophagi
pathway
order
step
autophagi
process
affect
cytokin
methamphetamin
data
reveal
interferon
type
ii
decreas
autophagi
level
autophagi
induct
methamphetamin
use
physiolog
concentr
significantli
alter
cytokin
modul
autophagi
current
work
aim
examin
cytokinereceptor
pathway
interact
methamphetamin
autophagi
process
biochem
process
cytokin
signal
unravel
mechan
autophagi
disrupt
subsequ
neurodegener
neuroaid
presenc
absenc
use
abus
substanc
develop
broad
rang
tumor
neural
crest
glial
origin
evid
associ
tantigen
rang
tumorsuppressor
protein
includ
prb
signal
molecul
play
role
oncogen
function
jcv
tantigen
demonstr
tantigen
express
suppress
glucos
depriv
medulloblastoma
cell
glioblastoma
xenograft
endogen
express
tantigen
mechanist
studi
indic
glucos
deprivationmedi
suppress
tantigen
partli
influenc
amp
kinas
ampk
import
sensor
ampatp
ratio
cell
addit
glucos
deprivationinduc
cell
cycl
arrest
phase
block
ampk
inhibit
also
prevent
tantigen
downregul
furthermor
tantigen
prevent
arrest
sustain
cell
phase
glucos
depriv
function
level
tantigen
downregul
partial
depend
reactiv
oxygen
speci
ro
product
glucos
depriv
tantigen
prevent
ro
induct
loss
atp
product
cytotox
induc
glucos
depriv
addit
found
tantigen
downregul
glycolyt
inhibitor
pentos
phosphat
inhibitor
oxythiamin
tantigen
modul
express
glycolyt
enzym
hexokinas
pentos
phosphat
enzym
indic
potenti
link
tantigen
metabol
regul
studi
point
possibl
involv
jcv
tantigen
medulloblastoma
prolifer
metabol
phenotyp
may
enhanc
understand
role
viral
protein
glycolyt
tumor
metabol
thu
provid
use
target
treatment
virusinduc
tumor
work
made
possibl
grant
award
nih
kk
long
termin
repeat
ltr
regul
gene
express
interact
multipl
host
viral
factor
crosssect
studi
prehaart
era
demonstr
singl
nucleotid
polymorph
snp
cebp
site
sp
site
iii
peripher
bloodderiv
ltr
increas
frequenc
diseas
sever
increas
correl
dementia
current
studi
focu
identif
ltr
signatur
deriv
peripher
blood
viru
use
molecular
marker
identifi
individu
prone
develop
advanc
stage
diseas
andor
neurolog
diseas
prospect
longitudin
studi
conduct
patient
current
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
histori
illicit
drug
alcohol
medic
use
tcell
count
viral
load
collect
approxim
everi
month
snp
densiti
within
entir
ltr
determin
comparison
conb
refer
sequenc
show
area
increas
variabl
collect
extens
clinic
paramet
patient
allow
crosspopul
longitudin
analys
impact
paramet
develop
snp
cours
diseas
date
multipl
snp
detect
significantli
associ
tcell
count
viral
load
well
chang
tcell
count
chang
viral
load
snp
identifi
area
ltr
previous
report
import
viral
promot
function
area
less
well
function
character
result
suggest
genom
swarm
may
evolv
cours
diseas
respons
select
pressur
lead
chang
preval
ltr
snp
ltr
snp
may
produc
alter
viral
function
predict
advanc
stage
hiv
diseas
human
immunodefici
hiv
major
public
health
issu
signific
cn
complic
infect
neuroaid
vivo
microgliamacrophag
main
cell
infect
howev
low
signific
number
hiv
infect
astrocyt
also
detect
role
pathogenesi
neuroaid
well
understood
previou
data
indic
hiv
infect
astrocyt
increas
express
glycoprotein
protein
solubl
inhibitor
wnt
pathway
hiv
infect
cultur
human
astrocyt
secret
highli
regul
function
gap
junction
channel
hemichannel
also
demonstr
express
astrocyt
increas
human
brain
tissu
section
individu
hiv
enceph
compar
tissu
section
uninfect
individu
demonstr
primari
cell
secret
particip
bystand
kill
uninfect
astrocyt
viral
reactiv
howev
secret
regul
neuron
damag
measur
collaps
neuron
process
thu
demonstr
hiv
infect
astrocyt
dysregul
secret
mechan
involv
gap
junction
well
hemichannel
contribut
neuropathogenesi
observ
hiv
infect
individu
werner
ouwendijk
ravi
mahalingam
vicki
trainadorg
geert
van
amerongen
mari
wellish
albert
osterhau
donald
gilden
georg
verjan
email
ravimahalingam
ucdenveredu
depart
virolog
erasmu
medic
center
rotterdam
netherland
varicellazost
viru
vzv
caus
varicella
chickenpox
becom
latent
ganglia
along
entir
neuraxi
may
reactiv
caus
herp
zoster
shingl
vzv
may
infect
ganglia
via
retrograd
axon
transport
infect
skin
hematogen
spread
simian
varicella
viru
svv
infect
rhesu
macaqu
provid
use
model
system
studi
pathogenesi
human
varicella
zoster
viru
vzv
infect
dissect
viru
host
immun
factor
acut
svv
infect
analyz
four
svvseroneg
chines
rhesu
macaqu
infect
intratrach
cellassoci
x
plaqueform
unit
pfu
svvexpress
green
fluoresc
protein
x
pfu
wildtyp
svv
monkey
develop
viremia
svvspecif
adapt
band
tcell
immun
respons
none
develop
skin
rash
necropsi
day
postinfect
svv
dna
found
ganglia
along
entir
neuraxi
viscera
svv
rna
found
ganglia
viscera
amount
svv
inoculum
correl
extent
viremia
immun
respons
viru
find
demonstr
acut
svv
infect
chines
rhesu
macaqu
lead
ganglion
infect
hematogen
rout
induct
virusspecif
adapt
memori
respons
absenc
skin
rash
raymond
l
ownbi
amarili
acevedo
email
novaedu
effect
cognit
age
hiv
infect
studi
assess
whether
peopl
hiv
infect
year
older
perform
poorli
execut
function
measur
compar
hivinfect
younger
individu
method
part
larger
studi
person
treat
hiv
infect
particip
complet
measur
execut
function
includ
trail
make
test
tower
london
purdu
pegboard
iowa
gambl
task
perform
person
year
older
compar
younger
particip
use
ancova
model
correct
educ
race
count
result
older
particip
perform
poorli
sever
measur
execut
function
correct
possibl
confound
includ
iowa
gambl
task
trail
make
test
trail
trail
b
older
particip
perform
equal
well
younger
particip
tower
london
measur
simpl
motor
speed
purdu
conclus
person
year
age
older
may
perform
poorli
measur
execut
function
younger
person
show
less
evid
implicit
learn
iowa
gambl
task
lower
level
psychomotor
speed
trail
b
differ
may
result
hiv
infect
cognit
age
interact
understand
impact
execut
function
context
hiv
plu
age
import
given
age
hiv
popul
sinc
abil
may
signific
impact
everyday
function
hyperphosphoryl
tau
hptau
detach
microtubul
form
pair
helic
filament
tangl
lead
neuron
dysfunct
healthi
age
aberr
protein
hptau
clear
cell
heat
shock
respons
hsr
machineri
case
hptau
hsr
complex
sort
aberr
tau
either
repair
degrad
howev
cellular
machineri
fail
clear
abnorm
protein
accumul
aberr
protein
occur
accumul
hptau
account
neuropatholog
diseas
includ
ad
hive
context
discov
protein
call
pinch
bind
hptau
may
function
clearanc
neuron
likewis
pinch
detect
csf
hiv
ad
patient
nearli
undetect
healthi
control
briefli
pinch
compos
doubl
zinc
finger
domain
catalyt
activ
pinch
highli
conserv
play
key
role
multiprotein
complex
format
facilit
cell
spread
migrat
surviv
grow
evid
point
signific
overlap
mechan
involv
hivassoci
neurocognit
disord
hand
agerel
neurodegen
diseas
hiv
individu
diagnos
decad
ago
begin
face
ageassoci
cn
chang
combin
infect
longterm
exposur
cart
agerel
neurodegener
may
exacerb
neuron
stress
pinch
protein
requir
maintain
neurit
extens
addit
studi
cancer
suggest
pinch
promot
cell
surviv
direct
mechan
identifi
show
cellular
stress
respons
pinch
bind
hptau
may
contribut
chang
intracellular
level
hptau
studi
address
new
mechan
age
hand
may
interact
hypothes
diseas
tauopathi
compon
pinch
express
neuron
promot
cell
surviv
interact
tau
heat
shock
protein
respons
machineri
marco
pacifici
serena
delbu
pasqual
ferrant
duan
jeansonn
ferdou
kadri
steve
nelson
francesca
peruzzi
email
pasqualeferrant
unimiit
lsu
health
scienc
center
unit
state
univers
milan
itali
univers
milan
itali
lsu
health
scienc
center
unit
state
lsu
health
scienc
center
unit
state
lsu
health
scienc
center
unit
state
lsu
health
scienc
center
unit
state
hivassoci
neurolog
disord
hand
compris
cognit
motor
behavior
impair
variou
entiti
affect
substanti
number
infect
individu
understand
biolog
brain
infect
identifi
marker
patholog
manifest
includ
hivenceph
critic
import
continu
activ
field
research
microrna
short
noncod
rna
modul
gene
express
translat
repress
high
stabil
intracellular
well
extracellular
environ
mirna
recent
emerg
import
biomark
sever
human
diseas
test
csf
hivposit
individu
present
result
pilot
studi
aim
investig
put
mirna
signatur
csf
hivposit
individu
neurolog
disord
util
high
throughput
approach
mirna
detect
array
focus
identif
differenti
express
mirna
csf
ten
hivposit
individu
compar
ten
hivneg
sampl
group
hiv
individu
contain
nine
case
hand
among
four
hive
hivsampl
nonvir
acut
dissemin
encephalomyel
sign
cognit
impair
comparison
analysi
reveal
downregul
mirna
p
hand
compar
hivneg
group
interestingli
mirna
found
upregul
group
comparison
hive
hivgroup
show
differenti
regul
mirna
p
three
upregul
although
valid
independ
number
clinic
sampl
requir
tri
definit
conclus
work
offer
base
futur
investig
support
mh
role
chemokin
pathogenesi
viral
enceph
daniela
pajek
gerard
j
graham
john
k
fazakerley
email
researchglaacuk
univers
glasgow
unit
kingdom
univers
glasgow
unit
kingdom
univers
edinburgh
unit
kingdom
plethora
virus
spread
mosquito
mani
caus
debilit
often
fatal
neurolog
diseas
acut
enceph
semliki
forest
viru
sfv
low
risk
neurotrop
pathogen
provid
excel
model
studi
neuroinvas
immun
respons
viral
enceph
chemokin
import
leukocyt
entri
cn
viru
clearanc
howev
influx
leukocyt
may
also
promot
neuropatholog
includ
neuron
damag
thu
chemokin
play
damag
pathogen
role
viral
enceph
unfortun
limit
insight
precis
natur
chemokin
involv
enceph
improv
understand
import
axi
central
develop
novel
therapi
sfv
model
system
comprehens
investig
chemokin
express
cn
parenchyma
develop
viral
enceph
view
associ
coincid
leukocyt
entri
therefor
mice
infect
intraperiton
sfv
brain
harvest
analyz
taqman
lowdens
array
examin
compar
chemokin
express
time
infect
postinfect
day
pid
express
significantli
upregul
fold
coincid
leukocyt
influx
cn
start
peak
immunohistochem
stain
show
tcell
macrophag
accumul
mening
associ
isol
foci
viru
brain
parenchyma
bcell
appear
brain
pid
local
primarili
around
ventricl
suggest
entri
bcell
cn
via
cerebrospin
fluid
csf
brain
barrier
summari
provid
first
comprehens
analysi
chemokin
express
sfv
enceph
subsequ
highlight
novel
potenti
therapeut
target
chemokin
express
mediat
leukocyt
recruit
inflam
tissu
like
pivot
viral
clearanc
physic
depend
opioid
medic
first
preclin
compar
studi
neuroaid
jonathan
palma
bassel
sawaya
khalid
benamar
email
kbenamar
templeedu
templ
univers
unit
state
templ
univers
unit
state
templ
univers
school
medicin
unit
state
drug
abus
hiv
repres
seriou
public
health
threat
interrel
influenc
function
opioid
depend
common
hiv
clinic
need
find
altern
effect
safe
medic
hivinfect
opioiddepend
patient
envelop
glycoprotein
implic
pathogenesi
neurolog
disord
associ
hiv
interfer
opioid
system
goal
examin
compar
chronic
effect
common
clinic
use
medic
opioid
depend
methadon
buprenorphin
presenc
brain
first
monitor
rat
weight
day
induct
period
buprenorphin
mgkg
well
subsequ
withdraw
period
absenc
presenc
brain
parallel
experi
methadon
mgkg
afford
posit
control
data
male
sd
rat
g
weigh
inject
sc
daili
buprenorphin
methadon
salin
indic
mean
weight
rat
receiv
buprenorphin
induct
differ
significantli
control
salin
anim
sudden
weight
loss
day
withdraw
associ
mgkg
day
buprenorphin
dose
schedul
infus
brain
precipit
alter
weight
loss
spontan
withdraw
period
buprenorphin
cessat
rat
mgkg
methadon
day
show
signific
bodi
weight
lost
day
withdraw
treatment
period
even
absenc
brain
base
data
appear
presenc
brain
chronic
use
buprenorphin
opioid
depend
advantag
methadon
financi
support
da
da
hiv
infect
preval
among
substanc
abus
evalu
relationship
illicit
drug
use
diseas
progress
patient
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
histori
illicit
drug
alcohol
medic
use
cell
count
viral
load
perform
approxim
everi
month
drug
abus
common
cohort
patient
admit
past
use
current
abus
drug
test
posit
drug
use
time
visit
cocain
use
heavili
favor
drugus
patient
admit
past
current
cocain
use
patient
use
multipl
drug
simultan
cohort
categor
nonus
pn
cocain
preferenti
pc
user
cannabinoid
preferenti
pm
user
multidrug
user
nonus
like
remain
haart
wherea
pc
less
like
overal
health
pn
subcohort
better
pc
subcohort
patient
pn
less
like
suffer
opportunist
infect
higher
current
nadir
count
addit
peak
current
viral
load
pn
substanti
lower
pc
patient
sinc
cocain
known
immunomodulatori
effect
cytokin
profil
pn
pc
individu
analyz
understand
effect
cocain
cytokin
modul
diseas
progress
among
cytokin
investig
interestingli
differenti
level
suppress
factor
rant
establish
within
pc
subcohort
conclus
illicit
drug
use
appear
facilit
diseas
progress
base
assess
background
extent
neurolog
damag
presymptomat
hivinfect
incomplet
understood
cerebrospin
fluid
csf
biomark
neurofila
light
chain
nfl
elev
subject
advanc
hivinfect
hivassoci
dementia
associ
central
nervou
system
impair
measur
nfl
csf
biomark
neuron
injuri
primari
hivinfect
phi
method
antiretrovir
subject
phi
csf
nfl
analyz
use
new
highlysensit
twosit
enzymat
quantit
immunoassay
lower
limit
detect
ngl
detect
ttau
solubl
amyloid
precursor
proteinalpha
beta
use
standard
elisa
analys
employ
mannwhitney
test
spearman
correl
result
phi
subject
median
age
year
cell
count
cellsul
plasma
hiv
rna
level
day
postinfect
hivuninfect
control
median
age
year
median
nfl
phi
subject
elev
ngl
compar
ngl
control
p
median
ngl
phi
subject
compar
ngl
control
histori
neurolog
symptomat
seroconvers
associ
higher
nfl
signific
differ
ttau
detect
subset
phi
subject
control
nfl
correl
csf
inflammatori
marker
includ
neopterin
white
blood
cell
count
p
csf
plasma
albumin
ratio
r
p
nfl
also
correl
plasma
csf
hiv
rna
level
csf
ttau
r
p
csf
r
conclus
biomark
neuron
damag
elev
subject
phi
compar
hivuninfect
control
nfl
sensit
marker
neuron
injuri
correl
marker
csf
inflamm
phi
find
suggest
hivrel
neuron
damag
start
earli
hivinfect
mediat
neuroimmun
activ
period
fuwang
peng
honghong
yao
shilpa
buch
email
fuwangpeng
unmcedu
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
univers
nebraska
medic
center
unit
state
plateletderiv
growth
factorcc
pdgfcc
third
member
pdgf
famili
implic
embryogenesi
well
develop
cn
biolog
function
isoform
remain
larg
unexplor
context
hivassoci
neurocognit
disord
hand
pdgfcc
critic
embryon
develop
homolog
vegf
present
studi
demonstr
exposur
human
neuroblastoma
cell
hiv
transactiv
protein
tat
result
decreas
intrins
express
pdgfcc
evidenc
rtpcr
western
blot
assay
reciproc
pretreat
cell
pdgfcc
abrog
tatmedi
neurotox
mitig
tatinduc
apoptosi
neurit
loss
use
pharmacolog
loss
function
approach
identifi
role
phosphatidylinositol
akt
signal
pdgfccmediat
neuroprotect
report
novel
find
involv
transient
receptor
potenti
canon
trpc
channel
pdgfccmediat
neuroprotect
next
examin
key
signal
downstream
synthas
kinas
beta
inactiv
increas
phosphoryl
respons
pdgfcc
valid
cell
transfect
dominantneg
block
pdgfccmediat
neuroprotect
presenc
inhibitor
trpc
blocker
pdgfcc
lost
abil
inactiv
therebi
suggest
intersect
trpc
signal
import
mediat
downstream
also
demonstr
accumul
nucleu
cell
expos
pdgfcc
taken
togeth
find
lead
suggest
pdgfcc
could
develop
therapeut
target
mitig
tatmedi
neurotox
implic
hand
perron
aloi
lang
curtin
patric
march
patric
morand
jeanloui
tourain
email
hp
geneurocom
geneuroinnov
franc
geneuro
switzerland
geneuro
switzerland
grenobl
univers
franc
grenobl
univers
franc
lyon
univers
franc
hervw
famili
human
dna
retain
copi
express
envelop
protein
env
activ
proinflammatori
autoimmun
cascad
interact
tolllik
receptor
antigenpres
cell
env
protein
evidenc
sever
independ
rtpcr
immunohistolog
studi
ms
brain
lesion
review
perron
et
al
j
neurol
sci
env
antigenaemia
detect
ms
sera
exvivo
confirm
parallel
quantit
rtpcr
well
sequenc
analys
anoth
confirm
presenc
endogen
retrovir
protein
ms
obtain
show
immunohistolog
detect
brain
demyelin
lesion
mostli
within
perivascular
macrophag
microgliocytess
parenchyma
similar
detect
pattern
obtain
lesion
ms
control
three
antienv
monoclon
specif
three
distant
epitop
multipl
sclerosi
journal
press
preclin
proof
concept
base
experiment
allerg
encephalomyel
eae
induc
env
protein
mice
mog
human
scid
huscid
mice
mbp
evidenc
clinic
symptom
correl
import
inflamm
evidenc
mri
associ
histolog
demyelin
tlymphocyt
antimyelin
autoimmun
also
shown
splenocyt
moreov
ms
model
murin
chimaer
human
antihervwenv
monoclon
antibodi
significantli
inhibit
clinic
symptom
compar
untreat
control
prevent
therapeut
iv
inject
protocol
radiol
antibodi
evidenc
accumul
cluster
env
antigen
mous
brain
stereotax
inject
env
cerebr
white
matter
sham
control
inject
buffer
regulatori
approv
preclin
toxicolog
packag
obtain
human
construct
phase
clinic
trial
achiev
europ
human
therapeut
antibodi
repres
first
attempt
treat
human
diseas
target
human
endogen
retrovir
protein
despit
immun
recoveri
individu
combin
antiretrovir
therapi
frequenc
hiv
associ
neurocognit
disord
hand
remain
high
reason
well
understood
hivassoci
neurodegener
driven
chronic
inflammatori
respons
brain
secondari
low
level
hiv
replic
cn
reservoir
cell
macrophag
microglia
injuri
blood
brain
barrier
bbb
mediat
proinflammatori
factor
blood
migrat
leukocyt
across
bbb
therapi
target
inflamm
hiv
replic
benefici
amelior
hand
inhibitor
emerg
potent
antiinflammatori
immunomodulatori
compound
although
modulatori
effect
parp
inhibitor
immun
cell
studi
extent
noth
known
effect
set
hiv
cn
infect
propos
parp
inhibit
attenu
bbb
injuri
caus
via
effect
monocyt
brain
endothelium
activ
microglia
infect
macrophag
found
increas
express
parp
brain
endothelium
macrophag
human
brain
hiv
enceph
parp
suppress
primari
human
brain
microvascular
endotheli
cell
bmvec
improv
bbb
integr
augment
express
tight
junction
protein
parp
inhibitor
prevent
barrier
disrupt
caus
inflamm
parp
inhibit
bmvec
diminish
monocyt
adhesionmigr
across
bbb
model
downregul
adhes
molecul
endothelium
decreas
activ
control
bbb
integr
monocyt
migrat
across
bbb
parp
inhibitor
regul
inflammatori
gene
increas
bmvec
monocyt
parp
inhibitor
regul
activ
form
parallel
suppress
parp
inhibitor
decreas
express
proinflammatori
molecul
diminish
hiv
replic
human
macrophag
vivo
treatment
parp
inhibitor
decreas
enhanc
bbb
permeabl
mice
system
inflamm
result
point
relev
parp
suppress
protect
bbb
set
infect
target
bdnf
deliveri
across
bloodbrain
barrier
neuroprotect
use
liposom
formul
magnet
nano
carrier
invitro
studi
sudheesh
pilakkakanthikeel
madhavan
nair
email
spilakka
fiuedu
florida
intern
univers
unit
state
florida
intern
univers
unit
state
parenter
use
drug
opiat
exert
immunomodulatori
effect
serv
cofactor
progress
infect
therebi
potenti
hiv
relat
neurotox
ultim
lead
progress
neuroaid
morphin
exposur
known
induc
apoptosi
regul
camp
respons
elementbind
creb
express
cultur
cell
use
neuroprotect
agent
bdnf
protect
neuron
apoptot
cell
death
receptor
antagonist
ctop
reduc
opiat
addict
block
synergist
neurotox
caus
opiat
could
therapeut
benefit
treatment
opiat
addict
current
treatment
effect
due
impenetr
therapeut
molecul
across
blood
brain
barrier
bbb
therefor
develop
drug
deliveri
system
cross
bbb
may
signific
therapeut
advantag
present
studi
hypothes
magnet
guid
nano
carrier
may
provid
viabl
approach
simultan
target
multipl
drug
across
bbb
develop
magnet
base
nanocarri
bound
bdnf
evalu
efficaci
abil
transmigr
across
bbb
use
vitro
bbb
model
investig
induct
apoptosi
flow
cytometri
creb
express
rtpcr
result
show
nano
formul
abl
cross
bbb
effect
suppress
apoptosi
induc
morphin
induc
creb
express
suggest
develop
nanocarri
provid
potenti
therapeut
approach
treat
opiat
addict
introduct
haart
result
significantli
lower
mortal
rate
culmin
hiv
epidem
increasingli
affect
older
adult
emphas
import
understand
risk
factor
associ
age
infect
frequenc
dementia
among
hivposit
patient
year
older
time
greater
seen
hivposit
patient
age
addit
immun
failur
commonli
occur
age
hiv
infect
current
studi
focu
impact
age
ltr
signatur
correl
clinic
paramet
cell
count
viral
load
prospect
longitudin
studi
conduct
seroposit
patient
current
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
histori
illicit
drug
alcohol
medic
use
tcell
count
viral
load
along
patient
histori
includ
age
collect
approxim
everi
month
use
linear
mix
model
longitudin
data
found
age
modifi
snp
effect
count
vl
differ
scale
howev
due
current
sampl
size
modif
close
signific
variat
locu
increas
count
individu
younger
group
individu
variat
much
larger
count
without
variat
addit
age
known
immunomodulatori
effect
cytokin
profil
adult
age
individu
analyz
understand
effect
age
infect
cytokin
modul
diseas
progress
among
cytokin
investig
interestingli
cytokin
level
appear
vari
two
popul
conclus
age
context
infect
appear
impact
viral
gene
express
immun
activ
hiv
progress
hivassoci
neurocognit
disord
hand
directli
indirectli
exacerb
substanc
abus
includ
opiat
mechan
opiat
aggrav
hiv
hand
complex
well
defin
one
critic
factor
neuropathogenesi
hiv
relat
interact
opioid
receptor
hiv
coreceptor
abundantli
express
immun
nervou
system
importantli
natur
ligand
chemokin
involv
fundament
neuron
glia
function
includ
neurotransmiss
cell
differenti
surviv
previou
studi
murin
model
shown
prolong
morphin
treatment
downregul
function
due
increas
level
novel
regul
ubiquit
iron
bind
protein
ferritin
heavi
chain
fhc
protein
mediat
effect
morphin
vitro
vivo
data
suggest
alter
function
induc
opiat
may
contribut
hiv
neuropatholog
via
regul
fhc
test
hypothesi
evalu
potenti
clinic
implic
measur
protein
express
fhc
ser
indic
receptor
statu
within
brain
tissu
sampl
control
subject
illicit
drug
abus
includ
opiat
user
hiv
patient
multispectr
immunohistolog
imag
analysi
result
demonstr
elev
fhc
protein
decreas
express
within
digit
isol
cortic
neuron
patient
histori
drug
use
hiv
addit
studi
nonhuman
primat
nhp
treat
morphin
siv
importantli
found
consist
result
human
nhp
cohort
suggest
opiat
hivsiv
alon
suffici
induc
neuron
fhc
express
vivo
associ
disrupt
signal
furthermor
preliminari
analys
human
nhp
cohort
suggest
neuron
fhc
express
associ
diseas
progress
neurocognit
impair
tnfalpha
stimul
outgrowth
neuron
process
upon
injuri
via
stimul
nfkappabinduc
signal
util
primari
mous
neuron
cultur
scratch
assay
determin
impact
tnfalpha
upon
neural
cell
surviv
growth
injuri
result
demonstr
treatment
scratch
neuron
cultur
tnfalpha
ngml
promot
neurit
outgrowth
length
complex
ngml
respons
injuri
suggest
effect
tnfalpha
may
allow
remodel
neuron
process
promot
regrowth
order
analyz
dynam
condit
human
neuron
stem
cell
cultur
treat
tnfalpha
subject
human
synapt
plastic
array
show
chang
express
gene
involv
synapt
plastic
ltp
ltd
reduc
express
arc
tnfalpha
treatment
reflect
lack
dendrit
stabil
allow
modif
process
respons
injuri
sever
gene
upregul
tnfalpha
treatment
directli
involv
growth
plastic
neuron
process
includ
bdnf
reln
shown
tnfalpha
induc
neuroprotect
effect
nfkappab
therefor
propos
upon
tnfalpha
treatment
follow
induc
injuri
neurit
outgrowth
occur
primarili
receptor
signal
via
stimul
nfkappab
observ
provid
new
avenu
investig
impact
neuron
cell
damag
involv
tnfalpha
cytokin
event
nanomedicin
revolution
convent
antiretrovir
therapi
art
improv
access
adher
toxic
reduct
mean
reach
goal
celltarget
drug
deliveri
mononuclear
phagocyt
mp
monocyt
dendrit
cell
macrophag
target
region
nanoformul
art
nanoart
could
affect
viru
elimin
end
develop
crystallin
nanoart
ritonavir
atazanavir
efavirenz
coat
either
folic
acid
nformyl
methionin
leucin
phenylalanin
fmlp
mannos
monom
conjug
polym
use
click
chemistri
nanosuspens
manufactur
highpressur
homogen
particl
size
charg
polydispers
determin
dynam
light
scatter
electron
microscopi
formul
composit
integr
determin
h
nuclear
magnet
reson
uptak
macrophag
measur
stimul
lipopolysaccharid
tumor
necrosi
factor
alpha
interferon
gamma
granulocyt
macrophag
colonystimul
factor
gmcsf
cytokin
mixtur
confoc
microscopi
revers
transcriptas
assay
use
determin
compartment
antiretrovir
efficaci
nanoart
size
rang
nm
nm
zeta
potenti
mv
mv
polydispers
indic
drug
load
macrophag
uptak
nanoatv
cell
satur
approxim
hr
folic
acid
mannoseco
nanoart
facilit
particl
uptak
cell
cultur
howev
fmlp
tag
nanoart
show
improv
uptak
gmcsf
nanoart
retain
macrophag
day
posit
acceler
particl
uptak
immun
modulatori
function
target
nanoart
make
attract
formul
antiretrovir
drug
deliveri
taxmirnachromatin
novel
mechan
concept
understand
viral
gene
express
postintegr
celltyp
depend
manner
saifur
rahman
kevin
quann
devanshi
pandya
shruti
singh
zafar
khan
pooja
jain
email
pjain
drexelmededu
rna
interfer
rnai
natur
cellular
mechan
silenc
gene
express
predominantli
mediat
microrna
mirna
target
messeng
rna
virus
manipul
cellular
process
necessari
replic
target
host
rnai
machineri
studi
explor
effect
human
tcell
leukemia
viru
type
transactiv
protein
tax
rnai
pathway
context
chromosom
integr
viral
long
termin
repeat
ltr
use
tcell
line
jurkat
transcript
factor
profil
ltr
stabli
integr
tcell
clone
transfect
tax
demonstr
increas
activ
substrat
factor
associ
chromatin
remodel
complex
use
mirna
microarray
bioinformat
experiment
approach
tax
also
shown
downregul
express
mirna
associ
translat
regul
factor
requir
chromatin
remodel
observ
valid
select
mirna
infect
cell
line
found
capabl
directli
target
pcaf
chromatin
remodel
factor
known
play
critic
role
pathogenesi
overal
result
first
line
establish
concept
open
new
avenu
toward
understand
retrovir
latenc
andor
replic
given
cell
type
tugofwar
dendrit
cell
lesson
vivo
studi
saifur
rahman
zafar
khan
feredr
tangi
pooja
jain
email
pjain
drexelmededu
drexel
univers
colleg
medicin
unit
state
drexel
univers
colleg
medicin
unit
state
institut
pasteur
franc
drexel
univers
colleg
medicin
unit
state
human
immun
system
constant
challeng
mani
virus
bodi
success
abl
clear
virus
evolv
escap
host
immun
respons
thu
persist
lead
develop
chronic
diseas
dendrit
cell
dc
profession
antigen
present
cell
play
major
role
innat
adapt
immun
differ
pathogen
past
year
effort
focus
explor
particip
dc
pathogenesi
observ
previous
deplet
dc
transgen
mice
enhanc
suscept
cellfre
infect
perform
hostpathogen
interact
studi
util
ligand
deriv
murin
bone
marrow
dc
fldc
first
kinet
viral
entri
provir
integr
express
viral
protein
tax
establish
effect
cellfre
examin
cell
phenotyp
fldc
demonstr
activ
produc
array
proinflammatori
cytokin
well
virusmatur
fldc
also
stimul
prolifer
autolog
cell
product
gene
express
studi
reveal
upregul
interferonstimul
gene
cytokin
transcript
factor
distinct
downregul
mani
chemokin
overal
result
highlight
critic
interact
dc
human
chronic
viru
import
earli
immun
respons
regul
altern
splice
muopioid
receptor
acut
morphin
treatment
function
implic
upregul
patrick
regan
ilker
sariy
kamel
khalili
email
pmregan
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
unit
state
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
unit
state
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
unit
state
intraven
drug
abus
includ
abus
opioid
contribut
substanti
hiv
epidem
addit
opioid
abus
shown
exacerb
hiv
patholog
particularli
neurocognit
dysfunct
despit
numer
studi
exact
interact
hiv
infect
opioid
signal
still
poorli
character
may
due
part
incomplet
understand
muopioid
receptor
mor
primari
receptor
opioid
abus
recent
multipl
isoform
muopioid
receptor
identifi
howev
function
signific
isoform
well
regul
express
poorli
character
known
mor
isoform
found
one
particular
isoform
design
significantli
upregul
morphin
treatment
furthermor
upregul
specif
cell
line
neuron
origin
also
evid
acut
morphin
treatment
alter
level
particular
splice
factor
howev
whether
directli
involv
regul
mor
altern
splice
upregul
isoform
still
determin
comparison
found
uniqu
ctermin
tail
contain
pka
phosphoryl
site
well
second
agonistinduc
phosphoryl
site
region
highli
conserv
among
opioid
receptor
function
analysi
found
upon
stimul
morphin
receptor
alter
multipl
gpcrregul
pathway
includ
apoptot
pathway
specif
morphin
treatment
cell
overexpress
result
increas
level
phosphoryl
decreas
level
bax
data
suggest
multipl
factor
includ
opioid
abus
alter
express
mor
isoform
alter
may
function
consequ
particularli
hiv
neuropathogenesi
alter
apoptot
pathway
work
made
possibl
grant
award
nih
kk
pahsinduc
ro
accumul
oxid
dna
damag
increas
mutagen
potenti
jc
polyomaviru
tantigen
polycycl
aromat
hydrocarbon
pah
product
incomplet
combust
organ
materi
present
cigarett
smoke
deepfri
food
natur
crude
oil
pah
interact
genom
dna
form
dna
adduct
caus
oxid
dna
damag
ask
chronic
exposur
pah
affect
transform
potenti
viral
oncoprotein
larg
tantigen
human
polyomaviru
jc
jcv
tantigen
extract
character
dmso
solubl
fraction
pah
crude
oil
obtain
deepwat
horizon
dwh
oil
spill
gulf
mexico
pah
detect
fraction
includ
fluoranthen
pyren
phenanthanen
chrysen
obtain
dmso
fraction
oilpah
test
exponenti
grow
cultur
jcv
tantigen
posit
neg
mous
embryo
fibroblast
pah
cytotox
rel
high
dose
dilut
condit
test
cell
respond
oilpah
cell
cycl
arrest
follow
apoptot
cell
death
howev
cell
growth
cell
surviv
practic
unaffect
oilpah
use
higher
dilut
rang
nontox
dose
oilpah
caus
accumul
reactiv
oxygen
speci
ro
oxid
dna
damag
dna
doubl
strand
break
dsb
dna
lesion
partial
neutral
ro
scaveng
nac
importantli
cell
expos
oilpah
demonstr
significantli
lower
involv
homolog
recombin
direct
dna
repair
hrr
higher
nonhomolog
end
join
nhej
mutagen
shift
dna
repair
mechan
accompani
signific
increas
clonogen
potenti
affect
cell
result
indic
potenti
synergist
action
viral
environment
factor
jcv
tantigen
attenu
hrr
oilpah
trigger
dna
damag
potenti
nhej
prime
pump
tat
prime
astrocyt
subsequ
cytokin
secret
quantit
morpholog
chang
bbb
disrupt
nicol
renner
hope
sans
andrew
lackner
andrew
maclean
email
amaclean
tulaneedu
tulan
univers
unit
state
tulan
univers
unit
state
tulan
univers
unit
state
tulan
univers
unit
state
despit
haart
therapi
one
third
individu
infect
hiv
continu
develop
hivassoci
neurocognit
disord
hand
includ
loss
bloodbrain
barrier
bbb
function
activ
numer
cell
type
within
brain
includ
astrocyt
loss
astrocyt
foot
process
contact
bbb
lead
bbb
dysfunct
astrocyt
express
tolllik
receptor
tlr
recogn
specif
pathogenassoci
molecular
pattern
tat
recent
shown
increas
express
increas
express
would
two
downstream
effect
astrocyt
would
like
respond
inflammatori
insult
either
secondaryopportunist
infect
second
round
viru
enter
brain
secondli
would
increas
secret
proinflammatori
cytokin
secret
astrocyt
object
quantifi
astrocyt
activ
follow
tat
prime
hypothesi
alter
tolllik
receptor
tlr
express
astrocyt
would
diminish
bbb
integr
ex
vivo
brain
slice
cultur
incub
sivinfect
macrophag
increas
astrocyt
shorten
thicken
astrocyt
foot
process
parallel
slice
subsequ
incub
agonist
compar
control
secret
increas
tenfold
slice
incub
siv
subsequ
stimul
agonist
prime
also
increas
vimentin
express
astrocyt
decreas
nestin
focal
adhes
kinas
stimul
tatprim
astrocyt
also
shown
diminish
integr
bloodbrain
barrier
model
measur
electr
resist
summari
data
confirm
prime
astrocyt
import
downstream
event
alter
morpholog
intermedi
filament
express
specif
prime
astrocyt
addit
proinflammatori
cytokin
known
import
lentivir
neuropathogenesi
dramat
upregul
understand
mechan
behind
inflamm
allow
ration
design
specif
antiinflammatori
develop
biodegrad
nanoparticl
codeliveri
mu
opioid
receptor
sirna
saquinavir
therapeut
potenti
posit
drug
user
introduct
substanc
abus
worldwid
public
health
concern
opiat
wide
abus
addict
drug
modul
immun
function
transmiss
human
immunodefici
viru
infect
also
possibl
consequ
addict
drug
use
applic
nanotechnolog
diagnos
treat
variou
diseas
attract
consider
interest
nanoparticl
use
deliv
wide
rang
payload
target
cell
surfac
modifi
form
stabl
electrostat
complex
anion
nucleic
acid
small
interf
rna
sirna
target
gene
silenc
propos
develop
multifunct
biodegrad
nanoparticl
potenti
therapeut
applic
posit
substanc
abus
user
method
propos
develop
drugsirna
codeliveri
biodegrad
nanosystem
fda
approv
polylact
acid
pla
polym
use
backbon
biodegrad
nanoparticl
saquinavir
proteas
inhibitor
mix
pla
backbon
encapsul
hydrophob
core
neg
charg
mu
opioid
receptor
sirna
conjug
cation
surfac
plasaquinavir
nanoparticl
electrostat
interact
produc
nanoplex
nanoplex
incub
normal
human
astrocyt
nha
human
monocyt
deriv
macrophag
mdm
uptak
nanoplex
determin
use
confoc
imag
gene
express
analyz
use
quantit
pcr
result
conclus
herein
confoc
microscopi
demonstr
uptak
plasirnasaquinavir
nanoplex
nha
mdm
addit
observ
decreas
gene
express
mu
opioid
receptor
nha
mdm
preliminari
result
show
decreas
viral
replic
mdm
treat
morphin
observ
indic
drugsirna
load
nanoparticl
deliv
therapeut
astrocyt
macrophag
result
highlight
potenti
nanoformul
treatment
posit
substanc
abus
user
potenti
use
neuroaid
neurolog
disord
maureen
richard
larisa
poluektova
eugen
major
lena
alharthi
email
maureenrichard
rushedu
rush
univers
medic
center
unit
state
univers
nebraska
medic
center
unit
state
nation
institut
neurolog
disord
stroke
unit
state
rush
univers
medic
center
unit
state
cell
infiltr
brain
earli
hivsiv
infect
role
whether
pathogen
protect
unclear
delic
environ
cn
highli
activ
cell
may
one
hand
control
hiv
replic
lead
bystand
damag
inflammatori
mediat
other
identifi
uniqu
subset
highli
activ
cell
dimli
express
surfac
doubl
posit
dp
cell
dp
cell
account
approxim
hivspecif
cell
respons
hiv
long
term
nonprogressor
use
nsg
mice
reconstitut
human
peripher
blood
lymphocyt
identifi
dp
cell
brain
dp
cell
constitut
cell
popul
brain
dp
cell
singl
posit
cell
permiss
hiv
infect
three
week
postinfect
major
singl
posit
cell
deplet
dp
cell
remain
interestingli
cultur
human
progenitor
deriv
astrocyt
supernat
primari
activ
cell
enrich
dp
cell
caus
signific
activ
astrocyt
measur
express
ifng
hladr
invers
supernat
astrocyt
lead
increas
express
cell
creat
feedcback
loop
activ
cell
alter
astrocyt
phenotyp
function
collect
data
demonstr
presenc
dp
cell
cn
persist
depsit
hiv
infect
highlight
dynam
interact
astrocyt
lymphocyt
mediat
inflammatori
respons
cn
background
preval
neurocognit
impair
nci
peopl
live
hiv
report
data
women
could
greater
risk
develop
complic
primari
object
cranium
studi
describ
preval
posit
screen
nci
depressionanxieti
infect
adult
popul
present
gender
analysi
result
preval
posit
screen
nci
method
cranium
epidemiolog
crosssect
studi
includ
infect
patient
year
old
attend
routin
clinic
visit
priori
recruit
target
femal
one
third
patient
artnaiv
one
third
pirand
one
third
nnrtibas
regimen
patient
arvtherapi
regimen
month
brief
neurocognit
screen
bnc
use
screen
nci
impair
level
addit
assess
predefin
categori
util
averag
tscore
mental
health
summari
score
mhss
calcul
use
moshiv
questionnair
result
evalu
patient
femal
includ
countri
mean
age
year
gender
femal
subject
caucasian
male
p
black
male
p
arvexperienc
male
p
femal
posit
screen
nci
male
p
averag
tscore
femal
normal
neurocognit
function
male
p
mhss
lower
femal
male
median
vs
conclus
preval
posit
screen
nci
women
exceed
significantli
higher
compar
male
patient
find
might
confirm
greater
vulner
femal
hivinfect
patient
nci
howev
differ
demograph
constitut
diseas
characterist
gender
need
consid
interpret
result
myosoti
frequent
use
opiat
among
patient
rais
concern
drug
impact
replic
cellular
molecular
level
previou
studi
indic
methadon
mtd
enhanc
replic
microglia
rais
major
concern
mtd
perhap
buprenorphin
bup
could
also
play
role
pathogenesi
hivassoci
neurocognit
disord
hand
infect
provok
immun
activ
macrophag
enhanc
migrat
brain
secret
neurotoxin
affect
glial
cell
neuron
studi
use
hivinfect
glianeuron
crosstalk
system
investig
whether
bup
mtd
modul
replic
use
quantit
rtpcr
measur
proinflammatori
cytokin
product
use
cytometr
bead
array
cba
neurotox
use
mtt
assay
show
mtd
bup
enhanc
replic
human
glial
cell
singl
cultur
cocultur
enhanc
associ
signific
increas
product
inflammatori
cytokin
furthermor
supernat
singl
cultur
cocultur
hivinfect
human
glial
cell
treat
mtd
bup
augment
neuron
toxic
increas
glutam
level
addit
studi
effect
hivtat
protein
experiment
model
show
combin
hivtat
opiat
upregul
express
receptor
product
also
show
diminut
glutam
uptak
astrocyt
result
suggest
addit
either
mtd
bup
hivinfect
tattreat
human
glia
cell
augment
inflamm
neurotox
find
also
provid
inform
cellular
molecular
mechan
opiat
may
modul
hand
pathogenesi
support
part
nihrcmi
grant
titl
v
ppoha
grant
number
us
dept
educ
ucc
recent
studi
anim
model
indic
meth
induc
impair
bbb
demonstr
meth
alter
bbb
function
direct
effect
endotheli
cell
confirm
observ
vivo
use
brain
macaqu
infect
simian
immunodefici
viru
siv
expos
meth
dose
similar
one
meth
abus
result
publish
cohort
indic
signific
increas
brain
viral
load
alter
natur
killer
cell
immun
respons
effect
meth
blood
viral
load
perform
immunostain
microglia
tight
junction
found
enhanc
microgliosi
white
matter
siv
meth
macaqu
compar
siv
quantit
analysi
show
signific
increas
stain
siv
methexpos
anim
compar
siv
macaqu
found
decreas
stain
siv
meth
vs
siv
macaqu
parallel
enhanc
microgliosi
play
role
junction
regul
suggest
target
meth
astrocyt
detect
immunostain
found
diminish
amount
brain
endothelium
siv
meth
compar
siv
group
confirm
intrigu
observ
treat
primari
human
brain
endotheli
cell
bmvec
meth
found
decreas
phosphoryl
glycogen
synthas
kinas
gsk
lead
degrad
involv
decreas
due
meth
exposur
inhibitor
licl
prevent
effect
inde
applic
licl
prevent
decreas
bmvec
function
signific
observ
confirm
transendotheli
electr
resist
measur
barrier
integr
bmvec
treat
meth
presenc
licl
meth
exposur
led
drop
resist
inhibit
prevent
decreas
studi
need
clarifi
pathway
alter
signal
meth
exposur
support
monocyt
macrophag
play
crucial
role
progress
hiv
infect
cell
initi
target
infect
provid
mean
viru
persist
sin
cn
explor
use
endocannabinoid
system
regul
replic
two
wellcharacter
cb
receptor
distinct
physiolog
properti
psychoact
effect
cannabinoid
associ
receptor
receptor
known
antiinflammatori
action
fac
reveal
express
regul
upon
differenti
monocyt
macrophag
increas
observ
macrophag
infect
day
confirm
previous
us
observ
increas
infect
brain
macrophag
test
commerci
avail
agonist
novel
resorcinolbas
compound
result
multipl
donor
use
revers
transcriptas
assay
rt
qpcr
gag
pol
indic
addit
increas
concentr
rang
markedli
attenu
replic
day
post
infect
rt
show
attenu
replic
greater
provid
inhibit
compar
control
mechan
action
interfer
infect
sinc
coreceptor
unaffect
activ
result
suggest
signal
affect
replic
singl
round
infect
along
use
report
assay
show
signific
decreas
ltr
activ
follow
activ
action
agonist
specif
receptor
sinc
antagonist
nullifi
action
result
provid
indic
use
specif
target
activ
control
pathogenesi
support
endogen
neural
stemprogenitor
cell
nsc
respond
inflammatori
cue
brain
prolifer
migrat
differenti
new
neuron
glial
cell
howev
littl
known
nsc
respons
inflamm
herp
simplex
enceph
hse
quantit
phenotyp
analysi
neurogen
region
herp
simplex
viru
hsv
infect
brain
show
signific
increas
number
prolifer
endogen
brain
cell
dpi
analysi
found
increas
number
nestin
stem
cell
delay
dpi
indic
celltyp
specif
prolif
respons
infect
brain
interestingli
dpi
prolifer
brain
cell
abrog
prolifer
cell
nestin
stem
cell
decreas
significantli
compar
uninfect
anim
vs
vs
respect
data
suggest
tempor
cell
type
specif
modul
prolif
respons
hse
specif
cellular
phenotyp
involv
prolif
respons
current
investig
determin
modul
nsc
prolifer
associ
express
neurogen
factor
gene
express
analysi
perform
use
pcr
array
express
sever
neurogen
factor
found
downregul
dpi
includ
noggin
epiderm
growth
factor
egf
fibroblast
growth
factor
fgf
analysi
express
kinet
hse
found
gene
significantli
upregul
dpi
subsequ
downregul
dpi
suggest
associ
observ
inhibit
brain
cell
prolifer
chang
growth
factor
express
studi
underway
identifi
mechan
alter
neurogenesi
hse
studi
help
identifi
novel
point
intervent
develop
therapi
neurolog
deficit
ensu
viral
enceph
object
examin
associ
presenc
oxid
stress
relat
impair
nicotinamid
adenin
dinucleotid
nad
metabol
activ
cellular
oxidas
nicotinamid
adenin
dinucleotid
phosphat
nadph
dual
oxidas
duox
proinflammatori
respons
express
hiv
transgen
tg
rat
designmethod
frozen
section
brain
month
old
tg
wildtyp
wt
fisher
control
rat
examin
immunofluoresc
stain
number
gfap
astrocyt
cell
macrophagemicrogli
cell
colabel
cell
tat
nef
vif
tissu
also
examin
express
nad
glycohydrolas
deplet
intraand
extracellular
nad
express
nadph
duox
isoform
respect
pcr
result
number
gfap
cell
similar
tg
wt
rat
wherea
cell
number
higher
tg
rat
express
demonstr
astrocyt
mm
cell
higher
brain
tg
wt
rat
astrocyt
mm
cell
express
tat
wherea
nef
vif
express
primarili
astrocyt
express
higher
brain
tg
rat
coloc
stain
gfap
gene
express
also
increas
tg
rat
brain
rel
wt
rat
conclus
studi
proinflammatori
respons
effect
hiv
protein
express
activ
cellular
oxidas
hiv
tg
model
may
provid
clue
develop
treatment
approach
cognit
impair
result
hiv
infect
human
neurocognit
impair
among
object
examin
outcom
neuropsycholog
np
test
among
individu
risk
hivrel
neurocognit
impair
nci
nigeria
million
infect
hiv
burden
hivaid
second
highest
countri
worldwid
designmethod
seroposit
sp
seroneg
sn
control
subject
recruit
two
antiretrovir
treatment
clinic
np
test
data
obtain
time
studi
enrol
analyz
multipl
regress
analys
perform
hiv
serolog
statu
educ
ethnic
includ
covari
effect
size
determin
estim
cohen
statist
result
date
individu
recruit
studi
administ
complet
neuropsycholog
batteri
sp
sn
among
sp
group
stage
four
stage
ii
three
stage
iii
one
stage
iv
mean
age
sex
ratio
similar
howev
sp
group
lower
level
educ
signific
relationship
found
hiv
serostatu
perform
overal
np
batteri
test
learn
speed
inform
process
execut
function
memori
effect
size
analys
rang
full
batteri
sp
score
sd
mean
control
score
sd
mean
ethnic
educ
impact
perform
test
conclus
hivrel
neurocognit
abnorm
frequent
patient
group
overal
present
earlier
stage
infect
virtual
laboratori
space
possibl
experi
differ
molecular
biolog
laboratori
experi
vr
program
model
weight
loss
skill
virtual
environ
deliv
relax
protocol
patient
undergo
chemotherapi
develop
realtim
feedback
virtual
physic
world
use
tool
track
differ
inform
real
user
complet
prevent
infect
human
mice
neutral
monoclon
antibodi
envelop
number
viral
encephalitid
disproportion
affect
young
andor
old
accordingli
rate
encephalitisassoci
hospit
highest
year
old
children
year
old
lacv
common
caus
pediatr
enceph
asept
mening
midwestern
unit
state
princip
mosquito
vector
ochlerotatu
triseriatu
resid
case
lacv
infect
result
nonspecif
febril
ill
small
proport
childrenalmost
exclus
year
agethi
follow
acut
enceph
agedepend
suscept
lacv
enceph
parallel
murin
model
diseas
newborn
mice
sensit
subcutan
sq
inocul
plaqueform
unit
pfu
lacv
wherea
weanl
adult
mice
resist
much
higher
dose
pfu
administ
rout
howev
underli
biolog
basi
agedepend
suscept
fulli
understood
studi
describ
primari
rat
embryon
day
neuron
cultur
model
lacv
infect
also
reflect
agedepend
suscept
diseas
primari
neuron
cultur
becom
resist
lacvmedi
toxic
matur
follow
approxim
day
vitro
compar
gene
express
profil
young
vulner
primari
rat
neuron
cultur
matur
cultur
resist
lacvmedi
toxic
identifi
pathway
involv
determin
agedepend
suscept
resist
lacvmedi
toxic
methamphetamin
meth
abus
seriou
public
health
concern
lead
irrevers
damag
brain
seem
increas
risk
infect
last
year
use
highlyact
antiretrovir
therapi
haart
increas
longev
hiv
patient
howev
preval
hivassoci
neurocognit
disord
hand
continu
grow
also
combin
effect
potenti
interact
recreat
drug
therapeut
drug
viru
brain
poorli
understood
therefor
address
present
studi
first
analyz
neuron
injuri
meth
haart
separ
use
mix
neuronalgli
cerebrocort
cell
cultur
deriv
rat
neuron
injuri
death
analyz
fix
cell
use
specif
marker
neuron
synaps
synaptophysin
combin
nuclear
dna
hoechst
stain
subsequ
fluoresc
microscopi
observ
treatment
neuron
meth
lower
concentr
increas
neuron
damag
surprisingli
meth
increas
neuron
damag
induc
meth
partial
amelior
toxic
viral
envelop
analyz
effect
haart
compound
repres
four
differ
pharmacolog
categori
azt
nvp
presenc
absenc
none
chemic
caus
signific
neuron
injuri
h
exposur
howev
incub
neuron
synaps
compromis
surprisingli
posit
dendrit
spare
contrarili
haart
separ
caus
signific
neuron
injuri
death
period
time
paradox
combin
therapeut
compound
psychostimul
drug
primarili
compromis
neuron
dendrit
spare
synaptophysinreact
presynapt
termin
altogeth
find
indic
overal
posit
effect
haart
hiv
infect
accompani
neurotox
possibl
aggrav
presenc
abus
drug
carboxyterminu
dna
bind
domain
stimul
dna
bind
jc
viru
larg
tantigen
ori
evid
coupl
viral
dna
replic
encapsid
jc
viru
jcv
etiolog
agent
fatal
brain
diseas
known
progress
multifoc
leukoencephalopathi
pml
jcv
member
polyomaviru
famili
latent
infect
major
human
popul
reactiv
lytic
infect
oligodentrocyt
central
nervou
system
cn
patient
underli
immunosuppress
condit
includ
hodgkin
lymphoma
lymphoprol
diseas
aid
recent
year
howev
pml
also
steadili
increas
small
percent
patient
autoimmun
disord
includ
multipl
sclerosi
ms
crohn
diseas
treat
antibodybas
regiment
natalizimab
efalizumab
rituximab
infecti
jcv
virion
compos
viral
dna
situat
innermost
core
virion
capsid
protein
synthes
cytosol
transport
nucleu
virion
assembl
howev
mechan
virion
assembl
jcv
complet
unknown
initi
studi
demonstr
capsid
protein
enhanc
larg
tantigen
ltag
bind
activ
viral
origin
ori
interact
far
ctermin
dna
bind
domain
suggest
capsid
protein
may
involv
effici
viral
dna
replic
addit
experiment
data
also
suggest
host
chaperon
protein
may
play
critic
role
tether
viral
capsid
protein
viral
replic
center
nucleu
mediat
interact
ltag
capsid
protein
support
idea
viral
dna
replic
coupl
encapsid
process
character
mechan
chain
event
take
place
jcv
virion
assembl
shed
light
understand
jcv
virion
biogenesi
may
provid
opportun
develop
effect
therapeut
strategi
jcv
infect
affect
individu
hydrophob
core
region
jc
viru
agnoprotein
involv
stabl
dimeroligom
format
protein
stabil
n
broad
street
philadelphia
pa
unit
state
agnoprotein
multifunct
regulatori
protein
polyomavirus
includ
jc
viru
jcv
bk
viru
bkv
simian
viru
form
highli
stabl
sdsresist
dimericoligomer
structur
whose
function
function
current
unknown
previou
map
studi
jcv
agnoprotein
indic
amino
acid
involv
dimeroligom
format
interestingli
region
also
involv
format
amphipath
helix
evidenc
three
dimension
model
studi
function
signific
region
examin
delet
analysi
viral
background
result
show
mutant
viru
unabl
sustain
replic
cycl
first
round
propag
highlight
import
region
agnoprotein
function
studi
defin
region
respons
dimer
oligom
format
examin
function
signific
region
mutagenesi
analysi
aminoand
carboxytermin
delet
mutant
jcv
agnoprotein
demonstr
dimeroligom
format
domain
confin
hydrophob
core
region
span
amino
acid
moreov
intern
delet
analysi
region
confirm
amino
acid
span
suffici
confer
dimeroligom
format
properti
agnoprotein
thu
play
critic
role
stabil
function
agnoprotein
inde
function
studi
demonstr
mutant
viru
lack
region
poorli
express
agnoprotein
replic
significantli
less
effici
wt
find
altogeth
demonstr
hydrophob
core
region
agnoprotein
critic
import
stabil
function
agnoprotein
thu
repres
prime
target
develop
novel
therapeut
agent
progress
multifoc
leukoencephalopathi
n
broad
street
philadelphia
pa
unit
state
agnoprotein
small
regulatori
protein
jc
viru
jcv
express
critic
import
success
complet
jcv
life
cycl
evid
extrem
poor
replic
behavior
agnoprotein
null
mutant
agnoprotein
mostli
resid
cytoplasm
high
concentr
accumul
around
perinuclear
region
infect
cell
small
amount
protein
also
consist
detect
nucleu
indic
possibl
nuclear
function
agnoprotein
studi
investig
regulatori
role
agnoprotein
viral
dna
replic
dna
bind
studi
demonstr
agnoprotein
enhanc
bind
activ
larg
tantigen
ltag
viral
origin
ori
without
directli
interact
dna
predict
amphipath
domain
agnoprotein
play
major
role
observ
enhanc
interestingli
agnoprotein
three
phe
residu
local
domain
shown
phe
residu
play
critic
role
proteinprotein
interact
protein
fold
stabil
function
relev
phe
residu
investig
sitedirect
mutagenesi
mutat
alanin
ala
individu
phe
mutant
lost
abil
enhanc
ltag
bind
exhibit
differenti
behavior
viral
dna
replic
howev
tripl
phe
mutant
show
greater
neg
effect
viral
dna
replic
individu
phe
mutant
alon
moreov
immunocytochem
replic
studi
suggest
strateg
subcellular
distribut
pattern
agnoprotein
also
import
execut
full
function
evidenc
substanti
decreas
observ
viral
dna
replic
protein
exclus
express
nucleu
collect
studi
indic
close
involv
agnoprotein
jcv
dna
replic
cycl
repres
target
therapeut
intervent
inhibit
progress
jcvcaus
diseas
progress
multifoc
leukoencephalopathi
pml
agnoprotein
releas
infect
cell
potenti
biomark
reactiv
jcv
progress
pml
ilker
sariy
kamel
khalili
email
isariy
templeedu
templ
univers
unit
state
templ
univers
unit
state
among
human
polyomavirus
jcv
abund
polyomaviru
human
popul
childhood
establish
persist
lifelong
infect
jcv
replic
glial
cell
brain
caus
fatal
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
pml
usual
seen
patient
underli
immunocompromis
condit
notabl
among
aid
patient
chronic
immunosuppress
regimen
littl
known
progress
diseas
sinc
biomark
detect
jcv
reactiv
infect
affect
individu
pml
case
diagnos
patient
late
stage
diseas
onset
neurolog
complic
establish
diagnost
marker
applic
clinic
predict
patient
develop
diseas
discov
small
viral
protein
agnoprotein
may
serv
biomark
detect
jcv
reactiv
replic
patient
risk
develop
pml
discov
agnoprotein
releas
cell
infect
jcv
detect
biolog
sampl
eg
serum
urin
process
develop
highli
sensit
specif
elisabas
test
agnoprotein
detect
human
serum
urin
sampl
believ
develop
detect
system
agnoprotein
biolog
sampl
patient
risk
develop
pml
great
interest
clinician
well
diagnost
test
laboratori
pharmaceut
compani
develop
market
immunosuppress
drug
associ
polyomavirusbas
diseas
condit
medium
pbmc
treat
adenosin
receptor
agonist
inhibit
jcv
propag
glial
cell
fatal
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
effect
therapi
caus
replic
human
neurotrop
polyomaviru
jc
jcv
glial
cell
brain
evid
proinflammatori
cytokin
promot
reactiv
latent
viru
onset
pml
adenosin
receptor
ar
mediat
varieti
antiinflammatori
protect
effect
overexpress
ar
featur
inflammatori
cell
pbmc
patient
inflammatori
diseas
investig
effect
ar
agonist
jcv
transcript
replic
direct
treatment
astrocyt
effect
indirect
treatment
astrocyt
condit
medium
pbmc
inhibit
jcv
infect
measur
viral
gene
express
viral
dna
replic
viru
particl
releas
cytokin
array
analysi
pbmccondit
media
show
induc
mark
chang
cytokin
profil
data
suggest
may
offer
novel
avenu
treatment
pml
replic
human
neurotrop
polyomaviru
jc
jcv
glial
cell
brain
caus
fatal
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
infect
glial
cell
jcv
express
viral
regulatori
structur
protein
lead
broad
rang
chang
gene
express
profil
host
mostli
favor
replic
viru
evid
protein
member
human
athanogen
bag
famili
protein
regul
apoptosi
downregul
upon
jcv
infect
effect
mediat
jcv
tag
via
repress
promot
function
molecular
cochaperon
interact
function
regul
cellular
stress
respons
prolifer
apoptosi
neuropathogenesi
hand
directli
relat
hiv
replic
cn
neuron
injuri
although
neuron
product
infect
injur
neurotoxin
includ
hivtat
releas
activ
microglia
macrophag
modul
intracellular
signal
pathway
includ
mitogenactiv
protein
kinas
mapk
cascad
mapk
erk
jnk
phosphoryl
direct
myocytespecif
enhanc
factor
multipl
divers
mutual
exclus
pathway
cell
prolifer
neuron
cell
surviv
differenti
synaps
develop
inflamm
cell
death
alter
neuron
integr
control
phosphoryl
mapk
previou
inform
suggest
apoptosi
brain
potenti
ethanol
ethanol
induc
neuron
cell
injuri
dysregul
sever
signal
pathway
also
control
part
mapk
preliminari
studi
indic
novel
plantderiv
phosphatas
inhibit
hivmedi
toxic
human
neuron
stimul
neuron
outgrowth
injuri
also
found
prevent
ethanolinduc
neuron
damag
regul
phosphoryl
map
kinas
downstream
target
regul
divers
cellular
process
data
also
suggest
ethanol
potenti
neuron
loss
prevent
tatand
ethanolmedi
neuron
injuri
preserv
impair
tat
ethanol
neuron
integr
synapt
plastic
human
neuron
identifi
signal
pathway
activ
ding
increas
surviv
neuron
expos
ethanol
find
propos
studi
provid
tool
reduc
deleteri
effect
ethanol
brain
contribut
better
understand
neuropathogenesi
aid
alcohol
work
made
possibl
grant
award
nih
sa
role
mitochondri
protein
porin
tatinduc
neurotox
nune
sarkissian
shohreh
amini
email
nsarkiss
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
unit
state
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
unit
state
transactiv
protein
tat
import
regul
neuron
cell
surviv
involv
modul
cell
cycl
differenti
cytoskeleton
dysfunct
apoptosi
util
neuron
sknmc
cell
line
constitut
express
tat
examin
molecular
event
involv
mitochondria
regul
cell
surviv
demonstr
level
express
mitochondri
outer
membran
protein
vdac
porin
inhibit
tatexpress
cell
inhibit
vdac
tat
neuron
cell
treatment
tatneg
cell
vdac
inhibitor
did
result
induct
activ
increas
dna
damag
progress
cell
cycl
tatposit
cell
delay
number
apoptot
cell
increas
mitochondri
bioenerget
strongli
affect
tat
importantli
mitochondri
content
tubulin
decreas
suggest
interact
mitochondria
cytoplasm
dysregul
tatposit
cell
reduc
level
vdac
also
observ
human
neuron
treat
recombin
tat
protein
data
demonstr
tat
dysregul
mitochondria
result
inhibit
mitochondri
vdac
activ
turn
lead
neuron
cell
injuri
work
made
possibl
grant
award
nih
sa
cell
small
subset
lymphocyt
involv
innat
immun
demonstr
cell
cytotox
activ
cell
infect
varieti
virus
howev
littl
evid
suggest
cytotox
activ
cell
cell
therefor
investig
whether
cell
play
protect
role
defens
use
pbmc
asymptomat
carrier
ac
patient
myelopathytrop
spastic
paraparesi
ham
tsp
assay
frequenc
cell
correl
frequenc
load
frequenc
cell
significantli
decreas
hamtsp
patient
compar
ac
frequenc
cell
invers
correl
provir
load
result
suggest
cell
protect
effect
individu
next
cell
separ
pbmc
individu
fac
provir
load
popul
quantifi
realtim
pcr
provir
load
cell
markedli
lower
lack
cell
furthermor
cultur
pbmc
individu
presenc
zoledron
major
cell
contain
cultur
becam
cell
provir
load
markedli
decreas
especi
cell
major
reservoir
deplet
pbmc
prior
cultur
cultur
pbmc
show
strong
cytotox
activ
cell
line
well
atl
cell
line
result
rais
possibl
cell
immunotherapi
individu
effect
sp
receptor
bind
nestin
human
fetal
brain
cell
children
perinat
infect
increas
risk
develop
neurocognit
deficit
behavior
psychiatr
disord
underli
cellular
mechan
may
includ
effect
hivassoci
neuroinflamm
cell
critic
brain
develop
specif
nestin
posit
neural
progenitor
astroglia
progenitor
potenti
substanc
p
sp
bind
receptor
implic
hivaid
neuroinflamm
neuropsychiatr
disord
sp
effect
neural
progenitor
examin
hivaid
human
fetal
brain
cell
hfbc
grown
fetal
bovin
serum
passag
p
confluenc
test
express
nestin
gfap
isoform
fluoresc
immunocytochemistri
icc
qpcr
normal
gapdh
respons
sp
determin
calcium
mobil
imped
assay
effect
sp
ngml
nestin
express
assess
product
sp
measur
elisa
pgml
nestin
posit
hfbc
express
full
length
low
amount
truncat
sp
provok
calcium
mobil
cell
contract
nestin
cell
present
cell
treatment
sp
effect
nestin
none
transcript
wherea
preliminari
icc
result
sp
incub
suggest
percent
cell
posit
gfap
increas
respect
nestin
posit
decreas
sp
exposur
result
increas
cell
earlier
passag
hfbc
effect
suggest
prolong
sp
exposur
may
hasten
progenitor
progress
restrict
astrogli
phenotyp
upregul
event
could
contribut
neuroinflamm
viral
entri
respect
support
regul
glucos
metabol
shown
play
import
role
pathogenesi
mani
diseas
primarili
deregul
metabol
pathway
lead
either
apoptosi
extend
life
span
cell
involv
human
immunodefici
viru
infect
activ
cell
well
termin
differenti
macrophag
cours
pathogenesi
henc
focus
possibl
regul
glycolyt
pathway
infect
two
differ
cell
type
monitor
effect
infect
activ
import
glycolyt
enzym
hexokinas
hk
dehydrogenas
pyruv
kinas
muscl
use
human
cell
line
jurkat
latent
infect
jlat
monocyt
cell
line
latent
infect
jurkat
cell
line
serv
control
tcell
line
monocyt
deriv
macrophag
respect
observ
activ
hk
enzym
markedli
differ
replic
two
cell
line
tcell
line
show
five
fold
increas
hk
activ
wherea
cell
line
show
six
fold
decreas
hk
activ
howev
case
activ
trend
revers
cell
activ
increas
three
fold
activ
infect
tcell
line
decreas
fold
enzym
also
show
cell
line
base
differ
activ
cell
activ
decreas
two
fold
viral
replic
jlat
cell
line
activ
show
steadi
trend
variat
thu
glycolyt
pathway
differ
target
cell
differ
affect
viral
replic
work
made
possibl
grant
award
nih
sa
role
neuronglia
crosstalk
neuropathogenesi
pankaj
seth
pretti
garg
manju
pant
email
pseth
nbrcacin
nation
brain
research
centr
india
nation
brain
research
centr
india
nation
brain
research
centr
india
human
brain
deriv
cell
cultur
model
help
understand
neuropathogenesi
great
extent
especi
reliabl
anim
model
studi
pathogenesi
hiv
associ
neurocognit
disord
hand
recent
studi
report
increas
connexin
express
upon
exposur
primari
human
astrocyt
live
hiv
viru
howev
underli
signal
pathway
consequ
augment
gap
junction
commun
remain
unexplor
attempt
gain
better
insight
molecular
mechan
underli
glia
mediat
hiv
neurotox
employ
human
neuronastrocyt
cocultur
model
use
cell
differenti
human
fetal
brain
deriv
neural
precursor
cell
explor
tat
mediat
alter
gap
junction
channel
one
major
mode
intercellular
commun
transfer
ion
may
modul
signal
pathway
observ
signific
increas
sever
connexin
cx
follow
exposur
full
length
tat
protein
increas
promot
cell
death
adjoin
neuron
elucid
tunel
assay
concomit
increas
connexin
express
notic
cell
prolifer
inhibit
evidenc
attenu
posit
cell
observ
revers
use
acid
gap
junction
blocker
pretreat
restor
cell
viabil
prolifer
experiment
data
pave
way
better
understand
neuronglia
interplay
glia
mediat
neuron
damag
hiv
neuropathogenesi
suggest
possibl
target
therapeut
manag
neuroaid
human
immunodefici
viru
type
gene
express
driven
long
termin
repeat
ltr
contain
bind
site
interact
multipl
host
viral
factor
select
pressur
within
host
well
low
effici
revers
transcriptas
lead
genet
alter
within
viral
genom
result
viral
quasispeci
differenti
regul
potenti
form
nich
within
specif
cell
type
tissu
previou
studi
identifi
singl
nucleotid
polymorph
snp
within
cebp
site
ctot
chang
posit
site
correl
dementia
addit
current
patient
cohort
show
snp
within
sp
site
iii
ctot
chang
posit
site
occur
frequent
consensu
subtyp
b
sequenc
stabli
transfect
cell
line
develop
use
bone
marrow
progenitor
monocyt
cell
line
jurkat
respect
explor
ltr
phenotyp
associ
genotyp
chang
integr
microenviron
lai
ltr
coupl
green
fluoresc
protein
gfp
polyclon
ltrgfp
stabl
cell
line
develop
examin
mechan
ltr
driven
gene
express
well
epigenet
modif
may
control
clone
deriv
popul
cell
clone
examin
respect
basal
transcript
cytokin
treatment
tat
transactiv
result
suggest
nonexpress
clone
within
monocyt
cell
line
induc
express
condit
examin
howev
nonexpress
lai
lai
jurkat
clone
genotyp
could
induc
express
result
demonstr
site
ltr
integr
epigenet
modif
viral
host
dna
cellular
phenotyp
genet
variat
may
determin
overal
level
ltr
activ
potenti
activ
quiescent
state
background
knowledg
central
nervou
system
cn
opportunist
infect
oi
hivinfect
popul
subsaharan
africa
limit
object
sought
character
preval
cn
oi
urban
zambian
adult
hiv
popul
use
pcr
technolog
freshli
collect
csf
method
analyz
csf
hiv
patient
evalu
singl
neurologist
os
symptom
concern
cn
oi
univers
teach
hospit
lusaka
zambia
use
pathogenspecif
primer
detect
dna
jcv
vzv
cmv
ebv
hsv
mycobacterium
tuberculosi
mtb
toxoplasma
gondii
tg
via
realtim
pcr
corbett
rotorgen
sampl
run
duplic
genom
dna
respect
organ
use
control
result
csf
sampl
pcr
least
one
pathogen
dna
ebv
found
mtb
cmv
jcv
vzv
tg
none
addit
bacteriolog
diagnosi
show
cryptococcu
pneumococcu
averag
avail
tcell
count
patient
csf
infect
rang
vzv
jcv
pathogenspecif
treatment
given
patient
cryptococcu
mtb
pneumococcu
mortal
high
rang
jcv
ebv
cmv
hospit
interestingli
csf
sampl
two
three
pathogen
ebv
sampl
coinfect
one
two
agent
includ
cryptococcu
mtb
mtb
cmv
jcv
vzv
pneumococcu
conclus
cn
oi
frequent
potenti
treatabl
complic
aid
zambia
multipl
pathogen
often
coexist
ebv
preval
cn
organ
isol
coinfect
whether
true
pathogen
mere
marker
cn
inflamm
requir
investig
investig
polyomavirus
replic
nephropat
pediatr
popul
receiv
rituximab
therapi
rituximab
chimer
monoclon
antibodi
react
antigen
bcell
propos
treatment
idiopath
nephrot
syndrom
in
recurr
idiopath
nephropathi
rin
focal
segment
glomerulosclerosi
fsg
refractori
steroid
rituximab
influenc
tcell
immun
may
predispos
patient
opportunist
infect
progress
multifoc
leukoencephalopathi
pml
caus
polyomaviru
jc
jcv
littl
known
risk
latent
virus
infect
reactiv
pediatr
patient
receiv
biolog
therapi
longitudin
studi
report
herein
effect
rituximab
jcv
bk
viru
bkv
replic
investig
blood
serum
urin
sampl
obtain
eleven
pediatr
patient
mean
age
year
in
rin
rituximab
therapi
initi
everi
month
least
six
month
jcv
bkv
real
time
pcr
perform
follow
sequenc
viral
protein
non
code
control
region
nccr
investig
conduct
sampl
collect
eight
pediatr
patient
control
mean
age
year
in
fsg
treat
convent
chemotherapi
jcv
detect
urin
one
patient
one
control
wherea
bkv
detect
urin
patient
control
sporad
blood
sampl
four
patient
signific
differ
observ
mean
viral
load
viral
molecular
character
two
group
conclus
polyomavirus
replic
seem
associ
rituximab
therapi
pediatr
popul
cerebr
blood
flow
cbf
disregul
person
human
immunodefici
viru
reason
remain
unclear
test
whether
disregul
cbf
might
due
virallyinduc
neuroinflamm
use
welldefin
anim
model
gfapdriven
doxycyclineinduc
tat
transgen
tattg
mice
exposur
brief
hypercapnia
reveal
underli
cerebrovascular
patholog
tattg
mice
control
anim
brief
hypercapnia
induc
brisk
increas
cortic
flow
vascular
dilat
measur
laser
doppler
flowmetri
vivo
twophoton
microscopi
respons
significantli
attenu
tattg
mice
cortic
microvascular
morpholog
capillari
densiti
unalt
suggest
function
patholog
could
attribut
vascular
remodel
examin
mechanist
basi
diminish
cerebrovascular
respons
brief
hypercapnia
tattg
mice
treat
gisadenafil
phosphodiesteras
inhibitor
prevent
degrad
cgmp
ii
tetrahydrobiopterin
limit
cofactor
necessari
product
gisadenafil
larg
restor
normal
vasoreact
brief
hypercapnia
tattg
mice
wherea
littl
effect
data
show
hivassoci
neuroinflamm
caus
cerebrovascular
patholog
effect
cgmp
metabol
possibl
myocyt
enhanc
involv
tax
transactiv
protein
human
cell
leukemia
viru
type
tax
requir
activ
viral
promot
ltr
long
termin
repeat
capabl
regul
viru
host
transcript
howev
clear
molecular
mechan
taxmedi
viral
gene
express
known
studi
propos
herein
perform
extens
proteindna
transcript
factor
array
analys
infect
cell
line
latent
cell
line
taxexpress
cell
line
comparison
normal
cell
line
jurkat
primari
target
infect
cell
poupul
interestingli
cell
demonstr
upregul
transcriptom
profil
cell
show
either
express
downregul
major
factor
analyz
signific
chang
observ
sever
new
nuclear
cytoplasm
factor
case
infect
cell
whose
ltrbind
activ
confirm
promot
bind
assay
factor
myocyt
enhanc
chromatinremodel
factor
found
great
interest
therefor
recruit
ltr
confirm
chip
assay
primari
cell
furthermor
incraes
express
observ
upon
infect
order
understand
nechan
activ
confirm
bind
tax
coimmunoprecipit
also
observ
direct
effect
infect
overal
studi
first
elucid
involv
novel
chromatin
remodel
factor
pathogenesi
maryl
solbrig
yijun
fan
email
hscmbca
univers
manitoba
canada
univers
manitoba
canada
background
cannabinoid
promis
therapi
support
neurogenesi
deceler
diseas
progress
neuroinflammatori
degen
disord
object
present
studi
use
rodent
model
chronic
viral
enceph
base
borna
diseas
viru
compar
effect
gener
specif
cannabinoid
receptor
agonist
frontostriat
neurogenesi
gliogenesi
method
brdu
use
label
neural
progenitor
subventricular
zone
striatum
frontal
cortex
borna
diseas
rat
adolesc
male
lewi
rat
ic
infect
bdv
rat
treat
gener
cannabinoid
agonist
win
mgkg
ip
bid
week
specif
agonist
mgkg
ip
week
brain
process
brduimmunoreact
cell
cell
type
specif
marker
result
one
week
treatment
win
limit
reactiv
gliogenesi
macrophag
activ
favor
new
cell
particularli
oligodendroglia
develop
howev
wintreat
rat
develop
toler
antiinflammatori
effect
week
show
signific
differ
win
vehicl
treat
group
time
hand
week
treatment
attenu
inflammatori
diseas
progress
limit
microglia
activ
prolifer
reduc
brdu
cell
destruct
phagocytosi
conclus
activ
receptor
microglia
nontoler
mechan
control
cn
inflamm
viral
enceph
use
nonpsychotrop
cannabinoid
agonist
challeng
neurotherapeut
develop
hivassoci
neurocognit
disord
hand
joseph
steiner
tongguang
wang
elliot
choi
avindra
nath
email
joestein
nihgov
nihnind
unit
state
nihnind
unit
state
nihnind
unit
state
nihnind
unit
state
despit
adequ
viral
suppress
peripheri
neurolog
complic
aris
hiv
infect
rang
peripher
sensori
neuropathi
cognit
declin
dementia
continu
persist
like
viral
replic
brain
may
complet
control
drug
may
toxic
hiv
protein
secret
infect
macrophag
astrocyt
cytotox
surround
neuron
cell
mechanist
neurotox
may
mediat
via
hiv
proteininduc
oxid
stress
neuroinflamm
howev
clinic
trial
use
antiinflammatori
neuroprotect
agent
fail
hand
henc
develop
approach
screen
drug
neuroprotect
antiinflammatori
properti
also
protect
adult
neural
progenitor
cell
facilit
prolifer
differenti
andor
neuron
regener
purpos
develop
techniqu
gener
neuron
skin
fibroblast
hematogen
stem
cell
use
moder
throughput
screen
distinct
advantag
select
patient
may
best
respond
drug
identifi
drug
screen
use
approach
candid
drug
test
abil
achiev
target
tissu
concentr
vivo
candid
neuroprotect
agent
plausibl
mechan
action
elucid
effect
therapeut
agent
address
issu
viral
reservoir
cn
final
adjunct
neurotherapeut
may
possess
antiretrovir
activ
minimum
promot
hiv
replic
infect
individu
compound
combin
agent
complementari
mechan
fulfil
requir
may
becom
potenti
therapeut
hand
syndrom
aid
unit
state
attribut
inject
drug
use
frequent
involv
abus
opioid
opioid
abus
individu
lead
rapid
diseas
progress
increas
viral
replic
peripher
viral
load
increas
incid
sever
neurocognit
abnorm
compar
nondrug
abus
bloodbrain
barrier
bbb
obstacl
must
overcom
neuroinvas
hivassoci
neurocognit
disord
hand
develop
protein
directli
impact
bbb
permeabl
drug
abus
includ
cocain
methamphetamin
shown
increas
bbb
leaki
cellular
transmigr
previou
vitro
vivo
studi
address
role
muopioid
alter
bbb
suggest
exposur
increas
cellular
transmigr
overal
barrier
leaki
studi
human
brain
microvascular
endotheli
cell
hbmec
line
use
establish
vitro
transwel
model
bbb
investig
effect
chronic
h
morphin
treatment
barrier
structur
function
observ
cell
form
confluent
monolay
basal
rate
passag
kda
tracer
molecul
compar
primari
hbmec
chronic
morphin
treatment
induc
overal
barrier
leaki
mrna
level
tight
junction
protein
observ
chang
throughout
cours
chronic
treatment
futur
experi
investig
impact
chronic
morphin
treatment
transcellular
migrat
mononuclear
cell
tight
junction
protein
express
adhes
molecul
surfac
express
cytokinechemokin
secret
regul
progranulin
express
human
microglia
proteolysi
progranulin
matrix
hyeonsook
suh
namjong
choi
leonid
tarassishin
background
essenti
role
progranulin
pgrn
neurotroph
factor
demonstr
discoveri
haploinsuffici
due
grn
gene
mutat
caus
frontotempor
lobar
dementia
addit
neuron
microglia
vivo
express
pgrn
littl
known
regul
pgrn
express
microglia
goal
current
studi
examin
regul
express
function
pgrn
proteolyt
enzym
macrophag
elastas
well
inhibitor
pgrn
proteolysi
secretori
leukocyt
proteas
inhibitor
slpi
human
cn
cell
method
cultur
primari
human
microglia
astrocyt
stimul
tlr
ligand
lp
poli
ic
cytokin
cytokin
result
analyz
qpcr
immunoblot
elisa
role
slpi
pgrn
cleavag
also
examin
result
unstimul
microglia
produc
nanogram
level
pgrn
pgrn
releas
microglia
suppress
tlr
ligand
increas
unexpectedli
astrocyt
stimul
proinflammatori
factor
releas
larg
amount
slpi
none
detect
microgli
cultur
also
identifi
pgrn
proteolyt
enzym
slpi
inhibitor
pgrn
proteolysi
experi
employ
pgrn
sirna
demonstr
microgli
pgrn
involv
cytokin
chemokin
product
follow
activ
effect
conspicu
conclus
studi
first
detail
examin
pgrn
human
microglia
result
establish
microglia
signific
sourc
pgrn
slpi
modul
pgrn
proteolysi
neg
posit
regul
microgli
pgrn
releas
stimuli
respect
suggest
fundament
differ
aspect
pgrn
regul
compar
known
microgli
activ
product
microgli
pgrn
appear
function
endogen
modul
innat
immun
respons
target
neuropsycholog
deficit
hivhcv
coinfect
coinfect
subject
healthi
control
detect
liver
damag
recent
illicit
drug
use
nineteen
hcv
monoinfect
hivhcv
coinfect
control
male
evalu
nonclin
depress
np
domain
address
attent
execut
function
inform
process
fine
motor
speed
verbalvisu
learn
memori
np
assess
summar
global
deficit
score
gd
integr
normal
relev
np
test
result
unitari
global
score
better
reflect
effect
cognit
impair
account
background
intellig
variat
cognit
reserv
score
cr
also
evalu
cr
composit
educ
occup
gener
intellig
quotient
cr
reflect
baselin
start
point
cognit
evalu
higher
cr
mean
potenti
compens
loss
cognit
abil
found
hivhcv
higher
beck
depress
inventori
ii
bdi
score
hcv
monoinfect
control
hivhcv
also
higher
gd
score
hcv
monoinfect
control
correl
bdi
gd
found
control
higher
cr
score
hcv
mono
coinfect
coinfect
also
demonstr
lower
perform
control
verbal
learn
visual
memori
hcv
monoinfect
show
differ
domain
test
compar
control
conclud
firstli
cognit
reserv
play
import
role
evalu
neurolog
perform
secondli
even
suppress
hiv
hcvinfect
patient
impact
neurolog
impair
cellular
immun
exhaust
progress
multifoc
leukoencephalopathi
pml
background
progress
multifoc
leukocencephalopathi
pml
deadli
brain
diseas
caus
reactiv
human
polyomaviru
jc
jcv
asymptomat
jcv
primari
infect
occur
gener
popul
reactiv
result
pml
observ
mainli
immunosuppress
individu
current
avail
treatment
half
pml
patient
rapid
fatal
outcom
shown
jcvspecif
cytotox
lymphocyt
ctl
play
crucial
role
contain
pml
progress
improv
surviv
host
ctl
dysfunct
may
associ
cell
exhaust
involv
inhibitori
receptor
program
cell
death
exhaust
cell
express
high
level
chronic
viral
infect
blockad
pathway
result
increas
expans
activ
viral
specif
cell
examin
contribut
host
cellular
immun
dysfunct
pml
method
enrol
subject
includ
pmlhivposit
pmlhivneg
patient
hivposit
patient
healthi
control
character
cell
well
jcvspecif
cell
express
flow
cytometri
furthermor
blockad
perform
detect
augment
jcvspecif
ctl
result
express
elev
total
tcell
median
pml
patient
compar
healthi
control
subject
median
pml
patient
jcvspecif
cytotox
tlymphocyt
ctl
express
frequent
total
tlymphocyt
mean
block
receptor
increas
interferon
gamma
releas
subgroup
pml
patient
conclus
express
jcvspecif
ctl
indic
immun
exhaust
play
role
pml
augment
jcv
ctl
immun
respons
blockad
suggest
receptor
may
valid
therapeut
target
deadli
diseas
human
mice
provid
ideal
model
studi
jcv
primari
infect
latenc
reactiv
method
immunodefici
mice
engraft
human
hematopoiet
cell
thymu
jcv
cy
archetyp
strain
inject
intraperiton
mice
sacrif
day
initi
infect
lymphocyt
phenotyp
flow
cytometri
detect
antijcv
igm
igg
perform
elisa
jcv
dna
extract
whole
blood
plasma
urin
detect
perform
quantit
pcr
qpcr
jcvspecif
tcell
respons
measur
splenocyt
elispot
ic
assay
jcv
pcr
perform
urin
day
post
infect
hematopoiet
organ
kidney
brain
test
presenc
jcv
nucleic
acid
qpcr
protein
immunohistochem
stain
result
mice
toler
intraperiton
inject
infect
jcv
without
develop
ill
similar
primari
infect
human
jcv
dna
detect
plasma
whole
blood
mice
day
two
mice
also
detect
jcv
dna
urin
antijcv
igm
detect
jcvci
infect
mice
day
infect
postinfect
day
infect
mice
detect
jcv
specif
tcell
respons
ic
elispot
assay
conclus
human
mice
provid
anim
model
earli
event
surround
jcv
infect
primari
infect
asymptomat
viru
rare
detect
whole
blood
plasma
occasion
excret
urin
mice
develop
humor
cellular
immun
respons
jcv
model
may
prove
valuabl
studi
jcv
primari
infect
host
immun
respons
determin
viral
latenc
reactiv
background
jcv
caus
progress
multifoc
leukoencephalopathi
pml
immunocompromis
patient
gener
popul
seroposit
jcv
jcvspecif
cellular
immun
respons
necessari
contain
viral
prolifer
mechan
jcv
reactiv
immun
transplant
immun
system
remain
unclear
method
prospect
enrol
patient
undergo
allogen
hsct
collect
blood
urin
sampl
pre
hsct
month
hsct
detect
jcv
dna
pcr
blood
urin
sampl
perform
elisa
detect
jcv
igm
igg
well
elispot
ic
measur
tcell
respons
jcv
detect
jcvepitop
specif
tcell
tetram
stain
patient
multivari
analysi
account
condit
regimen
cancer
diagnosi
concurr
viremia
age
transplant
type
result
pre
hsct
jcv
dna
detect
urin
pbmc
plasma
sampl
viruria
remain
stabl
throughout
viremia
detect
plasma
none
pbmc
sampl
month
hsct
preval
antijcv
igg
remain
stabl
pre
hsct
month
antijcv
igm
rare
detect
elispot
ic
tetram
stain
result
correl
signific
increas
cell
respons
month
hsct
observ
tcell
jc
viruria
correl
detect
antijcv
antibodi
cellular
immun
respons
jcv
measur
elispot
invers
correl
antijcv
igg
respons
conclus
jc
viruria
trigger
antibodi
respons
hsct
howev
increas
jcvspecif
cellular
immun
respons
month
hsct
lead
suppress
jc
viremia
decreas
jcv
humor
immun
respons
prospect
studi
hsct
patient
provid
model
provid
model
interact
host
immun
respons
viral
activ
multipl
compart
observ
lexic
retriev
impair
among
hiv
patient
consist
disrupt
frontalstriat
function
may
becom
compromis
sever
immunosuppress
howev
patient
demonstr
overt
neurobehavior
impair
purpos
current
studi
examin
whether
hiv
infect
confer
brain
function
chang
phonem
access
light
normal
neurobehavior
perform
twentyeight
particip
hiv
posit
hiv
seroneg
recruit
undergo
fmri
engag
word
retriev
task
neuroimag
data
analyz
use
fsl
immunosuppress
measur
use
current
count
result
signific
differ
hiv
hiv
group
overt
phonem
retriev
perform
howev
function
activ
differ
found
function
hiv
statu
hiv
individu
demonstr
greater
activ
basal
ganglia
structur
caudat
putamen
globu
pallidu
structur
compar
hivindividu
correct
z
valu
p
within
hiv
group
lower
count
associ
increas
activ
frontalstriat
region
find
consist
recent
fmri
studi
hivassoci
neurolog
impair
suggest
hiv
patient
hyperactiv
frontalstriat
network
compensatori
mechan
neurolog
compromis
background
hiv
patient
live
longer
consequ
highli
activ
antiretrovir
therapi
haart
howev
mani
hiv
individu
continu
cognit
impair
despit
medic
older
hiv
patient
may
increas
risk
develop
neurodegen
disord
method
studi
use
rest
state
function
connect
magnet
reson
imag
rsfcmri
noninvas
investig
neurobiolog
five
function
defin
brain
network
hiv
haart
hivcontrol
network
composit
score
comput
five
network
defaultmod
network
dmn
control
network
con
salienc
network
sal
dorsal
attent
network
dan
sensorimotor
network
smn
independ
chang
rsfcmri
due
hiv
age
assess
ancova
result
reduct
rsfcmri
correl
seen
within
dmn
con
sal
network
dan
smn
remain
rel
spare
compensatori
increas
correl
seen
within
network
neither
marker
hiv
hiv
viral
load
cell
count
degre
cognit
impair
associ
hiv
correl
rsfcmri
measur
age
led
decreas
correl
within
dmn
p
sal
network
hiv
hivsubject
howev
interact
present
hiv
age
conclus
result
suggest
hiv
age
caus
similar
decreas
rsfcmri
hiv
could
serv
model
acceler
neurodegener
within
brain
network
connect
longitudin
studi
older
hiv
patient
need
hivvpr
hippocampu
impair
novel
recognit
learn
lilith
torr
rj
noel
jr
email
litorr
stupsmedu
ponc
school
medicin
health
scienc
puerto
rico
ponc
school
medicin
health
scienc
puerto
rico
human
immunodefici
viru
hiv
infect
individu
may
increas
risk
develop
neurolog
abnorm
viral
protein
vpr
consid
caus
neuron
damag
may
play
role
hippocamp
loss
function
viral
protein
promot
activ
cellular
pathway
includ
apoptosi
immun
activ
vpr
known
proapoptot
neurotox
propos
hiv
vpr
involv
dysfunct
hippocampaldepend
learn
disrupt
neuron
integr
live
rat
test
novel
object
novel
locat
task
assess
hivvpr
effect
hippocampaldepend
learn
memori
control
rat
treat
gfp
show
increas
object
explor
rat
treat
vpr
show
impair
object
explor
expect
vprtreat
anim
show
learn
defici
correl
histopatholog
sign
neuron
disrupt
expect
vpr
neurotox
studi
well
help
clarifi
role
vpr
dcsign
may
prevent
earli
infect
human
neurotrop
polyomaviru
jc
jcv
induc
broad
rang
neuralorigin
tumor
experiment
anim
repeatedli
detect
sever
human
cancer
notabl
neuralcrest
origin
tumor
includ
medulloblastoma
glioblastoma
oncogen
activ
jcv
attribut
viral
earli
gene
product
larg
small
antigen
evid
result
vitro
cell
cultur
vivo
anim
studi
recent
shown
altern
splice
factor
capac
exert
neg
effect
transcript
splice
jcv
gene
glial
cell
direct
associ
specif
dna
motif
within
viral
promot
region
demonstr
asf
suppress
larg
antigen
express
jcvtransform
tumor
cell
line
express
asf
tumor
cell
therebi
inhibit
transform
capac
viral
tumor
antigen
moreov
downregul
viraltransform
tumor
cell
line
induc
growth
prolifer
tumor
cell
map
analysi
minim
peptid
domain
asf
respons
jcv
promot
silenc
tumor
suppressor
activ
suggest
amino
acid
residu
function
suffici
suppress
growth
tumor
cell
employ
genet
approach
identifi
function
domain
involv
suppress
jcv
transcript
chemic
approach
design
cyclic
peptid
base
nmr
solut
structur
peptid
platform
may
offer
novel
strategi
treatment
pml
support
grant
award
nih
kk
patient
undergo
immun
modulatori
therapi
treatment
autoimmun
diseas
multipl
sclerosi
individu
impairedimmun
system
notabl
aid
patient
high
risk
group
develop
progress
multifoc
leukoencephalopathi
pml
fatal
demyelin
diseas
white
matter
caus
human
neurotrop
polyomaviru
jcv
reactiv
immunosuppress
condit
replic
oligodendrocyt
lead
multifoc
demyelin
lesion
brain
previous
demonstr
cellular
altern
splice
factor
neg
regul
jcv
glial
cell
inhibit
splice
jcv
gene
also
show
strong
suppress
basal
transcript
viral
earli
late
promot
neg
impact
depend
abil
bind
specif
region
within
viral
promot
map
bp
repeat
region
viru
order
investig
import
second
bp
repeat
region
regul
jcv
gene
express
replic
creat
mutant
jcv
strain
one
bp
repeat
domain
also
serv
one
bind
site
surprisingli
larg
delet
within
viral
nccr
increas
rate
viral
earli
transcript
assess
report
gene
construct
howev
replic
effici
mutant
viru
similar
wild
type
viru
also
creat
mutant
strain
bind
site
transcript
replic
effici
mutant
viru
analyz
phfa
cell
interestingli
show
three
two
fold
higher
earli
promot
activ
respect
howev
mutant
viru
unabl
propag
phfa
cell
analys
transcript
mediat
mutant
promot
sequenc
reveal
defect
late
gene
transcript
support
grant
award
nih
kk
multipl
sclerosi
autoimmun
diseas
character
acut
inflamm
demyelin
viral
etiolog
suggest
possibl
contributor
pathogenesi
ms
either
method
link
molecular
mimicri
result
direct
effect
viral
entiti
studi
initi
develop
anim
model
experiment
allerg
encephalomyel
eae
util
transgen
tg
rat
incorpor
noninfecti
hiv
genom
method
induct
eae
hiv
tg
rat
wildtyp
wt
rat
inocul
guinea
pig
myelin
basic
protein
mbp
pertussi
toxin
pt
tg
wt
rat
inocul
mbp
alon
rat
evalu
day
sign
weak
level
disabl
measur
use
eae
score
weak
weak
limb
weak
leg
weak
result
day
postimmun
tg
rat
immun
mbp
pt
develop
mild
tail
paralysi
hind
limb
paralysi
day
subsequ
complet
recoveri
next
two
day
tg
rat
immun
mbp
alon
develop
mild
tail
paralysi
day
hind
limb
paralysi
day
quadriparesi
day
contrast
wt
rat
immun
mbp
pt
result
quadriparesi
day
death
day
wherea
wt
rat
immun
mbp
alon
develop
tail
weak
day
moribund
day
conclus
hiv
tg
rat
develop
less
sever
clinic
eae
wt
rat
diseas
sever
attenu
use
pt
immun
regimen
improv
observ
rat
immun
mbp
pt
may
analog
clinic
remiss
observ
patient
multipl
sclerosi
astrocyteelev
modul
astrocyt
respons
injuri
stress
possibl
role
reactiv
astrogliosi
neha
vartak
kathleen
borgmann
lin
tang
anuja
ghorpad
email
nvartak
liveunthscedu
univers
north
texa
health
scienc
center
unit
state
univers
north
texa
health
scienc
center
unit
state
univers
north
texa
health
scienc
center
unit
state
univers
north
texa
health
scienc
center
unit
state
astrocyt
elev
novel
human
immunodefici
viru
tumor
necrosi
factor
tnf
oncogen
engend
tremend
interest
field
cancer
research
therapeut
target
mani
metastat
aggress
tumor
howev
littl
known
role
regul
astrocyt
behavior
function
noncancer
condit
infect
brain
base
oncogen
role
cancer
investig
whether
induct
astrocyt
alter
respons
reactiv
astrogliosi
hallmark
cn
patholog
like
infect
trauma
ischemia
neurodegener
preliminari
studi
vivo
mous
model
reactiv
astrogliosi
reveal
signific
induct
express
follow
injuryinduc
astrogliosi
support
subsequ
vitro
studi
dramat
increas
nucleolar
local
protein
note
cultur
human
astrocyt
follow
injuri
andor
treatment
hydrogen
peroxid
induc
ro
hint
toward
plausibl
role
nucleolu
show
protect
astrocyt
oxid
stressinduc
dna
damag
play
role
astrocyt
recruit
injuri
increas
migratori
prolif
potenti
perform
dna
fragment
elisa
mtt
invitro
cell
migrat
assay
address
question
supplement
find
also
studi
correl
express
brain
age
one
mani
factor
respons
astrogliosi
diseasefre
condit
analyz
mrna
express
cohort
hivhuman
brain
mrna
sampl
within
age
group
year
conclus
studi
suggest
may
play
role
protect
human
astrocyt
oxid
damag
induc
reactiv
astrogliosi
increas
migratori
prolif
potenti
follow
injuri
hypocretinorexin
hcrtox
system
compos
hypothalam
peptid
relat
narcolepsyinsomnia
obes
motiv
behavior
relationship
hcrt
ox
level
dementia
unclear
recent
hypothalam
dysfunct
shown
associ
mood
disord
drug
abus
hivseroposit
patient
thu
studi
associ
csf
hcrtox
level
hivseroposit
women
histori
depend
cognit
function
retrospect
studi
hivseroposit
women
csf
control
patient
stratifi
smoke
habit
use
fagestrom
test
nicotin
depend
ftnd
urin
toxicolog
never
smoker
prior
smoker
smoker
smoker
marijuana
smoker
cocain
hand
determin
use
modifi
aan
hiv
dementia
criteria
differ
age
educ
viral
load
plasma
csf
current
nadir
hepat
c
viru
bmi
bdi
hand
observ
group
csf
hcrtox
level
determin
use
fluoresc
immunoassay
kit
phoenix
pharmaceut
intraand
interassay
valid
respect
parametr
non
parametr
statist
use
analysi
associ
observ
csf
hcrtox
level
hivseroposit
women
stratifi
smoke
drug
abus
correl
observ
csf
hcrtox
level
age
bdi
bmi
viral
immun
profil
ftnd
score
control
drug
abus
correl
observ
csf
hcrtox
level
hand
p
hiv
normal
group
lower
level
impair
group
neg
correl
observ
csf
hcrtox
level
npz
psychomotor
speed
verbal
memori
domain
p
find
suggest
csf
hcrtox
level
use
evalu
hivseroposit
women
drug
abus
depend
howev
may
role
hand
studi
perform
support
current
find
regardless
great
advanc
antiretrovir
therapi
hivassoci
neurocognit
disord
hand
persist
major
clinic
problem
hiv
infect
popul
sever
biochem
mechan
neuropathogenesi
hand
impli
still
identif
biomark
current
need
proper
balanc
sphingolipid
necessari
normal
neuron
function
level
ceramid
alter
sever
neurodegen
condit
includ
alzheim
diseas
hand
ceramid
consist
relat
neuron
dysfunct
neuron
death
hand
progress
howev
ceramid
might
also
alter
use
neurotox
drug
cocain
marijuana
studi
use
lipidom
approach
examin
level
respect
precursor
sphingomyelin
csf
hivseroposit
women
patient
test
marijuana
cocain
day
csf
collect
neg
marijuana
cocain
cognit
perform
determin
use
modifi
aan
criteria
stratifi
normal
cognit
asymptomat
impair
mcmd
hivassoci
dementia
interestingli
find
differ
sphingomyelinceramid
scce
ratio
analyz
patient
hand
analysi
patient
neg
toxicolog
reveal
three
sc
ce
ratio
lower
signific
p
regardless
hand
patient
test
posit
marijuana
cocain
consist
lower
level
three
scce
ratio
higher
level
ce
neg
toxicolog
p
cocain
alter
scce
ratio
present
use
drug
abus
howev
subacut
effect
drug
abus
lipid
metabol
may
occur
earlier
hand
propos
perform
toxicolog
test
studi
lipidom
biomark
hand
sinc
proper
balanc
sphingolipid
might
alter
use
specif
drug
patient
ms
investig
presenc
specif
ocb
isoelectr
focus
affin
immunoblot
csf
antibodi
chemiluminescencebas
immunoassay
patient
ms
find
correl
viral
dna
detect
csf
nest
pcr
diseas
activ
assess
contrast
enhanc
mri
lesion
cel
nine
ms
patient
specif
ocb
five
dna
csf
dna
csf
associ
low
level
antibodi
csf
patient
dna
csf
significantli
cel
patient
specif
ocb
dna
csf
addit
cel
found
often
mri
patient
posit
dna
csf
sever
lesion
burden
also
invers
associ
antibodi
csf
result
suggest
intrathec
produc
antibodi
present
virusspecif
ocb
might
play
role
maintain
latenc
limit
dissemin
reactiv
cn
patient
undetect
low
level
antibodi
might
therefor
prone
reactiv
latent
viru
cn
seen
viral
dna
csf
might
lead
consequ
inflamm
hallmark
activ
plaqu
ms
brain
tissu
methamphetamin
use
exacerb
hivassoci
neurocognit
impair
acut
earli
hiv
infect
methamphetamin
use
risk
factor
hiv
infect
comorbid
present
associ
addit
structur
function
injuri
frontostriat
neural
circuitri
includ
neurocognit
impair
yet
littl
known
role
express
neurocognit
compromis
acut
earli
stage
hiv
infect
aeh
associ
rapid
viral
replic
increas
immun
activ
alter
brain
metabol
present
studi
examin
impact
use
hivassoci
neurocognit
impair
hnci
among
adult
median
durat
infect
day
current
count
particip
administ
brief
neurocognit
batteri
adjust
demograph
assess
execut
function
memori
psychomotor
speed
verbal
fluenci
sixtyon
percent
particip
evidenc
hnci
determin
global
deficit
score
gd
particip
also
administ
drug
abus
screen
test
use
alcohol
use
disord
identif
test
audit
spearman
rho
correl
reveal
moder
relationship
dast
total
gd
wherebi
individu
greater
risk
use
disord
exhibit
lower
neurocognit
function
particularli
fine
motor
coordin
within
small
subset
particip
underw
lumbar
punctur
dast
total
correl
trend
level
viral
load
csf
plasma
p
alcohol
use
associ
neurocognit
function
viral
load
ps
result
suggest
use
may
play
import
role
risk
neurocognit
impair
increas
hiv
rna
csf
aeh
neural
mechan
appar
exacerb
cn
injuri
aeh
remain
determin
may
involv
dopaminerg
system
vulner
effect
neuroinflamm
vasculopathi
andor
oxid
stress
previous
report
chronic
infect
user
intrarect
intravagin
fortythre
monkey
becam
virem
develop
aid
monkey
aid
develop
giant
cell
enceph
sive
rapid
progressor
phenotyp
evid
adapt
util
coreceptor
coreceptor
switch
observ
macaqu
sive
previou
studi
demonstr
high
level
viral
replic
sustain
macrophag
anim
underw
coreceptor
switch
late
diseas
consequ
abil
adapt
viru
bind
effici
sive
lesion
present
gray
white
matter
cerebrum
cerebellum
brainstem
affect
anim
lesion
compris
viral
infect
macrophag
accompani
robust
astrogli
microgli
activ
character
upregul
gfap
respect
interest
four
macaqu
greatest
amount
viru
macrophagemicrogli
activ
brain
inocul
mucos
either
intrarect
intravagin
summari
rhesu
macaqu
provid
new
robust
model
hiv
enceph
contribut
better
understand
viral
tropism
brain
addit
coreceptor
adapt
may
play
import
role
lentivir
neuropathogenesi
melissa
whiteman
alan
barrett
email
mcwhitem
utmbedu
univers
texa
medic
branch
unit
state
univers
texa
medic
branch
unit
state
japanes
enceph
je
viru
mosquitoborn
positivesens
rna
viru
member
genu
flaviviru
famili
flavivirida
je
serocomplex
includ
west
nile
wn
st
loui
enceph
murray
valley
enceph
virus
among
other
je
lead
caus
viral
enceph
worldwid
caus
signific
morbid
mortal
case
report
annual
studi
neuropathogenesi
je
viru
strain
inocul
mice
via
intraperiton
rout
mous
model
brief
viremia
follow
invas
central
nervou
system
cross
bloodbrain
barrier
undetermin
mechan
variou
time
point
brain
harvest
formalin
fix
paraffin
embed
slide
prepar
je
viru
antigen
found
throughout
brain
includ
neuron
endotheli
cell
astrocyt
neuropatholog
alter
includ
hemorrhag
perivascular
infiltr
observ
previou
vivo
studi
je
wn
virus
shown
mortal
follow
neuroinvas
diseas
correl
high
viremia
titer
wherea
mice
low
undetect
viremia
show
clinic
sign
diseas
detect
viru
brain
examin
mous
brain
harvest
earli
late
time
point
je
infect
shed
light
neuropathogenesi
diseas
human
immunodefici
viru
hiv
enter
central
nervou
system
cn
earli
primari
infect
result
deficit
known
hand
hiv
associ
neurocognit
disord
hiv
infect
individu
despit
success
combin
antiretrovir
therapi
monocyt
critic
cell
involv
hand
bring
viru
cn
upon
transmigr
across
blood
brain
barrier
bbb
mechan
monocyt
transmigr
across
bbb
fulli
understood
propos
facilit
junction
protein
alcam
jama
subset
circul
matur
monocyt
surfac
increas
hiv
infect
individu
accumul
brain
hand
monocyt
subset
highli
suscept
hiv
infect
found
harbor
viral
dna
develop
cultur
system
enrich
subpopul
show
monocyt
preferenti
transmigr
across
vitro
model
human
bbb
respons
potent
monocyt
chemoattract
elev
cn
hiv
infect
individu
hand
demonstr
monocyt
higher
surfac
express
alcam
jama
rel
may
promot
preferenti
entri
cn
upon
hiv
infect
increas
transmigr
subpopul
across
bbb
respons
compar
uninfect
cell
high
level
infect
disrupt
bbb
integr
block
antibodi
alcam
jama
inhibit
transmigr
uninfect
hiv
infect
monocyt
baselin
level
suggest
import
facilit
monocyt
transmigr
across
bbb
target
increas
junction
protein
present
matur
hiv
infect
monocyt
preferenti
infiltr
cn
repres
novel
therapeut
strategi
may
reduc
ongo
chronic
neuroinflamm
occur
hand
macrophag
microglia
thought
play
promin
role
develop
hivassoci
neuron
damag
toxic
action
receiv
consider
attent
also
grow
appreci
potenti
benefici
effect
macrophag
chang
phenotyp
abil
control
macrophag
action
import
therapeut
implic
littl
known
condit
support
develop
wide
vari
phenotyp
recent
work
lab
document
express
neurotrophin
receptor
nerv
growth
factor
ngf
receptor
tropomyosinreceptor
kinas
trka
human
monocytederiv
macrophag
human
monocyt
exposur
macrophag
hiv
virion
induc
secret
neurotoxin
suppress
secret
sever
growth
factor
addit
natur
ligand
ngf
macrophag
result
widespread
chang
profil
secret
protein
decreas
hivinduc
neurotoxin
product
effect
mimick
experiment
neurotrophin
ligand
select
target
promot
widespread
chang
protein
express
includ
tgfassoci
protein
tnfa
mmp
variou
growth
factor
suppress
toxin
product
also
seen
blockad
wortmannin
endosom
acidif
chloroquin
wherea
block
activ
gadolinium
result
small
suppress
ngf
increas
phosphoakt
macrophag
increas
could
account
protect
effect
blockad
trka
activ
enhanc
toxic
activ
medium
suggest
neurotrophin
signal
may
play
activ
role
toxic
outcom
togeth
data
show
macrophag
express
function
neurotrophin
receptor
control
activ
may
offer
new
therapeut
target
control
inflammatori
damag
support
nimh
grant
singl
nucleotid
polymorph
within
ltr
correl
use
drug
drexelm
hivaid
genet
analysi
cohort
hiv
infect
preval
among
substanc
abus
howev
effect
illicit
drug
diseas
progress
well
establish
evalu
relationship
illicit
drug
use
diseas
progress
patient
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
histori
illicit
drug
alcohol
medic
use
cell
count
viral
load
perform
approxim
everi
month
drug
abus
common
cohort
patient
admit
past
use
current
abus
drug
test
posit
drug
use
time
visit
cocain
marijuana
use
heavili
favor
drugus
patient
admit
past
current
cocain
use
admit
marijuana
use
patient
use
multipl
drug
simultan
cohort
categor
nonus
pn
cocain
preferenti
pc
user
cannabinoid
preferenti
pm
user
multidrug
user
nonus
like
remain
haart
wherea
pc
pm
less
like
respect
drug
user
exhibit
lower
current
cell
count
lower
nadir
cell
higher
current
viral
load
higher
peak
viral
load
nonus
addit
singl
nucleotid
polymorph
snp
uniqu
cocain
marijuana
nonus
identifi
conclus
illicit
drug
use
appear
facilit
diseas
progress
select
genet
variat
uniqu
monoand
multius
hivaid
patient
cohort
cooper
role
regul
jcv
abstract
human
polyomaviru
jc
jcv
etiolog
agent
rare
devast
neurolog
diseas
progress
multifoc
leukoencephalopathi
global
preval
infect
jcv
high
jcv
believ
persist
latent
state
primari
infect
even
though
jcv
common
popul
pml
extrem
rare
suggest
viru
tightli
regul
cellmedi
immun
previous
laboratori
other
shown
jcv
promot
transcript
activ
regul
multipl
transcript
factor
provid
evid
jc
viru
promot
activ
goe
anoth
level
regul
epigenet
event
involv
protein
acetyl
found
histon
deacetylas
inhibitor
profoundli
stimul
transcript
earli
late
jc
viru
promot
transient
transfect
experi
stabl
earli
late
report
cell
line
suggest
acetyl
statu
histon
may
classifi
major
group
activ
inflamm
inact
less
inflamm
furthermor
activ
patient
present
two
differ
clinic
cours
rapidli
progress
slowli
progress
inact
patient
clinic
lessor
nonprogress
classif
might
use
determin
therapeut
strategi
patient
hamtsp
cocainemedi
upregul
glial
fibillari
acid
protein
role
earli
growth
respons
gene
lu
yang
honghong
yao
crystal
bethelbrown
email
luyang
unmcedu
unmc
unit
state
unmc
unit
state
unmc
unit
state
astrocyt
special
glial
cell
make
cn
cellular
popul
respons
neural
injuri
viral
infect
substanc
abus
though
process
refer
reactiv
astrogliosi
process
character
enhanc
glial
fibrillari
acid
protein
gfap
express
cellular
hypertrophi
astrocyt
prolifer
howev
rel
studi
design
specif
access
effect
cocain
astrocyt
activ
dysfunct
also
cellular
molecular
mechan
underli
process
still
complet
defin
investig
role
cocain
trigger
quiescent
astrocyt
reactiv
astrocyt
detect
express
level
chang
gfap
vitro
vivo
cultur
astrocyt
exposur
rat
human
astrocyt
cocain
result
induct
gfap
mrna
protein
level
cell
use
receptor
antagonist
demonstr
cocain
induc
gfap
express
astrocyt
bind
cognat
receptor
also
provid
evid
cocaineinduc
gfap
express
activ
jnk
signal
pathway
use
select
pharmacolog
inhibitor
furthermor
effect
regul
activ
downstream
transcript
factor
earlygrowth
respons
vivo
studi
show
gfap
express
increas
within
week
cocain
inject
mous
togeth
enhanc
asctrocyt
prolifer
upregul
result
indic
cocain
could
activ
astrocyt
induc
gfap
express
effect
mediat
cognat
receptor
activ
mapk
depend
pathway
downstream
transcript
factor
understand
regul
gfap
express
may
provid
insight
develop
potenti
therapeut
target
neuroinflamm
associ
drug
abus
xiaoli
yu
scott
seitz
lingjia
hu
randal
cohr
ravi
mahalingam
gilden
email
xiaolilyu
ucdenveredu
univers
colorado
denver
unit
state
univers
colorado
denver
unit
state
univers
colorado
denver
unit
state
univers
colorado
denver
unit
state
univers
colorado
denver
unit
state
univers
colorado
denver
unit
state
primari
varicellazost
viru
vzv
infect
human
produc
varicella
chickenpox
viru
becom
latent
ganglion
neuron
analysi
physic
state
viral
nucleic
acid
viru
gene
express
latenc
requir
postmortem
acquisit
fresh
human
ganglia
develop
vitro
model
vzv
infect
human
neuron
obtain
highli
pure
termin
differenti
human
neuron
deriv
induc
pluripot
stem
cell
cellular
dynam
intern
infect
cellfre
vzv
zostavax
vaccin
fourteen
day
infect
cell
appear
normal
compar
human
fetal
lung
fibroblast
hfl
develop
cytopath
effect
cpe
less
week
vzv
infect
neither
tissu
cultur
medium
homogen
prepar
vzvinfect
neuron
produc
cpe
hfl
presenc
vzv
genom
infect
neuron
confirm
qpcr
use
vzv
primer
orf
million
copi
vzv
genom
per
ng
nucleic
acid
detect
infect
neuron
nonproduct
infect
neuron
also
examin
presenc
transcript
correspond
vzv
orf
four
transcript
found
copi
number
orf
abund
vzv
transcript
latent
infect
human
ganglia
time
higher
orf
abund
vzv
transcript
product
infect
cell
model
provid
uniqu
vitro
system
studi
vzvneuron
relationship
potenti
investig
mechan
vzv
reactiv
regulatori
cell
treg
cerebrospin
fluid
aidsassoci
cryptococc
mening
share
focusedt
cell
receptor
tcr
repertoir
classic
cell
exert
profound
inhibitori
effect
cell
prolifer
andr
f
zeavera
carlo
pardo
beatriz
parra
email
gmailcom
universidad
del
vall
colombia
john
hopkin
univers
unit
state
universidad
del
vall
colombia
background
treg
accumul
within
cn
opportunist
infect
cnsoi
thought
treg
induc
oi
cytokin
antigendriven
cell
classic
effector
cell
induc
treg
share
similar
tcr
repertoir
cell
determin
treg
csf
part
specif
immun
respons
cnsoi
assess
tcr
repertoir
modulatori
function
materi
method
treg
tcr
vb
chain
repertoir
phenotyp
flow
cytometri
fc
csf
blood
sampl
six
patient
aid
cryptococc
mening
cm
variabl
beta
vb
chain
famili
cover
tcr
repertoir
assess
csf
treg
inhibitori
effect
cell
prolifer
test
use
cocultur
purifi
treg
stimul
cell
label
carboxyfluorescein
succinimdyl
ester
quantifi
cellular
divis
fc
result
tcr
profil
treg
csf
mirror
vb
pattern
cell
compar
tcr
repertoir
blood
vb
chain
frequent
util
cell
csf
suggest
specif
recruit
expans
within
cn
contrast
tcr
repertoir
cell
judg
cell
differ
treg
cell
csf
least
one
vb
chain
common
use
cell
subpopul
csf
regulatori
effect
treg
csf
cell
prolifer
higher
cerebr
cell
compar
cell
contrast
cell
subset
blood
inhibit
treg
isol
csf
compart
conclus
studi
provid
evid
antigeninduc
origin
treg
traffick
csf
aidsassoci
cm
patient
reveal
immun
inhibitori
capabl
lt
critic
control
cm
postsynapt
membran
investig
site
action
studi
effect
spontan
electr
evok
mini
excitatori
postsynapt
current
mepsc
region
rat
hippocamp
slice
bath
perfus
significantli
reduc
spontan
mepsc
frequenc
without
chang
mepsc
amplitud
analysi
reveal
reduc
mean
quantal
content
taken
togeth
result
indic
inhibit
ltp
presynat
mechan
ltp
wide
consid
synapt
mechan
learn
memori
inhibit
ltp
may
contribut
hand
pathogenesi
antijcv
neutral
antibodi
potenti
therapi
treatment
pml
jc
polyomaviru
jcv
caus
agent
demyelin
diseas
central
nervou
system
progress
multifoc
leukoencephalopathi
pml
incid
pml
relat
prior
exposur
jc
viru
alter
immun
system
consequ
hivaid
certain
hematolog
malign
use
immunomodulatori
drug
current
specif
antivir
therapi
proven
effect
treatment
pml
jcv
common
pathogen
human
roughli
popul
seroposit
antijcv
antibodi
activ
shed
viru
urin
suggest
asymptomat
infect
urogenit
track
date
approxim
viru
isol
cn
pml
patient
contain
mutat
protein
never
observ
urin
isol
healthi
pml
afflict
patient
exact
role
mutat
current
unknown
distinct
chang
may
alter
receptor
tropism
may
repres
mechan
immun
escap
loss
recognit
neutral
antibodi
describ
bind
neutral
properti
monoclon
antibodi
jc
viru
capsid
protein
determin
affin
specif
antibodi
use
viru
like
particl
wild
type
variou
mutant
isol
pml
patient
furthermor
establish
neutral
capac
antibodi
inhibit
infect
wild
type
virus
virus
contain
pmlassoci
mutant
invitro
assay
model
serum
parenchym
antibodi
concentr
human
neutral
antibodi
perform
base
pharmacokinet
profil
mice
model
suggest
human
dose
antibodi
time
pml
diagnosi
may
offer
protect
window
limit
viral
spread
immun
reconstitut
occur
remov
underli
immunosuppress
discoveri
antibodi
success
abl
neutral
wide
rang
jcv
genotyp
may
provid
potenti
treatment
pml
